{"title":"Hematology \/ Oncology","description":"Hematology and Oncology courses","products":[{"product_id":"2023-psychopharmacology-in-cancer-care","title":"2023 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines","description":"\u003ch2\u003e\u003cspan style=\"font-size: 22px;\"\u003eSpecialties\u003c\/span\u003e\u003c\/h2\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Behavioral Care, Critical Care, General and Family Practice, Geriatric Medicine, Hematology, Integrative Medicine, Internal Medicine, Medical Oncology, Neurology, Nurse Anesthetist, Nurse Practitioner, Nursing, Pain Medicine, Psychiatry, Psychology, Social Work\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003e2023 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines Clinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. \u003cstrong\u003ePsychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however, psychiatric syndromes are often underdiagnosed and undertreated.\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e \u003c\/strong\u003eFew oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses, and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.\u003cbr\u003e\u003cbr\u003eThis course is \u003cstrong\u003edesigned for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology\u003c\/strong\u003e. Oncologists, palliative care clinicians, advanced practice nurses, and oncology nurses will find this course useful as well. The course will \u003cstrong\u003efocus on key target disorders and symptoms amenable to psychopharmacological intervention\u003c\/strong\u003e, including anxiety, depression, delirium, sleep disturbance, pain, fatigue, and weight and appetite loss.\u003cbr\u003e\u003cbr\u003eThe course will also include \u003cstrong\u003eupdates on COVID-19-related delirium and the use of novel interventions\u003c\/strong\u003e including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain. Participants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e2023 Program Highlights\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis year’s program includes topics on:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDepressive Disorders \u003c\/strong\u003e(Andrew Roth, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDelirium\u003c\/strong\u003e (William Breitbart, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnxiety Disorders \u003c\/strong\u003e(Andrew Roth, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSleep Disorders\u003c\/strong\u003e (Yesne Alici, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer-Related Fatigue\u003c\/strong\u003e (William Breitbart, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePain\u003c\/strong\u003e (Natalie Moryl, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeight and Appetite Loss \u003c\/strong\u003e(Yesne Alici, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer and Cancer-Treatment Related Cognitive Changes \u003c\/strong\u003e(Yesne Alici, MD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNovel Psychopharmacologic Interventions in Oncology\u003c\/strong\u003e (Christian Bjerre Real, MD, MMCI, FAPA)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eAdditionally, there will be ample time during program breaks to meet the faculty and ask questions. \u003ca href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/data\/Psychopharm_2023_Brochure.pdf\" rel=\"noopener\" target=\"_blank\"\u003eView the course brochure.\u003c\/a\u003e\n\u003cbr\u003e\u003ch4 class=\"activitysectionbold\"\u003eObjectives\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003eDescribe basic psycho-pharmaco-oncology principles for understanding and treating anxiety, depression and delirium in people with cancer.\u003c\/li\u003e\n\u003cli\u003eDiscuss basic psycho-pharmaco-oncology principles for understanding and improving quality of life and psychiatric palliative care in people with cancer, including managing cognitive changes, insomnia, fatigue, poor appetite and weight loss, and pain.\u003c\/li\u003e\n\u003cli\u003eIdentify the nuances of psycho-pharmaco-oncology related to COVID-19 related delirium and the use of novel interventions including ketamine, medical marijuana, and psilocybin for depression, anxiety, and pain in people with cancer.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47486752587930,"sku":"MED-AMB00239","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/40PhotoFixerBot_18-08-46_UTC.jpg?v=1772063534"},{"product_id":"2023-critical-care-oncology-symposium","title":"2023 Critical Care Oncology Symposium – On Demand","description":"\u003cdiv class=\"prod-format\"\u003e\n\u003ch3\u003e2023 Critical Care Oncology Symposium – On Demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col s12 m12 l6 xl6\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003ch4 class=\"activitysectionbold\"\u003eOverview\u003c\/h4\u003e\n\u003ch4 class=\"activitysectionbold\"\u003eThis annual Symposium is designed to \u003cstrong\u003eprovide a general overview of various critical care and oncology topics\u003c\/strong\u003e, including oncologic emergencies, ethical dilemmas, ARDS, and cardiovascular compromise in the critical care setting. The target audience for this Symposium includes nurse practitioners, physician assistants, nurses, respiratory therapists, physicians, and other healthcare professionals interested in critical care.\u003c\/h4\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eThis on demand includes recorded lectures from the Symposium and PDF’s of the speakers’ slides. 2023 lectures include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e(Aspects of) Central Venous Catheter Infections – Peter Mead, MD\u003c\/li\u003e\n\u003cli\u003eWhat Makes Your Patient Hypercapnic? – Elena Mead, MD\u003c\/li\u003e\n\u003cli\u003eKeep Calm \u0026amp; Carry Onc: Emergencies and How to Treat Them – Nicole Kuhnly, AGACNP-BC\u003c\/li\u003e\n\u003cli\u003eEthics in the ICU: Are We Doing the Right Thing? – Deborah Stein, ACNP-BC\u003c\/li\u003e\n\u003cli\u003eCardiovascular Emergencies in Cancer Patients – Kristin Jang, DO\u003c\/li\u003e\n\u003cli\u003eCerebral Vein and Dural Sinus Venous Thrombosis – Andrew Zhu, PA-C\u003c\/li\u003e\n\u003cli\u003eICU Design Evolution Over the Last Four Decades with a Peak into the Future – Neil Halpern, MD\u003c\/li\u003e\n\u003cli\u003eVentilator Emergencies – Ryan Sieli, MD\u003c\/li\u003e\n\u003cli\u003eYou Certainly Have SOMETHING: Diagnosing the Critically Ill – Brandon Oto, PA-C, FCCM\u003c\/li\u003e\n\u003cli\u003eOverview of Hyponatremia – Emad Alahiri, MD\u003c\/li\u003e\n\u003cli\u003eManaging RV Failure in the ICU – Callie Tennyson, DNP, ACNP-BC\u003c\/li\u003e\n\u003cli\u003eHuman Factors in Critical Care: Embracing Vulnerability for High Performance – Scott Tilton, DNP, AGACNP-BC, CCRN\u003c\/li\u003e\n\u003cli\u003eA Spoonful of Sugar: Hypoglycemia in the Critically Ill – Leon Chen, DNP, AGACNP-BC, FCCM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe diagnosis and management of hypoglycemic patients\u003c\/li\u003e\n\u003cli\u003eIdentify common ethical dilemmas when caring for the critically ill patient\u003c\/li\u003e\n\u003cli\u003eDelineate types of hyponatremia and corresponding treatment algorithms\u003c\/li\u003e\n\u003cli\u003eHighlight causes of hemodynamic compromise and cardiovascular emergencies in the oncology population\u003c\/li\u003e\n\u003cli\u003eRecognize the ICU design elements that have evolved over last 4 decades\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cbr\u003e\u003cbr\u003eSYllabus\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eAspects of Central Venous Catheter Infections\u003c\/strong\u003e\u003cbr\u003e8:05AM – 8:35AM\u003cbr\u003ePeter Mead, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/DSguLqnX-rJxcxg6G.js\u0026amp;VideoID=DSguLqnX\"\u003e\u003cimg alt=\"Aspects of Central Venous Catheter Infections - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53632\/01_MeadPeter_Central%20Venous%20Catheter%20Infections.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Aspects of Central Venous Catheter Infections - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eWhat Makes Your Patient Hypercapnic?\u003c\/strong\u003e\u003cbr\u003e8:35AM – 9:10AM\u003cbr\u003eElena Mead, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/kxIPD5tv-rJxcxg6G.js\u0026amp;VideoID=kxIPD5tv\"\u003e\u003cimg alt=\"What Makes Your Patient Hypercapnic? - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53633\/02_MeadElena_Patient%20Hypercapnic.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"What Makes Your Patient Hypercapnic? - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eKeep Calm \u0026amp; Carry Onc: Emergencies and How to Treat Them\u003c\/strong\u003e\u003cbr\u003e9:10AM – 9:40AM\u003cbr\u003eNicole Kuhnly, ACNPC-AG\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/QYwHpK8J-rJxcxg6G.js\u0026amp;VideoID=QYwHpK8J\"\u003e\u003cimg alt=\"Keep Calm \u0026amp; Carry Onc: Emergencies and How to Treat Them - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53634\/03_Kuhnly_Emergencies%20and%20How%20to%20Treat%20Them.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Keep Calm \u0026amp; Carry Onc: Emergencies and How to Treat Them - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eEthics in the ICU: Are We Doing the Right Thing?\u003c\/strong\u003e\u003cbr\u003e9:40AM – 10:10AM\u003cbr\u003eDeborah E Stein, NP\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/ZkfCUbfh-rJxcxg6G.js\u0026amp;VideoID=ZkfCUbfh\"\u003e\u003cimg alt=\"Ethics in the ICU: Are We Doing the Right Thing? - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53635\/04_Stein_Ethics%20in%20the%20ICU.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Ethics in the ICU: Are We Doing the Right Thing? - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCardiovascular Emergencies in Cancer Patients\u003c\/strong\u003e\u003cbr\u003e10:20AM – 10:50AM\u003cbr\u003eKristin Jang, DO\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/nb2flhGD-rJxcxg6G.js\u0026amp;VideoID=nb2flhGD\"\u003e\u003cimg alt=\"Cardiovascular Emergencies in Cancer Patients - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53636\/05_Jang_Cardiovascular%20Emergencies.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Cardiovascular Emergencies in Cancer Patients - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eCerebral Vein and Dural Sinus Venous Thrombosis\u003c\/strong\u003e\u003cbr\u003e10:50AM – 11:20AM\u003cbr\u003eAndrew Zhu, PA-C\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/UlCQ0BYo-rJxcxg6G.js\u0026amp;VideoID=UlCQ0BYo\"\u003e\u003cimg alt=\"Cerebral Vein and Dural Sinus Venous Thrombosis - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53637\/06_Zhu_Dural%20Sinus%20Venous%20Thrombosis.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Cerebral Vein and Dural Sinus Venous Thrombosis - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eICU Design Evolution Over the Last Four Decades with a Peak into the Future\u003c\/strong\u003e\u003cbr\u003e11:20AM – 12:00PM\u003cbr\u003eNeil A Halpern, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/8pB6JscU-rJxcxg6G.js\u0026amp;VideoID=8pB6JscU\"\u003e\u003cimg alt=\"ICU Design Evolution Over the Last Four Decades with a Peak into the Future - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53638\/07_Halpern_ICU%20Design%20Evolution.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"ICU Design Evolution Over the Last Four Decades with a Peak into the Future - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eVentilator Emergencies\u003c\/strong\u003e\u003cbr\u003e1:00PM – 1:35PM\u003cbr\u003eRyan J Sieli, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/4ZpAWz56-rJxcxg6G.js\u0026amp;VideoID=4ZpAWz56\"\u003e\u003cimg alt=\"Ventilator Emergencies - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53639\/08_Sieli_Ventilator%20Emergencies.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Ventilator Emergencies - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eYou Certainly Have SOMETHING: Diagnosing the Critically Ill\u003c\/strong\u003e\u003cbr\u003e1:35PM – 2:05PM\u003cbr\u003eBrandon Oto, PA-C, FCCM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/Fxye4EB7-rJxcxg6G.js\u0026amp;VideoID=Fxye4EB7\"\u003e\u003cimg alt=\"You Certainly Have SOMETHING: Diagnosing the Critically Ill - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53640\/09_Oto_Diagnosing%20the%20Critically%20Ill.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"You Certainly Have SOMETHING: Diagnosing the Critically Ill - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eOverview of Hyponatremia\u003c\/strong\u003e\u003cbr\u003e2:05PM – 2:40PM\u003cbr\u003eEmad Alahiri, MD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/b0VSvZso-rJxcxg6G.js\u0026amp;VideoID=b0VSvZso\"\u003e\u003cimg alt=\"Overview of Hyponatremia - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53641\/10_Alahiri_%20Hyponatremia.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Overview of Hyponatremia - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eManaging RV Failure in the ICU\u003c\/strong\u003e\u003cbr\u003e2:40PM – 3:10PM\u003cbr\u003eCallie Tennyson, DNP, ACNP-BC, AACC, CHSE\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/RS54zGCB-rJxcxg6G.js\u0026amp;VideoID=RS54zGCB\"\u003e\u003cimg alt=\"Managing RV Failure in the ICU - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53642\/11_Tennyson_Right%20Ventricular%20Failure%20.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Managing RV Failure in the ICU - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eHuman Factors in Critical Care: Embracing Vulnerability for High Performance\u003c\/strong\u003e\u003cbr\u003e3:10PM – 3:40PM\u003cbr\u003eScott Tilton , DNP, AGACNP-BC, CCRN\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/JkN69WJm-rJxcxg6G.js\u0026amp;VideoID=JkN69WJm\"\u003e\u003cimg alt=\"Human Factors in Critical Care: Embracing Vulnerability for High Performance - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53643\/12_Tilton_Human%20Factors%20in%20Critical%20Care.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"Human Factors in Critical Care: Embracing Vulnerability for High Performance - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\n\u003cstrong\u003eA Spoonful of Sugar: Hypoglycemia in the Critically Ill\u003c\/strong\u003e\u003cbr\u003e3:40PM – 4:10PM\u003cbr\u003eLeon Chen, DNP, FCCP, FAANP, FCCM\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\n\u003ca class=\"launcher image-link\" data-fancybox-type=\"iframe\" href=\"https:\/\/mskcc.cloud-cme.com\/LightBoxViewer.aspx?VideoLink=\/\/Content.jwplatform.com\/players\/QJjOH9vv-rJxcxg6G.js\u0026amp;VideoID=QJjOH9vv\"\u003e\u003cimg alt=\"A Spoonful of Sugar: Hypoglycemia in the Critically Ill - Video\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/video.png?v=1770128033\"\u003e\u003c\/a\u003e \u003ca class=\"image-link\" href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/Presentations\/53644\/13_Chen_Hypoglycemia%20in%20ICU.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cimg alt=\"A Spoonful of Sugar: Hypoglycemia in the Critically Ill - PDF\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pdf.png?v=1770128036\"\u003e\u003c\/a\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"6u 12u(small)\"\u003e\n\u003cdiv class=\"boxAgendaTitle\"\u003eTuesday, April 25, 2023\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47486915543194,"sku":"MED-AMB00275","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/40PhotoFixerBot_17-26-45_UTC.jpg?v=1772064159"},{"product_id":"msk-symposium-on-lymphoma","title":"7th Annual MSK Symposium on Lymphoma – On Demand 2023","description":"The \u003cstrong\u003e7th Annual MSK Symposium on Lymphoma\u003c\/strong\u003e features updated information on lymphoma biology, diagnosis, and ongoing efforts to translate scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes from world-renowned experts.\u003cbr\u003e\u003ch2\u003eVideos+PDF\u003c\/h2\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003ch2 class=\"activitysectionbold\"\u003eSpecialties\u003c\/h2\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Anatomic Pathology, Bone Marrow Transplant, Clinical Pathology, Geriatric Medicine, Hematology, Hematopathology, Immunotherapy, Internal Medicine, Laboratory Medicine, Lymphoma, Medical Oncology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eOverview\u003c\/div\u003e\u003cbr\u003eThe \u003cstrong\u003e7th Annual MSK Symposium on Lymphoma\u003c\/strong\u003e features updated information on lymphoma biology, diagnosis, and ongoing efforts to translate scientific discoveries into novel treatment strategies for a variety of lymphoma subtypes from world-renowned experts.\u003cbr\u003e\u003cbr\u003eThis year, the \u003cstrong\u003eclinical management of the most frequent lymphoma entities \u003c\/strong\u003eare addressed and \u003cstrong\u003efocused sessions related to new families of drugs being developed \u003c\/strong\u003ein these areas as well as in less common presentations are part of the program. Other highlights of this program include coverage of recent advances in the biology of lymphoma and how these will translate to innovative therapeutic interventions and panel discussions on how to best approach patients’ situations.\u003cbr\u003e\u003cbr\u003eThis on demand includes 15+ recorded lectures, along with select PDF versions of the speakers’ slides, from the live Symposium on May 5-6, 2023. Highlights of this on demand offering include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAccess to both breakout sessions from the live Symposium: \u003cstrong\u003eScience in Progress \u003c\/strong\u003eas well as the \u003cstrong\u003eNursing Professional Development\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eAccess to both the breakfast Symposium on \u003cstrong\u003eChronic Lymphocytic Leukemia \u003c\/strong\u003eas well as the luncheon session on \u003cstrong\u003eWhat’s new in Multiple Myeloma\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eA plenary lecture from \u003cstrong\u003eDr. Louis Staudt \u003c\/strong\u003eon\u003cstrong\u003e Precision Medicine in Diffuse Large B-cell lymphoma\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eSpecial sessions on \u003cstrong\u003eLymphoma Classifications\u003c\/strong\u003e, \u003cstrong\u003eInterpreting Real Life Data\u003c\/strong\u003e, \u003cstrong\u003eLate Effects of Therapy\u003c\/strong\u003e, and \u003cstrong\u003eCAR T cells: Update on Eligibility and Toxicity\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eBrochure\u003cbr\u003e\u003cbr\u003e\u003cspan style=\"color: #3366ff;\"\u003e\u003ca href=\"https:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/data\/Lymphoma2023_Brochure.pdf\" style=\"color: #3366ff;\"\u003ehttps:\/\/mskcc.cloud-cme.com\/Assets\/mskcc\/data\/Lymphoma2023_Brochure.pdf\u003c\/a\u003e\u003c\/span\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47486924456090,"sku":"MED-AMB00276","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/5940421880903221808_121.jpg?v=1772064179"},{"product_id":"geriatric-oncology-for-the-advanced","title":"Geriatric Oncology for the Advanced Practice Provider: Impacting Care Across the Globe – On Demand 2023","description":"\u003cdiv class=\"prod-format\"\u003e\n\u003ch3\u003eGeriatric Oncology for the Advanced Practice Provider: Impacting Care Across the Globe – On Demand 2023\u003c\/h3\u003e\n\u003cbr\u003eAging is a risk factor for the development of cancer.As the United States population ages, \u003cstrong\u003ethe need for clinicians skilled in the care of older adults with cancer will increase\u003c\/strong\u003e. Research however suggests that \u003cstrong\u003ecommon geriatric syndromes and many psychosocial needs of older adult oncology patients are often unintentionally overlooked or under-addressed\u003c\/strong\u003e.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col s12 m12 l6 xl6\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch2\u003eVideos+PDF\u003c\/h2\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e19 videos + 17 pdfs, size: 4.7 GB\u003c\/h2\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003ch3 class=\"activitysectionbold\"\u003eSpecialties\u003c\/h3\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Allergy and Immunology, Anesthesiology, Bone Marrow Transplant, Breast Medical Oncology, Breast Surgery, Cardiology, Cardiothoracic Surgery, Colorectal Surgery, Critical Care, Dentistry, Dermatology, Emergency Medicine , Endocrinology, Diabetes and Metabolism, ENT, Gastroenterology, Gastrointestinal Oncology, General Surgery, Genitourinary Oncology, Geriatric Medicine, Gynecologic Oncology, Head and Neck Oncology, Head and Neck Surgery, Hematology, Hepatology, Hospice and Palliative Medicine, Infectious Diseases, Integrative Medicine, Internal Medicine,\u003c\/li\u003e\n\u003cli\u003eInterventional Radiology, Leukemia, Lymphoma, Nephrology, Neurology, Neuro-Oncology, Neurosurgery, Oncology and Hematology, Ophthalmology, Oral and Maxillofacial Surgery, Orthopedic Surgery, Otolaryngology, Physical Medicine and Rehabilitation, Plastic and Maxillofacial Surgery, Plastic Surgery, Preventive and Occupational Medicine, Psychiatry, Pulmonary Medicine, Pulmonology, Radiation Oncology, Rheumatology, Sleep Medicine, Surgical Oncology, Thoracic Medical Oncology, Thoracic Surgery, Urology, Vascular Surgery\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003ch2 class=\"activitysectionbold\"\u003eOverview\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eThis one-day evidence-based virtual program is designed to \u003cstrong\u003eoptimize the care of older adult oncology patients\u003c\/strong\u003e by advancing the knowledge and expertise of advanced practice providers. A \u003cstrong\u003egeneral overview of key geriatric oncology topics\u003c\/strong\u003e will be provided including: the use of the comprehensive geriatric assessment; communication strategies in the assessment of older adults; and assessment of fitness versus frailty, resilience, and risk stratification prior to cancer-directed therapies.\u003c\/li\u003e\n\u003cli\u003eAdditionally, the assessment, diagnosis, and treatment of \u003cstrong\u003ecognitive impairment\u003c\/strong\u003e will be addressed, including the role of neuropsychiatric testing, cognitive rehabilitation, and psychopharmacology interventions. Participants will be introduced to \u003cstrong\u003egeriatric collaborative programs\u003c\/strong\u003e in the context of breast medicine and bone marrow transplantation, and the \u003cstrong\u003eintersection of geriatric medicine and palliative care\u003c\/strong\u003e will be discussed. Comprehensive geriatric care will be highlighted in \u003cstrong\u003eacademic, community-based, and international settings\u003c\/strong\u003e. Content proficiency will be assessed with pre and post-conference evaluations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch1\u003eEvent date : Tuesday, April 18, 2023\u003c\/h1\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"12u\"\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e\u003cstrong\u003ePlease note only the presentations from faculty that have given their consent will be available below:\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"2u\"\u003e\u003cstrong\u003eGeriatric Assessment: Overview of the Evidence\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e8:10AM – 9:00AM\u003cbr\u003eMartine Puts, RN, PhD\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"2u\"\u003e\u003cstrong\u003eGeriatric Assessment for the Advanced Practice Provider\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"10u\"\u003e9:00AM – 9:30AM\u003cbr\u003eBeatriz Korc-Grodzicki, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eFitness vs. Frailty: Why Chronological Age is Old\u003c\/strong\u003e\u003cbr\u003e9:30AM – 10:00AM\u003cbr\u003eFarnia Amirnia, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eAdvancing Geriatric Oncology Knowledge for the APP Q\u0026amp;A\u003c\/strong\u003e\u003cbr\u003e10:00AM – 10:15AM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eCase Study: Collaborative Care\u003c\/strong\u003e\u003cbr\u003e10:25AM – 10:35AM\u003cbr\u003eSoo Jung Kim, MSN, RN\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eRisk Stratification of the Older Adult Prior to Cancer Directed Therapy\u003c\/strong\u003e\u003cbr\u003e10:35AM – 11:05AM\u003cbr\u003eHuiqian Han, NP\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eApplication of Geriatrics Principles of Care in Transplantation and Cellular Therapy\u003c\/strong\u003e\u003cbr\u003e11:05AM – 11:25AM\u003cbr\u003eRichard J Lin, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eThe Intersection of Geriatrics and Palliative Care\u003c\/strong\u003e\u003cbr\u003e11:25AM – 11:45AM\u003cbr\u003eKate Boskey, ACHPN\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eTreating Breast Cancer in Older Adults: Special Considerations to Maximize Benefit and Minimize Toxicity\u003c\/strong\u003e\u003cbr\u003e11:45AM – 12:05PM\u003cbr\u003eJasmeet Singh, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eGeriatric Oncology – Advancing Collaborative Care Q\u0026amp;A\u003c\/strong\u003e\u003cbr\u003e12:05PM – 12:15PM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eThe 3 D’s: Delirium, Dementia, and Depression in the Older Adult\u003c\/strong\u003e\u003cbr\u003e1:00PM – 1:25PM\u003cbr\u003eHeidi Yulico\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eNeuropsychological Evaluation and Cognitive Assessment of Older Adults\u003c\/strong\u003e\u003cbr\u003e1:25PM – 1:55PM\u003cbr\u003eStanford Singer, JD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eOccupational Therapy’s Role in Cognitive Rehabilitation\u003c\/strong\u003e\u003cbr\u003e1:55PM – 2:15PM\u003cbr\u003eRebecca Ewert\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003ePrimum Non Nocere: The Art of Geriatric Psychopharmacology\u003c\/strong\u003e\u003cbr\u003e2:15PM – 2:35PM\u003cbr\u003eYesne Alici, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eCognition and the Older Adult Q\u0026amp;A\u003c\/strong\u003e\u003cbr\u003e2:35PM – 2:45PM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eGeriatric Oncology in an Academic Institution: Cancer and Aging Clinic\u003c\/strong\u003e\u003cbr\u003e3:05PM – 3:25PM\u003cbr\u003eKoshy Alexander, MD, MBA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003e“It Can Be Done” Geriatric Oncology Assessment in a Community Cancer Center: The Hartford Experience\u003c\/strong\u003e\u003cbr\u003e3:25PM – 3:55PM\u003cbr\u003eMary Kate Eanniello, DNP\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eInternational Society of Geriatric Oncology: Bringing the World together to Improve the Care of Older Adults with Cancer\u003c\/strong\u003e\u003cbr\u003e3:55PM – 4:10PM\u003cbr\u003eArmin Shahrokni, MD, MPH\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eGlobal Geriatric Care: A Singapore Experience\u003c\/strong\u003e\u003cbr\u003e4:10PM – 4:40PM\u003cbr\u003eAngela Pang, MBBS, MRCP, Physician\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"2u\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e\n\u003cstrong\u003eGeriatric Oncology_A Global Perspective Q\u0026amp;A\u003c\/strong\u003e\u003cbr\u003e4:40PM – 5:00PM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47486933008538,"sku":"MED-AMB00277","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/5940421880903221823_121.jpg?v=1772064196"},{"product_id":"2023-astro-annual-refresher-course-live-recordings","title":"2023 ASTRO Annual Refresher Course Live Recordings","description":"\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003ch3\u003e2023 ASTRO Annual Refresher Course Live Recordings\u003c\/h3\u003e\n\u003ch3\u003eFormat : 3 Videos\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"prod-filesize\"\u003e\n\u003ch3\u003eFile Size : 52 GB\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003ch3\u003e\u003cspan style=\"color: #0000ff;\"\u003e\u003ca href=\"https:\/\/t.me\/medicalamboss1\/454\" style=\"color: #0000ff;\"\u003eSample\u003c\/a\u003e\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv class=\"prod-filesize\"\u003e\n\u003ch3\u003eRun time around 30 Hours\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cbr\u003eThank you for attending the 2023 ASTRO Annual Refresher Course. This course provided a comprehensive review of the latest treatment methods and core competencies for the major disease sites, with a look at the emerging trends and technologies that may impact daily practice. View the tiles below for more information about accessing the Refresher onDemand; learn how to claim continuing education credits and complete the course evaluation; and revisit the three \u003cem\u003ee\u003c\/em\u003eContouring sessions (liver, prostate and lung) that were included with registration.\u003cbr\u003e\u003cdiv class=\"micro_rightSide\"\u003e\n\u003cstrong\u003eCourse Schedule\u003c\/strong\u003e\n\u003cbr\u003e\u003ch4\u003eWednesday, April 26, 2023\u003c\/h4\u003e\n\u003cdiv class=\"ben_tableStyles\"\u003e\n\u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"30%\"\u003e8:50 a.m. – 9:00 a.m.\u003c\/td\u003e\n\u003ctd width=\"70%\"\u003e\n\u003cstrong\u003eWelcome and Program Introduction\u003c\/strong\u003e\u003cbr\u003eBeth A. Erickson, MD, FASTRO – Medical College of Wisconsin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00 a.m. – 10:15 a.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e\u003ci\u003ee\u003c\/i\u003eContouring for Lung Cancer\u003cbr\u003eModerator: \u003c\/strong\u003eSalma Jabbour, MD, FASTRO – Rutgers Cancer Institute of New Jersey\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Megan E. Daly, MD – University of California, Davis Medical Center\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15 a.m. – 12:00 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eLung\u003cbr\u003eModerator: \u003c\/strong\u003eSalma Jabbour, MD, FASTRO – Rutgers Cancer Institute of New Jersey\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Raymond H. Mak, MD – Dana-Farber\/Brigham and Women’s Cancer Center, Harvard Medical School\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:00 p.m. – 1:00 p.m.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eLunch Break\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:00 p.m. – 2:00 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSarcomas\u003cbr\u003eModerator: \u003c\/strong\u003eBeth A. Erickson, MD, FASTRO – Medical College of Wisconsin\u003cbr\u003e\u003cstrong\u003eSpeaker: \u003c\/strong\u003eSafia K. Ahmed, MD – Mayo Clinic, Phoenix\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:00 p.m. – 3:45 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eGastrointestinal\u003cbr\u003eModerator: \u003c\/strong\u003eBeth A. Erickson, MD, FASTRO – Medical College of Wisconsin\u003cbr\u003e\u003cstrong\u003eSpeakers:\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eUpper GI\u003c\/em\u003e\u003cbr\u003eWilliam A. Hall, MD – Medical College of Wisconsin\u003cbr\u003e\u003cem\u003eLower GI\u003c\/em\u003e\u003cbr\u003eJordan R. Kharofa, MD – University of Cincinnati\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:45 p.m. – 5:00 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eOligometastatic Cancers and SBRT\u003cbr\u003eModerator: \u003c\/strong\u003ePaul L. Nguyen, MD, MBA, FASTRO – Dana-Farber Cancer Institute\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e David Palma, MD, MSc, PhD – London Health Sciences Centre\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch4\u003eThursday, April 27, 2023\u003c\/h4\u003e\n\u003cdiv class=\"ben_tableStyles\"\u003e\n\u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"30%\"\u003e8:50 a.m. – 9:00 a.m.\u003c\/td\u003e\n\u003ctd width=\"70%\"\u003e\n\u003cstrong\u003eDay Two Welcome\u003c\/strong\u003e\u003cbr\u003ePaul L. Nguyen, MD, MBA, FASTRO – Dana-Farber Cancer Institute\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00 a.m. – 10:15 a.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e\u003cem\u003ee\u003c\/em\u003eContouring for Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator:\u003c\/strong\u003e Paul L. Nguyen, MD, MBA, FASTRO – Dana-Farber Cancer Institute\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Alexandra Diaz, MD, MS – The Ohio State University Wexner Medical Center\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15 a.m. – 12:00 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eGenitourinary\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator:\u003c\/strong\u003e Paul L. Nguyen, MD, MBA, FASTRO – Dana-Farber Cancer Institute\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Karen E. Hoffman, MD, MHSc, MPH, FASTRO – The University of Texas MD Anderson Cancer Center\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:00 p.m. – 1:00 p.m.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eLunch Break\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:00 p.m. – 2:30 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eBreast\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator: \u003c\/strong\u003eBeth A. Erickson, MD, FASTRO – Medical College of Wisconsin\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Mylin A. Torres, MD – Winship Cancer Institute, Emory University\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:30 p.m. – 4:15 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eGynecologic\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator: \u003c\/strong\u003eBeth A. Erickson, MD, FASTRO – Medical College of Wisconsin\u003cbr\u003e\u003cstrong\u003eSpeakers:\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eEndometrial Cancer\u003c\/em\u003e\u003cbr\u003eLara Hathout, MD – Rutgers Cancer Institute of New Jersey\u003cbr\u003e\u003cem\u003eCervical Cancer\u003c\/em\u003e\u003cbr\u003eMitchell R. Kamrava, MD, MHDS – Cedars-Sinai Medical Center\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:15 p.m. – 5:15 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eRadiobiology\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator:\u003c\/strong\u003e Wolfram Laub, PhD, MBA – Aspekt Solutions\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Phuoc T.  Tran, MD, PhD – University of Maryland School of Medicine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:15 p.m. – 6:15 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eLymphomas\u003cbr\u003eModerator:\u003c\/strong\u003e Wolfram Laub, PhD, MBA – Aspekt Solutions\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Bradford S. Hoppe, MD, MPH – Mayo Clinic, Jacksonville\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003ch4\u003eFriday, April 28, 2023\u003c\/h4\u003e\n\u003cdiv class=\"ben_tableStyles\"\u003e\n\u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"height: 522px;\" width=\"1178\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"30%\"\u003e8:50 a.m. – 9:00 a.m.\u003c\/td\u003e\n\u003ctd width=\"70%\"\u003e\n\u003cstrong\u003eDay Three Welcome\u003c\/strong\u003e\u003cbr\u003eGayle E. Woloschak, PhD, FASTRO – Northwestern University\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00 a.m. – 10:15 a.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e\u003ci\u003ee\u003c\/i\u003eContouring for Liver Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator: \u003c\/strong\u003eManisha Palta, MD – Duke University\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Jelena Lukovic, MD, MPH – Princess Margaret Cancer Centre\/University of Toronto\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15 a.m. – 12:00 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eCentral Nervous System\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator:\u003c\/strong\u003e Paul L. Nguyen, MD, MBA, FASTRO – Dana-Farber Cancer Institute\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Christina Tsien, MD – McGill University\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:00 p.m. – 1:00 p.m.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eLunch Break\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:00 p.m. – 2:45 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eHead and Neck\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator:\u003c\/strong\u003e Paul L. Nguyen, MD, MBA, FASTRO – Dana-Farber Cancer Institute\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e Sue S. Yom, MD, PhD, FASTRO – University of California, San Francisco\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:45 p.m. – 3:45 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePediatrics\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator:\u003c\/strong\u003e Gayle E. Woloschak, PhD, FASTRO – Northwestern University\u003cbr\u003e\u003cstrong\u003eSpeaker:\u003c\/strong\u003e John T. Lucas Jr., MS, MD – St. Jude Children’s Research Hospital\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:45 p.m. – 5:30 p.m.\u003cbr\u003e(includes 15 min Q\u0026amp;A)\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eRadiopharmaceuticals\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eModerator:\u003c\/strong\u003e Gayle E. Woloschak, PhD, FASTRO – Northwestern University\u003cbr\u003e\u003cstrong\u003eSpeakers:\u003c\/strong\u003e\u003cbr\u003eRobert Francois Hobbs, PhD – Johns Hopkins Medicine\u003cbr\u003eAna Kiess, MD, PhD – Johns Hopkins Medicine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487007162522,"sku":"MED-AMB00289","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/2023-ASTRO-Annual-Refresher-Course-Live-Recordings.jpg?v=1772064410"},{"product_id":"uscap-thorax-deconstructed-experts-guide","title":"USCAP THORAX DECONSTRUCTED Experts Guide to What Can Go Wrong Inside the Chest 2023","description":"\u003ch1\u003eUSCAP THORAX DECONSTRUCTED Experts Guide to What Can Go Wrong Inside the Chest 2023\u003c\/h1\u003e\u003cbr\u003ePathologists are generally unfamiliar with a variety of entities in lung, pleural, cardiac and mediastinal pathology, leading to diagnostic errors and creating practice gaps requiring attention. The panorama covered in this interactive microscopy course includes interstitial lung disease, lung infections, pulmonary vasculitis, mesothelial proliferations, mediastinal neoplasia, lung allograft rejection and mimics, heart transplant rejection and distinction from mimics, best practices for optimal triage of lung cancer samples for molecular testing, the cytology of pleural effusions, criteria for aortic vasculitis and other large vessel pathology, recognition of heart valvular pathology, criteria for diagnosis of giant cell arteritis, native heart biopsy interpretation and thoracic soft tissue neoplasms. This faculty ensemble has the professional experience to improve your practice with confidence. You will see cases that make an indelible impression. \u003cem\u003eBreathe easy: this is USCAP, at the heart of education\u003c\/em\u003e.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch4\u003e+ Include: 12 videos + 12 pdfs, size:  GB\u003c\/h4\u003e\n\u003ch4\u003e+ Target Audience: pathologists\u003c\/h4\u003e\n\u003ch4\u003e+ Information:\u003c\/h4\u003e\n\u003ch4\u003eOriginal release date: April 12, 2023\u003cbr\u003eAccess to this course expires on: February 9, 2026 at 11:59 PM Pacific Time\u003c\/h4\u003e\n\u003ch4\u003eCME 16.25\u003c\/h4\u003e\n\u003ch3\u003eCourse Description\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch5\u003ePathologists are generally unfamiliar with a variety of entities in lung, pleural, cardiac and mediastinal pathology, leading to diagnostic errors and creating practice gaps requiring attention. The panorama covered in this interactive microscopy course includes interstitial lung disease, lung infections, pulmonary vasculitis, mesothelial proliferations, mediastinal neoplasia, lung allograft rejection and mimics, heart transplant rejection and distinction from mimics, best practices for optimal triage of lung cancer samples for molecular testing, the cytology of pleural effusions, criteria for aortic vasculitis and other large vessel pathology, recognition of heart valvular pathology, criteria for diagnosis of giant cell arteritis, native heart biopsy interpretation and thoracic soft tissue neoplasms. This faculty ensemble has the professional experience to improve your practice with confidence. You will see cases that make an indelible impression. Breathe easy: this is USCAP, at the heart of education.\u003c\/h5\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTarget Audience\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch4\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003ch5\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003eEstablish the criteria for diagnosis of a variety of areas in pulmonary pathology\u003c\/li\u003e\n\u003cli\u003eEstablish criteria for the diagnosis of mesothelioma and benign mesothelial proliferations\u003c\/li\u003e\n\u003cli\u003eProvide pathologists with the tools to interpret post-transplant heart and lung biopsy specimens\u003c\/li\u003e\n\u003cli\u003eEstablish criteria for the diagnosis of malignant and benign mediastinal lesions\u003c\/li\u003e\n\u003cli\u003eHelp pathologists be able to provide clinically meaningful diagnoses of native heart endomyocardial biopsy specimens\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e Topics:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eInfections – Maxwell L. Smith, MD\u003c\/li\u003e\n\u003cli\u003eCA Lung and Other Tumors – Maxwell L. Smith, MD\u003c\/li\u003e\n\u003cli\u003eHeart \u0026amp; Vessels – Brandon T. Larsen, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSoft Tissue Tumors – Brandon T. Larsen, MD, PhD\u003c\/li\u003e\n\u003cli\u003eLecture: CT-Pathology Correlations – Henry D. Tazelaar, MD\u003c\/li\u003e\n\u003cli\u003ePleura – Andrew Churg, MD\u003c\/li\u003e\n\u003cli\u003eILD-1 – Andrew Churg, MD\u003c\/li\u003e\n\u003cli\u003eLecture: Drug Reactions – Andrew Churg, MD\u003c\/li\u003e\n\u003cli\u003eMediastinum – Anja C. Roden, MD\u003c\/li\u003e\n\u003cli\u003eH\/L Transplant – Anja C. Roden, MD and Henry D. Tazelaar, MD\u003c\/li\u003e\n\u003cli\u003eILD-2 and Problems – Andrew Churg, MD and Anja C. Roden, MD\u003c\/li\u003e\n\u003cli\u003eBiopsy Problems – Henry D. Tazelaar, MD\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487024038042,"sku":"MED-AMB00304","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/USCAP-THORAX-DECONSTRUCTED-Experts-Guide-to-What-Can-Go-Wrong-Inside-the-Chest-2023.jpg?v=1772064672"},{"product_id":"2023-highlights-of-ash-in-north-america","title":"2023 Highlights of ASH in North America","description":"\u003ch3\u003e2023 Highlights of ASH in North America\u003c\/h3\u003e\u003cbr\u003e2023 Highlights of ASH in North America Highlights of ASH in North America is a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical (non-malignant) hematology.\u003cbr\u003e\u003ch4\u003eFormat : 19 MP4 files\u003cbr\u003eFile Size : 9.94 GB\u003c\/h4\u003e\u003cbr\u003eHighlights of ASH in North America is a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical (non-malignant) hematology.\u003cbr\u003e\u003cbr\u003eHighlights of ASH delivers a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.\u003cbr\u003e\u003ch4\u003eThrough the meeting content, you will be able to:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eRecap stand-out abstracts from the most recent ASH annual meeting\u003c\/li\u003e\n\u003cli\u003eDiscuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field\u003c\/li\u003e\n\u003cli\u003eParticipate in interactive panel discussions and attend small group lunch sessions with the experts\u003c\/li\u003e\n\u003cli\u003eImprove therapeutic and overall practice methods\u003c\/li\u003e\n\u003cli\u003eDiscover new treatments for patients\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eThis meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eMathematics of Radioactivity\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487194923162,"sku":"MED-AMB00334","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/2023-Highlights-of-ASH-in-North-America-CME-VIDEOS.png?v=1772065323"},{"product_id":"scripps-5th-annual-scripps","title":"Scripps 5th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2022","description":"\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003eScripps 5th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2022 The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state‐of‐the‐art, comprehensive, case‐based curriculum that addresses important clinical topics relevant to  cardiomyopathy and cardiovascular health of cancer survivors.\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003e\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003eCardio‐oncology is a growing field that has great importance as newly developed cancer treatments improve cancer survival rates but can be associated with cardiovascular  toxicities. Similarly, cardiac amyloidosis is a burgeoning disease with exciting new treatments.\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003e\u003c\/div\u003e\n\u003cdiv data-canvas-width=\"205.2818749803922\"\u003eThe program is intended for those involved in the care of patients with cardiomyopathies, diastolic heart failure, chemotherapy or radiation induced heart disease, and cardiomyopathy related arrhythmic diseases. Nationally recognized faculty will use case‐based discussion to cover challenging heart failure topics related to common cardiomyopathies. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Include: 18 videos, size: 1.87 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: cardiologist, oncologist\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eBest Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Cardiologist’s Perspective-Margot Davis, MD, MSc.mp4\u003c\/li\u003e\n\u003cli\u003eBest Practices in Managing Cardiac Toxicity in the Breast Cancer Patient The Oncologist’s Perspective-Carrie Costantini, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCancer Survivorship How to Monitor for Cardiac Disease Following Treatment-Ann Kuo, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac Sarcoidosis Making the Diagnosis, An Imaging Primer-Ajay Srivastava, MD.mp4\u003c\/li\u003e\n\u003cli\u003eCardiac Sarcoidosis Who and How to Treat-Sumeet Mitter, MD.mp4\u003c\/li\u003e\n\u003cli\u003eClinical Presentation of Cardiac Amyloid Who Should We Suspect-Rajeev Mohan, MD.mp4\u003c\/li\u003e\n\u003cli\u003eContemporary Management of AL Amyloidosis-Anuj Mahindra, MD.mp4\u003c\/li\u003e\n\u003cli\u003eHow to Make the Diagnosis of Cardiac Amyloid-Rola Khedraki, MD.mp4\u003c\/li\u003e\n\u003cli\u003eManaging End-Stage Heart Failure in the Cancer Survivor-Brian Hardaway, MD.mp4\u003c\/li\u003e\n\u003cli\u003eManaging Venous Thromboembolic Disease in the Cancer Patient-Scott Cameron, MD, PhD.mp4\u003c\/li\u003e\n\u003cli\u003eMulti-Modality Imaging in Cardio-Oncology-Ballaji Tamarappoo, MD, PhD.mp4\u003c\/li\u003e\n\u003cli\u003ePharmacogenomics in Heart Failure-David Lanfear, MD, MS.mp4\u003c\/li\u003e\n\u003cli\u003eQ\u0026amp;A Panel Discussion-Carrie Costantini, MD, Margot Davis, MD, MSc, and Prabhakar Tripuraneni, MD.mp4\u003c\/li\u003e\n\u003cli\u003eQ\u0026amp;A Panel Discussion-David Lanfear, MD, MS, Sumeet Mitter, MD, and Julie Rosenthal, MD.mp4\u003c\/li\u003e\n\u003cli\u003eStrategies to Minimize Radiation-Induced Heart Disease-Prabhakar Tripuraneni, MD.mp4\u003c\/li\u003e\n\u003cli\u003eThe Spectrum of Myocarditis From COVID to Immune Therapy-Nicolas Palaskas, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTreatment of ATTR Amyloid Current Options-Julie Rosenthal, MD.mp4\u003c\/li\u003e\n\u003cli\u003eTreatment of ATTR Amyloid The Emerging Landscape-Ronald Witteles, MD.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487372296346,"sku":"MED-AMB00367","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Scripps-5th-Annual-Scripps-Cardiomyopathy-and-Cardio-Oncology-Symposium-2022.jpg?v=1772065856"},{"product_id":"2023-uscap-contemporary-issues-in-breast-pathology","title":"2023 USCAP Contemporary Issues in Breast Pathology","description":"\u003ch3\u003e2023 USCAP Contemporary Issues in Breast Pathology\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e2023 USCAP Contemporary Issues in Breast Pathology  will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized. This course includes a combination of lectures, interactive microscopy sessions, and a panel Q\u0026amp;A.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eUpon completion of this educational activity, learners will be able to:\u003c\/li\u003e\n\u003cli\u003eDescribe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies\u003c\/li\u003e\n\u003cli\u003eDiscuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis\u003c\/li\u003e\n\u003cli\u003eDiscuss prognostic and predictive assays in patients with breast cancer\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eLearning Objectives: After participating in this educational initiative, attendees will achieve the following learning objectives:\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eIn-depth Understanding: Articulate the diagnostic criteria and clinical significance associated with a diverse array of benign, in situ, and malignant breast lesions frequently encountered in surgical specimens and core needle biopsies.\u003c\/li\u003e\n\u003cli\u003eDifferential Diagnosis Proficiency: Engage in discussions regarding diagnostic challenges commonly encountered in breast pathology. Comprehend the utility and constraints of supplementary immunohistochemical and molecular assays in facilitating precise diagnoses.\u003c\/li\u003e\n\u003cli\u003eInsights into Patient Management: Delve into the realm of prognostic and predictive assays applicable to patients afflicted with breast cancer. Gain proficiency in interpreting these assays, which play a crucial role in guiding treatment decisions.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eThis educational course is an indispensable platform for clinicians, pathologists, and researchers seeking to augment their grasp of contemporary issues in breast pathology. By integrating cutting-edge knowledge and practical methodologies, participants will be well-equipped to address diagnostic uncertainties and contribute to optimal patient care.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTOPICS\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eLobular, Mucinous, and Fibroepithelial Lesions – Laura C. Collins, MD\u003c\/li\u003e\n\u003cli\u003eSection: 3 Presentations 3 Documents\u003c\/li\u003e\n\u003cli\u003eLumpectomy Margin Evaluation, Lesions, and Salivary Gland-like Tumors of the Breast – Stuart J. Schnitt, MD\u003c\/li\u003e\n\u003cli\u003eSection: 3 Presentations 3 Documents\u003c\/li\u003e\n\u003cli\u003ePapillary Lesions, Spindle Cell Lesions, and Uncommon Breast Cancers – Kimberly H. Allison, MD\u003c\/li\u003e\n\u003cli\u003eSection: 3 Presentations 3 Documents\u003c\/li\u003e\n\u003cli\u003eNeoadjuvant Chemotherapy, Vascular Lesions, and Intraductal Proliferative Lesions – Gregory R. Bean, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSection: 3 Presentations 3 Documents\u003c\/li\u003e\n\u003cli\u003eDuctal, Nipple, Inflammatory, and Reactive Lesions – Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSection: 3 Presentations 3 Documents\u003c\/li\u003e\n\u003cli\u003eSmall Glandular Proliferations, Fibroepithelial Lesions, and ER, PR, and HER2 Testing – Ashley M. Cimino-Mathews, MD\u003c\/li\u003e\n\u003cli\u003eSection: 3 Presentations 3 Documents\u003c\/li\u003e\n\u003cli\u003eFREE: Hot and Controversial Topics in Breast Pathology\u003c\/li\u003e\n\u003cli\u003eSection: 1 Presentation\u003c\/li\u003e\n\u003cli\u003eFREE: Q\u0026amp;A Panel Discussions\u003c\/li\u003e\n\u003cli\u003eSection: 3 Presentations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e22 videos +PDF\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487832260762,"sku":"MED-AMB00552","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/contemporary-issues-in-breast-pathology-510x132-1.png?v=1772068809"},{"product_id":"harvard-breast-cancer-new-horizons","title":"Cummings Otolaryngology: Head and Neck Surgery, 3 Volumes Set, 8th edition (True PDF)","description":"\u003cp style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 1.3em; margin-top: 0px; color: rgb(0, 0, 0); font-family: Lato, sans-serif; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;\"\u003eBy Howard W. Francis, Bruce H. Haughey MD FACS, Marci M. Lesperance MD, Valerie J. Lund CBE MS FRCS FRCSEd, K. Thomas Robbins MD FACS, Stephen S. Park MD, Alexander Hillel\u003c\/p\u003e\n\u003cp style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 1.3em; margin-top: 0px; color: rgb(0, 0, 0); font-family: Lato, sans-serif; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;\"\u003eFor otolaryngologists at all levels and across all subspecialties, Cummings Otolaryngology: Head and Neck Surgery, Eighth Edition, remains the #1 reference of choice for authoritative answers and easily accessible clinical content on every topic in this complex field. This award-winning text is ideal for all stages of your career―from residency and board certification through the challenges faced in daily clinical practice. Now meticulously reviewed and updated throughout, this modern classic keeps you up to date with the latest minimally invasive procedures, recent changes in rhinology, new techniques and technologies that are shaping patient outcomes, and much more.\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\" style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; list-style: disc; margin-top: 0px; padding: 0px; margin-bottom: 1.3em; color: rgb(0, 0, 0); font-family: Lato, sans-serif; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;\"\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eProvides comprehensive, accessible coverage of every area of the field in three convenient volumes, covering general otolaryngology, facial plastic surgery, sinus\/rhinology, laryngology, head and neck surgery and oncology, otology and neurotology, and pediatric otolaryngology\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eContains 11 new chapters, including Healthcare Disparities in Otolaryngology, COVID-19 in Otolaryngology, Gender Affirming Surgery, Functional Rhinoplasty, Laryngeal Paralysis, Subglottic and Tracheal Stenosis, Gender Affirming Voice Care, Tumor Immunology and Immunotherapy, 22q11 Deletion Syndrome, Enlarged Vestibular Aqueduct Syndrome, and Pediatric Thyroid Disorders\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eOffers new insights in allergy, olfaction, nonallergic rhinitis, epistaxis, nasal measurement, the management and outcomes of chronic rhinosinusitis, facial pain, the sino-orbital interface, systemic diseases affecting the nose and sinuses, and more\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eFeatures outstanding visual support with 4,000+ high-quality images (many new to this edition) and hundreds of quick-reference tables and boxes\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eIncludes access to 165 videos―more than double the number in the previous edition. Videos include key indicator (Accreditation Council for Graduate Medical Education Key Indicator Procedures) and surgical videos, offering residents and practitioners the opportunity to visualize and better understand the critical elements of these core procedures\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eProvides a fresh perspective on facial plastic and reconstructive surgery from new editor, Dr. Stephen S. Park, as well as new perspectives from associate editors who contribute their knowledge and expertise to various sections throughout the text\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; color: rgb(85, 85, 85); margin-bottom: 0.5em; margin-top: 0px; text-rendering: optimizespeed; width: 1050px; font-size: 1.25em; font-family: Lato, sans-serif; font-weight: bold; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;\"\u003eProduct Details\u003c\/h3\u003e\n\u003cul style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; list-style: disc; margin-top: 0px; padding: 0px; margin-bottom: 1.3em; color: rgb(0, 0, 0); font-family: Lato, sans-serif; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;\"\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003ePublisher ‏ : ‎ Elsevier\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003ePublication date ‏ : ‎ October 14, 2025\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eEdition ‏ : ‎ 8th\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eISBN-10 ‏ : ‎ 0443119848\u003c\/li\u003e\n\u003cli style=\"--tw-border-spacing-x: 0; --tw-border-spacing-y: 0; --tw-translate-x: 0; --tw-translate-y: 0; --tw-rotate: 0; --tw-skew-x: 0; --tw-skew-y: 0; --tw-scale-x: 1; --tw-scale-y: 1; --tw-scroll-snap-strictness: proximity; --tw-ring-offset-width: 0px; --tw-ring-offset-color: #fff; --tw-ring-color: rgb(59 130 246 \/ 0.5); --tw-ring-offset-shadow: 0 0 #0000; --tw-ring-shadow: 0 0 #0000; --tw-shadow: 0 0 #0000; --tw-shadow-colored: 0 0 #0000; box-sizing: border-box; margin-bottom: 0.6em; margin-left: 1.3em;\"\u003eISBN-13 ‏ : ‎ 978-0443119842\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487856541850,"sku":"MED-AMB00561","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/CummingsOtolaryngology.jpg?v=1776286902"},{"product_id":"11th-annual-hematology-and-medical","title":"11th Annual Hematology and Medical Oncology Board Review: Contemporary Practice – On Demand","description":"\u003ch3\u003e11th Annual Hematology and Medical Oncology Board Review: Contemporary Practice – On Demand\u003c\/h3\u003e\u003cbr\u003eRecorded over 3.5 days, this on demand includes an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures provided by expert faculty from Memorial Sloan Kettering focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.\u003cbr\u003e\u003cbr\u003e“This is an excellent conference and not just for the boards. I take it every 2-3 years as a refresher and to see what is coming down the pipeline.”\u003cbr\u003e\u003cbr\u003e“World-class speakers!”\u003cbr\u003e\u003cbr\u003e“Delving into each subspecialty of oncology is important as we … care for oncologic patients outside of .. our focused daily practice.”\u003cbr\u003e\u003cbr\u003e-Attendee Feedback\u003cbr\u003e\u003cbr\u003eThis on demand course contains 35+ recorded lectures along with PDF versions of the speakers’ slides. Select the ‘Register’ tab at the top of this page to purchase this program. Once you have successfully registered, access to the course materials will be available under the ‘Course Content‘ tab.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003cbr\u003e1-Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.\u003cbr\u003e2-Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice\u003cbr\u003e3-Prepare for ABIM examinations in medical oncology and hematology.\u003cbr\u003e\u003cbr\u003e“This is an excellent conference and not just for the boards. I take it every 2-3 years as a refresher and to see what is coming down the pipeline.”\u003cbr\u003e\u003cbr\u003e“World-class speakers!”\u003cbr\u003e\u003cbr\u003e“Delving into each subspecialty of oncology is important as we … care for oncologic patients outside of .. our focused daily practice.”\u003cbr\u003e\u003cbr\u003e-Attendee Feedback\u003cbr\u003e\u003cbr\u003eThis on demand course contains 35+ recorded lectures along with PDF versions of the speakers’ slides. Select the ‘Register’ tab at the top of this page to purchase this program. Once you have successfully registered, access to the course materials will be available under the ‘Course Content‘ tab.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003cbr\u003e1-Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.\u003cbr\u003e2-Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice\u003cbr\u003e3-Prepare for ABIM examinations in medical oncology and hematology.\u003cbr\u003e\u003cbr\u003eThis on demand course includes 35+ recorded lectures and PDF versions of the speakers’ slides on the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures are provided by expert faculty from Memorial Sloan Kettering and focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Attendee feedback has been positive and objectives include defining the state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor and hematologic cancers, discussing recent treatment advances, and preparing for ABIM examinations in medical oncology and hematology.","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487858409626,"sku":"MED-AMB00572","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/11th-Annual-Hematology-and-Medical-Oncology-Board-Review-Contemporary-Practice-_E2_80_93-On-Demand.jpg?v=1772069138"},{"product_id":"penn-radiology-neuro-and-chest","title":"Penn Radiology Neuro and Chest Imaging Update 2023","description":"\u003ch3\u003e\u003cstrong style=\"color: #1b1919; font-size: 28px;\"\u003ePenn Radiology Neuro and Chest Imaging Update 2023\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"\" class=\"--description panel\" id=\"\" role=\"tabpanel\"\u003e\n\u003cbr\u003e\u003cbr\u003ePenn Radiology Neuro and Chest Imaging Update 2023 Penn Radiology’s widely acclaimed faculty provides critical pearls, pitfalls and protocols in the areas of neuroradiology, cardiothoracic and breast imaging.  Neuro and Chest Imaging Update focuses on practical imaging issues to improve interpretation across a wide range of common and uncommon clinical scenarios.  Multi-modality, cutting edge practices will be discussed, highlighting potential misinterpretations and strategies for optimal patient care.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003eProgram \u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eSession 1: Cardiothoracic\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"1293\"\u003eAcute Thoracic Aortic Syndromes\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"576\"\u003eElla Kazerooni\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardiovascular Tumors in the Chest\u003c\/td\u003e\n\u003ctd\u003eElla Kazerooni\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eCardiac CT in the Emergency Department\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eElla Kazerooni\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcute Pulmonary Embolism: An Update on Imaging\u003c\/td\u003e\n\u003ctd\u003eElla Kazerooni\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003ePanel\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eMultiple Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eSession 2: Neuro I\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"1300\"\u003eHow-to-Approach a “New Brain Mass” and Prepare for the Brain Tumor Board – 2021 WHO Updates\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"569\"\u003eSuyash Mohan, MD, PDCC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInfratentorial Tumors: Diagnostic Pearls\u003c\/td\u003e\n\u003ctd\u003eSuyash Mohan, MD, PDCC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eDemystifying the Central Skull Base: Pathology or a ‘Pitfall’\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eSuyash Mohan, MD, PDCC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInteractive Case-Based Misses \u0026amp; Misinterpretations in the Brain and Spine\u003c\/td\u003e\n\u003ctd\u003eSuyash Mohan, MD, PDCC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eMultiple Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eSession 3: Lung\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"1298\"\u003eLung Cancer Imaging – Current Concepts in Diagnosis and Follow-up\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"571\"\u003eArun C. Nachiappan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLung Cancer Survivorship: Patient Follow-Up After Curative Intent Therapy\u003c\/td\u003e\n\u003ctd\u003eJana Taylor\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eAdvanced Fibrotic Interstitial Lung Disease With Clinical Correlation\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eArun C. Nachiappan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLungRADs and Fleischner: How to Manage Lung Nodules\u003c\/td\u003e\n\u003ctd\u003eElla Kazerooni\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003ePulmonary Embolism: Diagnostic Dilemma\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eArun C. Nachiappan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging of Long Term Sequalae of COVID-19 Pneumonia\u003c\/td\u003e\n\u003ctd\u003eJana Taylor\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eShortness of Breath: Uncommon Causes\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eArun C. Nachiappan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eMultiple Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cp align=\"left\"\u003e\u003cstrong\u003eSession 4: Thyroid\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"1301\"\u003eChallenges in Thyroid Nodule Characterization\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"568\"\u003eJill E. Langer, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParathyroid Imaging: What the Surgeon Needs to Know\u003c\/td\u003e\n\u003ctd\u003eJill E. Langer, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eMultiple Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cp align=\"left\"\u003e\u003cstrong\u003eSession 5: Breast\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"1303\"\u003eUpdates on Breast Tomosynthesis: Challenging Cases\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"566\"\u003eSamantha P. Zuckerman, MD, MBE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging of Special Populations\u003c\/td\u003e\n\u003ctd\u003eSamantha P. Zuckerman, MD, MBE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eWhen the Stakes are High! Optimizing Breast MRI Interpretation for High and Average Risk Patients\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eSamantha P. Zuckerman, MD, MBE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging the Post-Operative Breast: Not-So-Easy!\u003c\/td\u003e\n\u003ctd\u003eSamantha P. Zuckerman, MD, MBE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eCancel That Biopsy! Don’t Touch Lesions in Breast Imaging\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eSamantha P. Zuckerman, MD, MBE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBreast-at-Its Best: Learning and Growing From Opportunity Cases\u003c\/td\u003e\n\u003ctd\u003eSamantha P. Zuckerman, MD, MBE\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eMultiple Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cp align=\"left\"\u003e\u003cstrong\u003eSession 6: Neuro II\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"1304\"\u003eHow-to-Eliminate ‘Mass’ Confusion! Mimics of Adult Intra-Axial Brain Neoplasms\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"565\"\u003eDr. John H. Woo, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePerfusion Imaging in Acute Stroke: Pearls, Pitfalls \u0026amp; Protocols\u003c\/td\u003e\n\u003ctd\u003eDr. John H. Woo, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eDegenerative Spine Imaging:Is Cervical Spine Different?\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eDr. John H. Woo, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePostoperative Imaging of the Spine Made Easy!\u003c\/td\u003e\n\u003ctd\u003eDr. John H. Woo, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eSpine-So-Fine: Interactive Case-Based Misses \u0026amp; Misinterpretations\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eDr. John H. Woo, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eMultiple Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cp align=\"left\"\u003e\u003cstrong\u003eSession 7: Chest Pest, Quest And Fest\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"1293\"\u003eChest Pest: Typical and Atypical Pulmonary Infections\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\" width=\"576\"\u003eArun C. Nachiappan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiseases of the Pleura\u003c\/td\u003e\n\u003ctd\u003eJana Taylor\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eChest Quest: Learning From Difficult Cases\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eArun C. Nachiappan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIncidental Findings in Radiology Practice: Creating a Safety Net for Patients\u003c\/td\u003e\n\u003ctd\u003eElla Kazerooni\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eChest Fest: Misses and Interpretive Errors\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003eElla Kazerooni\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003eMultiple Faculty\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eRelease Date: May 5, 2023\u003cbr\u003eExpiration Date: May 4, 2026\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487860768922,"sku":"MED-AMB00576","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/penn-radiology-neuro-and-chest-imaging-update-2023-course-510x248-1.jpg?v=1772069188"},{"product_id":"13th-annual-comprehensive","title":"13th Annual Comprehensive Hematology and Oncology Review Course 2022","description":"\u003ch3\u003e13th Annual Comprehensive Hematology and Oncology Review Course\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e13th Annual Comprehensive Hematology and Oncology Review Course 2022 Learn more about data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.\u003c\/li\u003e\n\u003cli\u003eOn completing the program, learners will gain a deeper understanding of the pathogenesis, diagnostic evaluation and therapeutic modalities available for a breadth of solid tumors and hematologic disorders, and the ability to integrate guideline-based treatments, new therapeutic modalities and diagnostic approaches into clinical practice.\u003c\/li\u003e\n\u003cli\u003eThis educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTopics :\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eBreast oncology\u003c\/li\u003e\n\u003cli\u003eBreast Cancer – Adjuvant Therapy\u003c\/li\u003e\n\u003cli\u003eBreast Cancer – Metastatic\u003c\/li\u003e\n\u003cli\u003eBreast Cancer – Non-Invasive\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eGI oncology\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAnal Cancer\u003c\/li\u003e\n\u003cli\u003eCholangiocarcinoma\u003c\/li\u003e\n\u003cli\u003eColorectal Cancer\u003c\/li\u003e\n\u003cli\u003eEsophageal\/Gastric Cancer\u003c\/li\u003e\n\u003cli\u003eGastrointestinal Neuroendocrine Tumors\u003c\/li\u003e\n\u003cli\u003eHepatocellular Cancer\u003c\/li\u003e\n\u003cli\u003ePancreatic Cancer\u003c\/li\u003e\n\u003cli\u003eGU oncology\u003c\/li\u003e\n\u003cli\u003eBladder Cancer\u003c\/li\u003e\n\u003cli\u003eProstate Cancer\u003c\/li\u003e\n\u003cli\u003eRenal Cell Carcinoma\u003c\/li\u003e\n\u003cli\u003eTesticular Cancer\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eGynecologic oncology\u003cbr\u003e\u003cdiv\u003eGynecologic Oncology – Cervical and Endometrial Cancers\u003c\/div\u003e\n\u003cdiv\u003eGynecologic Oncology – Ovarian Cancer\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003ch3\u003eHematology\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eBenign White Cell Disorders\u003c\/li\u003e\n\u003cli\u003eBleeding Disorders\u003c\/li\u003e\n\u003cli\u003eHematopoietic Stem Cell Transplantation\u003c\/li\u003e\n\u003cli\u003eInherited \u0026amp; Acquired Marrow Failure\u003c\/li\u003e\n\u003cli\u003eIron Metabolism Disorders \u0026amp; Hemolytic Anemias\u003c\/li\u003e\n\u003cli\u003eMyelodysplastic Syndromes\u003c\/li\u003e\n\u003cli\u003eMyeloproliferative Neoplasms\u003c\/li\u003e\n\u003cli\u003eThalassemia \u0026amp; Hemoglobinopathies\u003c\/li\u003e\n\u003cli\u003eThrombocytopenia\u003c\/li\u003e\n\u003cli\u003eThrombosis \u0026amp; Anticoagulation\u003c\/li\u003e\n\u003cli\u003eThrombotic Microangiopathies (TTP\/aHUS)\u003c\/li\u003e\n\u003cli\u003eTransfusion Medicine\u003c\/li\u003e\n\u003cli\u003eConsultative Hematology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLeukemia \u0026amp; myelomas\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAcute Lymphoblastic Leukemia\u003c\/li\u003e\n\u003cli\u003eAcute Myeloid Leukemia\u003c\/li\u003e\n\u003cli\u003eChronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) \u0026amp; Hairy Cell Leukemia\u003c\/li\u003e\n\u003cli\u003eChronic Myeloid Leukemia\u003c\/li\u003e\n\u003cli\u003eMGUS \u0026amp; Smoldering Myeloma\u003c\/li\u003e\n\u003cli\u003eMultiple Myeloma\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLymphomas\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAggressive Non-Hodgkin Lymphoma\u003c\/li\u003e\n\u003cli\u003eHodgkin Lymphoma\u003c\/li\u003e\n\u003cli\u003eIndolent Non-Hodgkin Lymphoma\u003c\/li\u003e\n\u003cli\u003eT-Cell Lymphoma\u003c\/li\u003e\n\u003cli\u003eMelanoma\u003c\/li\u003e\n\u003cli\u003eMelanoma and other Skin Cancers\u003c\/li\u003e\n\u003cli\u003eNeuro-oncology\u003c\/li\u003e\n\u003cli\u003eCNS Cancers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003eSarcomas\u003c\/div\u003e\n\u003ch3\u003eSarcoma\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSupportive care \u0026amp; associated specialties\u003c\/li\u003e\n\u003cli\u003eFamilial Syndromes\u003c\/li\u003e\n\u003cli\u003eInfectious Disease Complications\u003c\/li\u003e\n\u003cli\u003eIntegrative Oncology\u003c\/li\u003e\n\u003cli\u003ePharmacology I\u003c\/li\u003e\n\u003cli\u003ePharmacology II\u003c\/li\u003e\n\u003cli\u003eRadiation Oncology – Multi-disciplinary (Breast, Lung, Colorectal, and Palliative)\u003c\/li\u003e\n\u003cli\u003eSupportive Care\u003c\/li\u003e\n\u003cli\u003eThoracic, head and neck oncolog\u003c\/li\u003e\n\u003cli\u003eHead, Neck \u0026amp; Thyroid Cancer\u003c\/li\u003e\n\u003cli\u003eMesothelioma\u003c\/li\u003e\n\u003cli\u003eNon-Small Cell Lung Cancer – Adjuvant\/Locally Advanced\u003c\/li\u003e\n\u003cli\u003eNon-Small Cell Lung Cancer – Metastatic\u003c\/li\u003e\n\u003cli\u003eSmall Cell Lung Cancer\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eFile Size : 7.02 GB\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487931482266,"sku":"MED-AMB00593","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/images-9-510x266-1.jpg?v=1772069465"},{"product_id":"2022-hematology-and-medical-oncology-best-practices","title":"2022 HEMATOLOGY AND MEDICAL ONCOLOGY BEST PRACTICES ON DEMAND – FULL SESSION 8 Day course","description":"\u003ch3\u003e2022 HEMATOLOGY AND MEDICAL ONCOLOGY BEST PRACTICES ON DEMAND – FULL SESSION 8 Day course\u003c\/h3\u003e\u003cbr\u003eThis course is ideal for physicians preparing to take the Hematology and Oncology certification exams as well as individuals desiring a comprehensive review of hematology and medical oncology standards of care.\u003cbr\u003e\u003cbr\u003e2022 HEMATOLOGY AND MEDICAL ONCOLOGY BEST PRACTICES ON DEMAND – FULL SESSION 8 Day course\u003cbr\u003e\u003cbr\u003eHematology\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eUnderstand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and\u003c\/li\u003e\n\u003cli\u003ehematopoietic growth factors\u003c\/li\u003e\n\u003cli\u003eUnderstand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies\u003c\/li\u003e\n\u003cli\u003eUnderstand blood and marrow morphology and hematopathology\u003c\/li\u003e\n\u003cli\u003eUnderstand red cell disorders\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eHematologic Malignancies\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eUnderstand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs\u003c\/li\u003e\n\u003cli\u003eBe familiar with the diagnosis, evaluation, and management of hematologic malignancies\u003c\/li\u003e\n\u003cli\u003eIdentify strategies for taking the board examinations\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eOncology\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eUnderstand the epidemiology of malignant diseases and management of the medical complications of malignancy\u003c\/li\u003e\n\u003cli\u003eUnderstand the principles of management of gynecologic and other genito-urinary malignancies\u003c\/li\u003e\n\u003cli\u003eRecognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract\u003c\/li\u003e\n\u003cli\u003eRecognize principles of new developments in biologic therapy of cancer\u003c\/li\u003e\n\u003cli\u003eContend with complexity of HIV related malignancies\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eCOURSE OVERVIEW\u003cbr\u003e\u003cbr\u003eHematology Sessions:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSession 1: Hemoglobinopathies, White Cell Disorders, Bone Marrow Failure and Sickle Cell Disease Overview\u003c\/li\u003e\n\u003cli\u003eSession 2: Clotting and Bleeding Disorders\u003c\/li\u003e\n\u003cli\u003eSession 3: TTP, HUS, DIC, HIT, ABO Incompatibility, Hematopoietic Transplantation and Hematologic Complications of Pregnancy\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eHematologic Malignancies Sessions:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSession 4: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS\u003c\/li\u003e\n\u003cli\u003eSession 5: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms and Pharmacology\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eMedical Oncology Sessions:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSession 6: Breast Cancer, Lung Cancer, and Neuro-Oncology\u003c\/li\u003e\n\u003cli\u003eSession 7: Renal Cell, Prostate, Bladder, Testicular, Ovarian and Endometrial Tumors\u003c\/li\u003e\n\u003cli\u003eSession 8: GI Oncology, Mesothelioma and Sarcomas\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47487942099098,"sku":"MED-AMB00595","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/40PhotoFixerBot_20-02-04_UTC.jpg?v=1772069501"},{"product_id":"2022-econtouring-for-head","title":"2022 Econtouring For Head And Neck Cancer (VIDEOS)","description":"\u003ch3\u003e\u003cstrong\u003e2022 Econtouring For Head And Neck Cancer (VIDEOS)\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv\u003e2022 Econtouring For Head And Neck Cancer (VIDEOS) This educational activity with neuroradiology  and radiation oncology will focus on contouring PNI for parotid and oral cavity cancers.\u003c\/div\u003e\n\u003cdiv\u003eThis webinar was sponsored by the ROI Juan A. del Regato Fund.\u003c\/div\u003e\n\u003ch3\u003eTARGET AUDIENCE\u003c\/h3\u003e\n\u003cdiv\u003eThis program is designed to meet the interest of radiation oncologists, diagnostic radiologists, radiation dosimetrists and radiation oncology residents.\u003c\/div\u003e\n\u003ch3\u003eLEARNING OBJECTIVES\u003c\/h3\u003e\n\u003cdiv\u003eUpon completion of this activity, participants should be able to:\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eContour PNI for parotid cancers (facial nerve).\u003c\/li\u003e\n\u003cli\u003eContour PNI for oral cavity cancers (lingual nerve).\u003c\/li\u003e\n\u003cli\u003eCourse opens:  08\/01\/2022\u003c\/li\u003e\n\u003cli\u003eCourse expires:  12\/14\/2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003eFile Size : 205 MB\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eFormat : 1 Video\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47488060522650,"sku":"MED-AMB00620","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/40PhotoFixerBot_telechargement-1-1-1.jpg?v=1772070024"},{"product_id":"2022-astro-annual-meeting-on-demand","title":"2022 ASTRO Annual Meeting On Demand","description":"\u003ch3\u003e2022 ASTRO Annual Meeting On Demand\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. The theme for the 2022 ASTRO Annual Meeting is “Artificial Intelligence and Emotional Intelligence: Caring for the Patient in a Wireless World”. The meeting will highlight the potential of AI, Big Data and the latest scientific breakthroughs, in addition to showcasing the central role of human interaction in caring for and curing our patients.\u003c\/li\u003e\n\u003cli\u003eThe program will present the challenges and changes in radiation oncology practice in response to the global pandemic, approaches to serving underrepresented minority and rural patients and effective practices to reduce treatment side effects. We will emphasize on patient quality and safety issues in the delivery of radiation therapy especially advanced radiation techniques such as stereotactic body radiation therapy.\u003c\/li\u003e\n\u003cli\u003eThe program will address the disease sites most commonly treated in radiation oncology, the equipment and software used, terminology and professional responsibilities. Program content has been designed to address specific documented and clinically important practice gaps in physician knowledge and competence including disparities and inequities in radiation oncology. There also will be increased involvement of patients and patient advocates who will provide valuable input in all aspects of the meeting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTARGET AUDIENCE\u003c\/h3\u003e\u003cbr\u003eThis continuing medical education activity is designed to meet the interests of radiation oncologists, medical oncologists, radiation oncology residents, radiation biologists, radiation physicists, dosimetrists, oncologists working in related specialties, radiation therapists, radiation oncology nurses, radiation oncology administrators, diagnostic radiologists and all other health professionals involved in the field of radiation oncology.\u003cbr\u003e\u003ch3\u003eLEARNING OBJECTIVES\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAt the conclusion of this activity, the learner will be able to:\u003c\/li\u003e\n\u003cli\u003eImplement the advances in radiation oncology technology that help improve patient outcomes and quality of life.\u003c\/li\u003e\n\u003cli\u003eEmploy quality and safety measures in the delivery of radiation therapy.\u003c\/li\u003e\n\u003cli\u003eDevelop a broad understanding of all cancer treatments available to patients.\u003c\/li\u003e\n\u003cli\u003eDemonstrate ways to incorporate a person-centered approach in providing patient care.\u003c\/li\u003e\n\u003cli\u003eDiscuss factors that cause, and ways to improve, disparities and inequities in radiation oncology.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eProgram : Click here\u003cbr\u003e\u003cbr\u003eCourse opens:  10\/27\/2022\u003cbr\u003eCourse expires:  06\/01\/2023","brand":"meducours","offers":[{"title":"Default Title","offer_id":47488177406106,"sku":"MED-AMB00626","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/images-66-510x268-1.jpg?v=1772070357"},{"product_id":"radiopaedia-2020-virtual-conference","title":"Radiopaedia 2020 – Virtual Conference","description":"Radiopaedia 2020 – Virtual Conference is a four-day virtual radiology conference that combines 40 new online lectures contributed by experts from around the world with lectures from our existing library. It forms part of our ongoing effort to reduce the educational impact of COVID-19.\u003cbr\u003e\u003cbr\u003eThis event is intended for a broad audience, with the lectures conveniently divided into an advanced stream for radiologists and radiology trainees, and a general stream for all other healthcare professionals. Delegates are, however, welcome to watch any content from either stream to suit their learning needs\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics\/Speakers: \u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e– 01 Multiple sclerosis criteria, protocol  detection Frank Gaillard\u003cbr\u003e– 02 Skull base anatomy and pathology Jenny Hoang\u003cbr\u003e– 03 Head _ Neck imaging pearls Christine Glastonbury\u003cbr\u003e– 04 Neck infections Derek Smith\u003cbr\u003e– 05 Surgeons perspective parotid and parapharyngeal tumours Ben Dixon\u003cbr\u003e– 06 Brain – not bleeds Andrew Dixon\u003cbr\u003e– 07 Brain – bleeds Andrew Dixon\u003cbr\u003e– 08 Small but important fractures\u003cbr\u003e– 09 Case review session Jeremy Jones\u003cbr\u003e– 10 Oesophageal trauma Matt A Morgan\u003cbr\u003e– 11 HRCT imaging in fibrotic interstitial lung disease Jonathan Chung\u003cbr\u003e– 12 Incidental cardiac findings on general CT​ Naveen Sharma\u003cbr\u003e– 13 Case review interstitial lung disease Jonathan Chung\u003cbr\u003e– 14 Cancer mimics in the abdomen and pelvis Michael Hartung\u003cbr\u003e– 15 Problem solving in the post-op abdomen Vikas Shah\u003cbr\u003e– 16 PET-CT for the non-PET reporting radiologist David Little\u003cbr\u003e– 17 Abdominal x-rays Vikas Shah\u003cbr\u003e– 18 Right lower quadrant pain Matt A Morgan\u003cbr\u003e– 19 Case review session Vikas Shah\u003cbr\u003e– 20 Spring ligament MRI anatomy _ pathology Christoph Agten\u003cbr\u003e– 21 X-ray of adult hand arthropathies Henry Knipe\u003cbr\u003e– 22 Interpreting cervical spine radiographs Matt Skalski\u003cbr\u003e– 23 Bone scans what the radiologist needs to know Sally Ayesa\u003cbr\u003e– 24 Paediatric body oncology Jeremy Jones\u003cbr\u003e– 25 Ultrasound of ovarian masses Alexandra Stanislavsky\u003cbr\u003e– 26 The 11-13 week scan in the era of NIPT Sumathi Rajendran\u003cbr\u003e– 27 Contrast enhanced mammography Anat Kornecki\u003cbr\u003e– 28 Abdominal trauma Andrew Dixon\u003cbr\u003e– 29 Case review session Andrew Dixon\u003cbr\u003e– 30 A talk on giving talks Frank Gaillard\u003cbr\u003e– 31 Procedural tips for the non-IR Chris Nicholas\u003cbr\u003e– 32 How to make a great radiology report Michael Hartung\u003cbr\u003e– 33 How to prepare images for publication Frank Gaillard\u003cbr\u003e– 34 How to read a radiology AI paper Jarrel Seah\u003cbr\u003e– 35 Social media for radiologists Vikas Shah\u003cbr\u003e– 36 Preparing for radiology fellowship exams Sally Ayesa\u003cbr\u003e– 37 Radiology tips for medical interns Andrew Dixon\u003cbr\u003e– 38 Surviving the radiology viva tips and tricks George Harisis\u003cbr\u003e– 39 Trauma in pregnancy Craig Hacking\u003cbr\u003e– 40 Trauma Radiology with Dr Andrew Dixon\u003cbr\u003e– 41 Imaging of coccygeal pain Matt Skalski\u003cbr\u003e– 42 Patient not waking up trauma MRI brain scenario Andrew Dixon\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47488851280026,"sku":"MED-AMB00732","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/screenshot_28-510x288-1.jpg?v=1772072775"},{"product_id":"osler-radiation-oncology-2021","title":"Osler Radiation Oncology 2021 Online Review","description":"\u003ch2\u003eOsler Radiation Oncology 2021 Online Review\u003c\/h2\u003e\u003cbr\u003eThe Osler Institute utilized state-of-the-art equipment to record our Live Virtual Webinar March 2021 comprehensive Radiation Oncology Review Course and bring it to you! these Video files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection, watch or listen to on your phone, computer, or tablet – your learning experience is almost like being at the live activity, but without travel costs and time away from your practice. Included with each online review is a downloadable copy of the syllabus that corresponds to the Video lectures for your use while viewing or as a free-standing study or clinical practice guide.\u003cbr\u003e\u003cbr\u003eThis review provides senior trainees and\/or clinicians in practice a comprehensive update of clinical knowledge and helps prepare them for their Radiation Oncology exams (the initial certification and MOC). Emphasis is on evidence-based medicine and board-relevant standards of care as well as new concepts, treatments, and imaging approaches. The written exams emphasize anatomy, epidemiology, etiological agents, natural history, pathology, tumor markers, initial clinical evaluation, staging, routes of spread, selection of treatment modality and techniques, surgical and chemotherapy adjuvant treatments, follow-up treatment and evaluation, patterns of failure, and normal tissue effects including complications; all of these areas are addressed. The review also covers the basic principles of radiobiology and physics that are relevant to clinical practice.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003cbr\u003eAt the conclusion of this course, each participant should be able to perform the following tasks for all cancers of the eleven ABR defined component areas:\u003cbr\u003e- Describe the anatomy, epidemiology\/etiologic agents, and natural history\u003cbr\u003e- Explain the pathology and use of tumor markers\u003cbr\u003e- Describe the initial clinical evaluation, staging, and routes of disease spread (local and distant)\u003cbr\u003e- Summarize potential treatment modalities including optimum beam and radiation sources, volume and dose calculations, as well as fractionation\u003cbr\u003e- Discuss follow-up treatment and evaluation, patterns of failure, and normal tissue effects\u003cbr\u003e- Discuss the use of multimodality therapies, including sequence, interactions, and specific agents\u003cbr\u003e- Describe brachytherapy applications and issues for all disease sites\u003cbr\u003e- Outline the use of palliative care for brain, hepatic and skeletal lesions, plus various obstructive scenarios\u003cbr\u003e- Implement a basic program of ethics, patient safety, and quality assurance in clinical practice\u003cbr\u003e\u003ch3 class=\"yikes-custom-woo-tab-title yikes-custom-woo-tab-title-faculty-and-topics\"\u003e\u003cstrong\u003eFaculty and Topics\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch2\u003e\n\u003cimg alt=\"\" class=\"wp-image-74543 size-thumbnail alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_D_Blakaj-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_D_Blakaj-131x150.jpg\" width=\"131\"\u003eDukagjin Blakaj, MD, Ph.D.\u003cbr\u003eAssistant Professor of Radiation Oncology,\u003cbr\u003eOhio State University\u003c\/h2\u003e\u003cbr\u003eHead and Neck Cancer I – III\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"alignleft size-thumbnail wp-image-47417 entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2018\/03\/FAC_ROC_S_Lin-150x150.png\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2018\/03\/FAC_ROC_S_Lin-150x150.png\" width=\"150\"\u003eSteven Lin, MD, Ph.D.\u003cbr\u003eAssociate Professor of Radiation Oncology,\u003cbr\u003eMD Anderson Cancer Center\u003c\/h2\u003e\u003cbr\u003eEarly Stage NSCLC, Locally Advanced NSCLC, Small Cell Lung Cancer, Rare Mediastinal Tumors\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"alignleft size-thumbnail wp-image-43148 entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2017\/04\/FAC_ROC_V_Mangona-150x150.png\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2017\/04\/FAC_ROC_V_Mangona-150x150.png\" width=\"150\"\u003eVictor Mangona, MD\u003cbr\u003ePracticing Radiation Oncologist, Texas Center for Proton Therapy, Irvine, TX\u003c\/h2\u003e\u003cbr\u003ePediatric Brain Tumors, Brain Stem Glioma, Medulloblastoma, Intracranial Germ Cell Tumors, Ependymoma, Pediatric Gliomas, Pediatric CNS Questions, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Ewing’s Sarcoma, Pediatric Solid Questions\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"alignleft size-thumbnail wp-image-42901 entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2016\/12\/FAC_ROC_T_Swanson-150x150.png\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2016\/12\/FAC_ROC_T_Swanson-150x150.png\" width=\"150\"\u003eTodd Swanson, MD, PhD†\u003cbr\u003eAssistant Professor of Radiation Oncology, University of Texas, Galveston\u003c\/h2\u003e\u003cbr\u003eCNS Overview, Primary CNS Malignancies, CNS Metastasis of Brain, CNS Metastasis Spine, Benign disorders of CNS, Palliative Care, †Course Planning Committee\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74542 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_C_Tang-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_C_Tang-131x150.jpg\" width=\"131\"\u003eChad Tang, MD\u003cbr\u003eAssistant Professor\u003cbr\u003eRadiation Oncology\u003cbr\u003eInvestigational Cancer Therapeutics Translational Molecular Pathology\u003c\/h2\u003e\u003cbr\u003eEarly\/Intermediate-Risk Prostate Cancer, High Risk and Metastatic Prostate Cancer, Adjuvant\/Salvage Prostate Cancer\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74545 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_J_Gunther-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_J_Gunther-131x150.jpg\" width=\"131\"\u003eJillian R. Gunther, MD PhD\u003cbr\u003eAssistant Professor\u003cbr\u003eThe University of Texas\u003cbr\u003eMD Anderson Cancer Center\u003c\/h2\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eHodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Solitary Plasmacytoma\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74546 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_S_Silva-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_S_Silva-131x150.jpg\" width=\"131\"\u003e\u003cbr\u003eScott R. Silva MD, Ph.D.\u003cbr\u003eAssistant Professor\u003cbr\u003eUniversity of Louisville\u003cbr\u003eSchool of Medicine\u003c\/h2\u003e\u003cbr\u003eEndometrial Cancer, Cervical Cancer, Vulvar Cancer\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74544 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_T_Thomas-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_T_Thomas-131x150.jpg\" width=\"131\"\u003e\u003cbr\u003eTarita Thomas, MD, Ph.D., MBA\u003c\/h2\u003e\u003cbr\u003eEarly Stage Breast Cancer, Locally Advanced Breast Cancer, Carcinoma-in-situ and Misc (DCIS)\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74540 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_N_Hanna-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_N_Hanna-131x150.jpg\" width=\"131\"\u003e\u003cbr\u003eNavine Hanna, MD, MPH\u003cbr\u003eRadiation Oncology Specialists Advent Health Medical Group\u003cbr\u003ePalm Coast, FL\u003c\/h2\u003e\u003cbr\u003eEsophageal Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer, Anal Cancer, Liver Cancer, Pancreatic Ampullary Cancer, Bile Duct Cancer\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74090 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_PED_P_Khandhar-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_PED_P_Khandhar-131x150.jpg\" width=\"131\"\u003eParas Khandhar, MD, FAAP\u003cbr\u003eAttending, Pediatric Critical Care Medicine, Beaumont Children’s\u003cbr\u003eLead Inpatient Physician Informaticist – Beaumont Health\u003cbr\u003eAssociate Professor of Pediatrics, Oakland University William Beaumont School of Medicine\u003c\/h2\u003e\u003cbr\u003eEVIDENCED BASED MEDICINE (EBM), PATIENT SAFETY \u0026amp; QUALITY IMPROVEMENT\u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47488866255002,"sku":"MED-AMB00734","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/pd_roc_oslerolr.png?v=1772072957"},{"product_id":"rectal-cancer-virtual-case-review-2020","title":"ARRS MRI Staging of Rectal Cancer Virtual Case Review 2020","description":"\u003ch2\u003eARRS MRI Staging of Rectal Cancer Virtual Case Review 2020\u003c\/h2\u003e\u003cbr\u003eRectal Cancer Virtual Case Review 2020\u003cbr\u003e\u003ch3\u003e#ARRS  #oncology\u003c\/h3\u003e\u003cbr\u003ejoin us online Friday, November 6, 2:00–4:00 pm Eastern Time, for this interactive course on rectal cancer imaging. Using a case-based approach, faculty will highlight the pearls and pitfalls in using MRI for staging and follow-up evaluation of patients with rectal cancer. MR pointers on technique, anatomy, accurate staging, and pitfalls to avoid will be discussed and demonstrated on full case examples.\u003cbr\u003e\u003cbr\u003eAs participants are guided through 20 full case examples with case histories and self-assessment, they will become familiar with key staging features of rectal cancer on MRI, optimal image acquisition, and use of a standardized synoptic reporting template—all critical aspects for treatment planning.\u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489067090074,"sku":"MED-AMB00805","price":15.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/rectal-mri-1120x300-1-510x137-1.png?v=1772074422"},{"product_id":"comprehensive-review-of-radiation","title":"Comprehensive Review of Radiation Oncology 2020","description":"\u003ch1\u003eComprehensive Review of Radiation Oncology 2020\u003c\/h1\u003e\n\u003cstrong\u003eExplore Key Topics\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eComprehensive Review of Radiation Oncology consists of 30 one-hour lectures spanning a wide range of radiation therapy treatments that require a complex set of processes: diagnosis, consultation, simulation, contouring target volumes and normal tissue structures, treatment planning, chart review, treatment delivery, quality assurance, and patient follow-up. Authoritative and clinically experienced faculty guide you to more efficient, safer, and higher quality care for each patient. This online CME program will help you to better:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDescribe delivery speed and dose rates of FLASH radiation therapy\u003c\/li\u003e\n\u003cli\u003eList head and neck tumors for which radiotherapy is beneficial\u003c\/li\u003e\n\u003cli\u003eCompare radiotherapy for brain metastases and primary brain tumors\u003c\/li\u003e\n\u003cli\u003eSummarize differences in therapy for non-small versus small cell lung cancer\u003c\/li\u003e\n\u003cli\u003eDiscuss therapy for upper and lower GI malignancies\u003c\/li\u003e\n\u003cli\u003eContrast decision making involved in therapy after mastectomy and after breast conservation\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAt the conclusion of this activity, the participant should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDescribe the delivery speed and dose rates of FLASH radiation therapy\u003c\/li\u003e\n\u003cli\u003eList the head and neck tumors for which radiotherapy is beneficial\u003c\/li\u003e\n\u003cli\u003eCompare radiotherapy for brain metastases with radiotherapy for primary brain tumors\u003c\/li\u003e\n\u003cli\u003eSummarize the differences in radiation therapy for non-small cell lung cancer and small cell lung cancer\u003c\/li\u003e\n\u003cli\u003eDiscuss radiation therapy for upper and lower gastrointestinal malignancies\u003c\/li\u003e\n\u003cli\u003eContrast the decision making involved in radiation therapy after mastectomy and after breast conservation\u003c\/li\u003e\n\u003cli\u003eExplain effective treatment delivery for gynecological tumors\u003c\/li\u003e\n\u003cli\u003eDifferentiate the treatment planning required for Hodgkin lymphoma and non-Hodgkin lymphoma\u003c\/li\u003e\n\u003cli\u003eCompare the doses and beams of various intensities used in stereotactic body radiation therapy used for primary and metastatic gastrointestinal tumors and spinal tumors\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eDate of Original Release: December 31, 2020\u003cbr\u003eDate Credits Expire: December 31, 2023\u003cbr\u003eEstimated time to complete: 29.5 hours\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics\/Speakers :\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eProton Radiation Therapy in Adults - Thomas F. Delaney, MD\u003c\/li\u003e\n\u003cli\u003eImaging Applications in Radiation Therapy - Fang-Fang Yin, PhD\u003c\/li\u003e\n\u003cli\u003eNon-Invasive Cardiac Radioablation for Ventricular Tachycardia - Clifford Robinson, MD\u003c\/li\u003e\n\u003cli\u003eFLASH \u0026amp; PHASER: Potential New Radiotherapy Paradigm and Its Clinical Translation - Billy W. Loo, MD, PhD\u003c\/li\u003e\n\u003cli\u003eTreatment of Oligometastases in 2020 - Joseph K. Salama, MD, FASTRO\u003c\/li\u003e\n\u003cli\u003eImmunotherapy and Radiation Therapy - Yvonne M. Mowery, MD, PhD\u003c\/li\u003e\n\u003cli\u003ePractical Radiotherapy Management for Brain Metastases - Scott R. Floyd, MD, PhD\u003c\/li\u003e\n\u003cli\u003eRadiation Therapy in the Treatment of Adult Primary Brain Tumors - Zachary J. Reitman, MD, PhD\u003c\/li\u003e\n\u003cli\u003eThe Role of PET Scanning in Head and Neck Cancer - David M. Brizel, MD\u003c\/li\u003e\n\u003cli\u003eHead and Neck Tumors: HPV, Postop, Planning, Progression, Palliation - Yvonne M. Mowery, MD, PhD\u003c\/li\u003e\n\u003cli\u003eThoracic Tumors: Non-Small Cell Lung Cancer - Joseph K. Salama, MD, FASTRO\u003c\/li\u003e\n\u003cli\u003eSmall Cell Lung Cancer \u0026amp; Pleural Mesothelioma 2020 - Chris Kelsey, MD\u003c\/li\u003e\n\u003cli\u003eUpper Gastrointestinal Malignancies - Christopher G. Willett, MD\u003c\/li\u003e\n\u003cli\u003eClinical Indications: Radiation\/SBRT for Liver Metastases and Hepatocellular Carcinoma - Brian Czito, MD\u003c\/li\u003e\n\u003cli\u003eLower Gastrointestinal Cancers: Colon, Rectum, Anus - Manisha Palta, MD\u003c\/li\u003e\n\u003cli\u003eDefinitive Radiation Therapy for Prostate Cancer: Risk Stratification, Fractionation and Androgen Suppression - W. Robert Lee, MD, MS, MEd, FASTRO, FABS\u003c\/li\u003e\n\u003cli\u003eMulti-Disciplinary Care in Bladder Cancer: An Evidence-Based Review on the Role of Radiation Therapy - Stanley Liauw, MD\u003c\/li\u003e\n\u003cli\u003ePost-Prostatectomy Radiation Therapy: Advances and Controversies - Daniel E. Spratt, MD\u003c\/li\u003e\n\u003cli\u003eRadiotherapy in Breast Cancer: Decision Making After Mastectomy and Neoadjuvant Chemotherapy - Rachel C. Blitzblau, MD, PhD\u003c\/li\u003e\n\u003cli\u003eRadiotherapy in Breast Cancer: Decision Making After Breast Conservation - Susan G. R. McDuff, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSoft Tissue Sarcomas - David Kirsch, MD, PhD\u003c\/li\u003e\n\u003cli\u003eNon-Hodgkin Lymphomas - Colin E. Champ, MD\u003c\/li\u003e\n\u003cli\u003eHodgkin Lymphoma 2020 - Chris Kelsey, MD\u003c\/li\u003e\n\u003cli\u003eLocally Advanced Cervical Cancer - Akila N. Viswanathan, MD, MPH\u003c\/li\u003e\n\u003cli\u003eGynecological Tumors: Uterine Cancer - Junzo Chino, MD\u003c\/li\u003e\n\u003cli\u003eGynecological Tumors: Vaginal and Vulvar Cancer - Diandra N. Ayala-Peacock, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Tumors I - Nicole Larrier, MD, MSc\u003c\/li\u003e\n\u003cli\u003ePediatric Tumors II - Nicole Larrier, MD, MSc\u003c\/li\u003e\n\u003cli\u003eSkin Cancer - Paul M. Busse, MD, PhD\u003c\/li\u003e\n\u003cli\u003eManagement of Spinal Metastases - John P. Kirkpatrick, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch5\u003eFormat : 30 MP4 + 2 PDFs\u003c\/h5\u003e\n\u003ch5\u003eFile Size : 24.47 GB\u003c\/h5\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489223721114,"sku":"MED-AMB00860","price":15.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/0002341_comprehensive-review-of-radiation-oncology_300.jpg?v=1772075369"},{"product_id":"acro-annual-meeting","title":"ACRO Annual Meeting The Radiation Oncology Summit 2021 VIRTUAL","description":"\u003ch1\u003eACRO Annual Meeting The Radiation Oncology Summit 2021 VIRTUAL\u003c\/h1\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eACRO invites you to submit an abstract for an oral\/poster presentation at ACRO’s 2021 Annual Meeting. This conference will be an important scientific experience and will allow you to enjoy all of the latest research in the field, combined with outstanding educational programming, and you won’t even have to leave the comfort and safety of your home.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTopics\/Speakers :\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAgenda\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDate of Release :\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e February 24 – 27 – 2021\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eFormat : 36 Videos + 40 PDFs\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eFile Size : 46.2 GB\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489224179866,"sku":"MED-AMB00867","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/acro2021_1920x280_8-14-2020_v1-2-1024x149-1-510x74-1.png?v=1772075487"},{"product_id":"soft-tissue-tumors-masters-of-pathology","title":"Soft Tissue Tumors – Masters of Pathology Series 2018","description":"\u003ch2\u003eSoft Tissue Tumors – Masters of Pathology Series 2018\u003c\/h2\u003e\u003cbr\u003eSoft Tissue Tumors\u003cbr\u003eMasters of Pathology Series\u003cbr\u003e\u003cbr\u003eA wide-ranging review of soft tissue pathology focused on identifying and understanding common and rare tumors found within soft tissue. Earn Lifelong Learning and SAM credits.\u003cbr\u003e\u003cbr\u003eUnderstanding Morphologic Features\u003cbr\u003e\u003cbr\u003eSoft Tissue Tumors – Masters of Pathology Series 2018 This comprehensive review of soft tissue tumor pathology covers a broad range of practical topics useful for practicing pathologists and pathologists in training. It includes an approach to differential diagnosis based on dominant histologic patterns (spindle cell, epithelioid, pleomorphic, round cell, myxoid); a focus on distinctive tumors that arise at particular anatomic sites (gastrointestinal tract, skin, head and neck); and an emphasis on the application of immunohistochemistry and molecular genetics including an overview of recently developed markers and molecular tests.\u003cbr\u003e\u003ch3\u003eQUICK FACTS\u003c\/h3\u003e\u003cbr\u003eProvider: Oakstone\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCourse Director:\u003c\/li\u003e\n\u003cli\u003eJason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eProfessor of Pathology\u003c\/li\u003e\n\u003cli\u003eHarvard Medical School\u003c\/li\u003e\n\u003cli\u003eDirector of Surgical Pathology and Immunohistochemistry\u003c\/li\u003e\n\u003cli\u003eBrigham \u0026amp; Women’s Hospital\u003c\/li\u003e\n\u003cli\u003eBoston, MA\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003ch3\u003eUpon completion of this activity, the participant will be able to:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eFormulate a differential diagnosis for a wide range of soft tissue tumors\u003c\/li\u003e\n\u003cli\u003eApply immunohistochemistry to help resolve the differential diagnosis for a wide range of soft tissue tumors\u003c\/li\u003e\n\u003cli\u003eRecognize the most common molecular genetic alterations in soft tissue tumors that can be evaluated for diagnosis\u003c\/li\u003e\n\u003cli\u003eIntended Audience\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eThis educational activity is intended for Pathologists.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch3\u003eTOPICS\/SPEAKERS\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eIntroduction to Soft Tissue Tumors: Classification, Grading, Immunohistochemistry, and Molecular Genetics – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eEvolution of Diagnostic Immunohistochemistry for Soft Tissue Tumors: From Differentiation to Molecular Genetics (Part 1) – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eEvolution of Diagnostic Immunohistochemistry for Soft Tissue Tumors: From Differentiation to Molecular Genetics (Part 2) – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eThe Most Common Spindle Cell Tumors of Deep Soft Tissue: Differential Diagnosis and Best Markers (Part 1) – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eThe Most Common Spindle Cell Tumors of Deep Soft Tissue: Differential Diagnosis and Best Markers (Part 2) – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSubclassification of Pleomorphic Sarcomas: How and Why Should We Care? – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eAn Approach to Epithelioid Soft Tissue Tumors – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eAn Approach to Round Cell Sarcomas – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eBenign Nerve Sheath Tumors – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eHistiocytic and Dendritic Cell Tumors: An Update – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eGastrointestinal Stromal Tumors: An Update – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMesenchymal Tumors of the Gastrointestinal Tract (other than GIST) – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDifferential Diagnosis of Cutaneous Spindle Cell Tumors – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSuperficial Soft Tissue Tumors: What’s New? – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSoft Tissue Tumors of the Head and Neck: Virtual Slide Seminar – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eIntermediate Vascular Tumors – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMyxoid Tumors of Soft Tissue – Jason L. Hornick, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eDate of Original Release: March 31, 2018\u003cbr\u003eDate of Credit Termination: March 31, 2021\u003cbr\u003eEstimated Time to Complete: 12 hours\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489235976346,"sku":"MED-AMB00899","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/0001848_soft-tissue-tumors_300.jpg?v=1772076036"},{"product_id":"the-brigham-and-dana-farber","title":"The Brigham and Dana-Farber Board Review in Hematology and Oncology 2018","description":"\u003ch3\u003eThe Brigham and Dana-Farber Board Review in Hematology and Oncology 2018\u003c\/h3\u003e\n\u003cdiv\u003eThe Brigham and Dana-Farber Board Review in Hematology and Oncology\u003c\/div\u003e\n\u003cdiv\u003eBrigham and Women’s Hospital Board Review\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eThis comprehensive CME program offers an in-depth, case-base review of the clinical essentials in hematology and oncology. Ideal for MOC.\u003c\/div\u003e\n\u003ch3\u003eImprove Patient Care in Hematology and Oncology\u003c\/h3\u003e\n\u003cdiv\u003eThe Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification\/recertification requirements. Relevant topics are addressed in case-based board review presentations. Improve patient care by learning to:\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003ePerform differential diagnosis of complex hematologic and oncologic disorders\u003c\/li\u003e\n\u003cli\u003eIdentify and apply current therapeutic options for hematologic and oncologic disorders\u003c\/li\u003e\n\u003cli\u003eEvaluate and interpret up-to-date literature relevant to hematology and oncology\u003c\/li\u003e\n\u003cli\u003eIllustrate knowledge of pathophysiology of hematologic and oncologic disorders\u003c\/li\u003e\n\u003cli\u003eIllustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders\u003c\/li\u003e\n\u003cli\u003eApply knowledge gained to the ABIM certification\/recertification Hematology and Oncology examinations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTOPICS\/SPEAKERS\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMolecular Genetics of Cancer – Nikhil Wagle, MD\u003c\/li\u003e\n\u003cli\u003eAdvances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD\u003c\/li\u003e\n\u003cli\u003eInfections in Cancer Patients – Lindsey Baden, MD\u003c\/li\u003e\n\u003cli\u003eSymptom Management in Patients with Cancer – Janet L. Abrahm, MD\u003c\/li\u003e\n\u003cli\u003eCommunication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD\u003c\/li\u003e\n\u003cli\u003eBiology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD\u003c\/li\u003e\n\u003cli\u003eBiology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD\u003c\/li\u003e\n\u003cli\u003eAcute Leukemias – Daniel J. DeAngelo, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMyelodysplastic Syndrome – David P. Steensma, MD\u003c\/li\u003e\n\u003cli\u003eChronic Myelogenous Leukemia – Joseph H. Antin, MD\u003c\/li\u003e\n\u003cli\u003eMyeloproliferative Syndromes – Ann M. Mullally, MD\u003c\/li\u003e\n\u003cli\u003eMultiple Myeloma – Kenneth C. Anderson, MD\u003c\/li\u003e\n\u003cli\u003eWaldenstrom Macroglobulinemia, Amyloidosis – Irene M. Ghobrial, MD\u003c\/li\u003e\n\u003cli\u003eLow Grade Lymphomas – Caron A. Jacobson, MD\u003c\/li\u003e\n\u003cli\u003eHigh Grade Lymphomas – Eric D. Jacobsen, MD\u003c\/li\u003e\n\u003cli\u003eHodgkin’s Lymphoma – Ann S. LaCasce, MD\u003c\/li\u003e\n\u003cli\u003eDiagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD\u003c\/li\u003e\n\u003cli\u003eHead and Neck Cancer – Robert I. Haddad, MD\u003c\/li\u003e\n\u003cli\u003eNatural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD\u003c\/li\u003e\n\u003cli\u003eNon Small Cell Lung Cancer – Mark Awad, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMesothelioma and Thymoma – David M. Jackman, MD\u003c\/li\u003e\n\u003cli\u003eThyroid Cancer – Jochen Lorch, MD\u003c\/li\u003e\n\u003cli\u003eCarcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD\u003c\/li\u003e\n\u003cli\u003eEsophageal and Gastric Cancer – Peter C. Enzinger, MD\u003c\/li\u003e\n\u003cli\u003ePancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD\u003c\/li\u003e\n\u003cli\u003eAnal Cancers – Robert J. Mayer, MD\u003c\/li\u003e\n\u003cli\u003eColorectal Cancers – Robert J. Mayer, MD\u003c\/li\u003e\n\u003cli\u003eGastrointestinal Cancer – Genetic Syndromes – Matthew Yurgelun, MD\u003c\/li\u003e\n\u003cli\u003eGerm Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Mark M. Pomerantz, MD\u003c\/li\u003e\n\u003cli\u003eRenal and Bladder Cancer – Toni K. Choueiri, MD\u003c\/li\u003e\n\u003cli\u003eProstate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD\u003c\/li\u003e\n\u003cli\u003eProstate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMelanoma – F. Stephen Hodi, MD\u003c\/li\u003e\n\u003cli\u003eSarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD\u003c\/li\u003e\n\u003cli\u003eOvarian Cancer – Ursula A. Matulonis, MD\u003c\/li\u003e\n\u003cli\u003eCervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD\u003c\/li\u003e\n\u003cli\u003eNeuro-oncology – David A. Reardon, MD\u003c\/li\u003e\n\u003cli\u003eBreast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH\u003c\/li\u003e\n\u003cli\u003eBreast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD\u003c\/li\u003e\n\u003cli\u003eManagement for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD\u003c\/li\u003e\n\u003cli\u003eBreast Cancer Survivorship – Ann H. Partridge, MD, MPH\u003c\/li\u003e\n\u003cli\u003eHematopoiesis and Cytokines – David T. Scadden, MD\u003c\/li\u003e\n\u003cli\u003eAcquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD\u003c\/li\u003e\n\u003cli\u003eCongenital Bone Marrow Failure – David A. Williams, MD\u003c\/li\u003e\n\u003cli\u003eHemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD\u003c\/li\u003e\n\u003cli\u003eAnemia: An Overview – Ronald P. McCaffrey, MD\u003c\/li\u003e\n\u003cli\u003eIron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD\u003c\/li\u003e\n\u003cli\u003eImmune Hemolytic Anemia – Richard M. Kaufman, MD\u003c\/li\u003e\n\u003cli\u003eNon-immune Hemolytic Anemia – David E. Golan, PhD, MD\u003c\/li\u003e\n\u003cli\u003eSickle Cell Disease – Maureen M. Achebe, MD, MPH\u003c\/li\u003e\n\u003cli\u003eThalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD\u003c\/li\u003e\n\u003cli\u003eDisorders of Neutrophils – Nancy Berliner, MD\u003c\/li\u003e\n\u003cli\u003eAcquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD\u003c\/li\u003e\n\u003cli\u003eHemophilia – Aric D. Parnes, MD\u003c\/li\u003e\n\u003cli\u003eVon Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH\u003c\/li\u003e\n\u003cli\u003eCongenital and Acquired Thrombophilia – Kenneth A. Bauer, MD\u003c\/li\u003e\n\u003cli\u003eNew Oral Anticoagulants – Jean M. Connors, MD\u003c\/li\u003e\n\u003cli\u003eTransfusion Medicine for the Clinician – Walter H. Dzik, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cdiv\u003eUpon completion of this activity, the participant will be able to:\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eApply current\/recommended Hematology and Oncology guidelines in clinical practice\u003c\/li\u003e\n\u003cli\u003ePerform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders\u003c\/li\u003e\n\u003cli\u003eIdentify\/apply current therapeutic options for for specific Hematologic and Oncologic disorders\u003c\/li\u003e\n\u003cli\u003eEvaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology\u003c\/li\u003e\n\u003cli\u003eIllustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders\u003c\/li\u003e\n\u003cli\u003eApply knowledge gained to the ABIM certification\/recertification Hematology and Oncology examinations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eIntended Audience\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eThe activity was planned for fellows\/trainees, practicing Hematology and Oncology specialists (MDs), and other professional affiliates (internists with an interest in Hematology and Oncology) who are preparing to take ABIM Board Review or Recertification Examinations, or who seek CME activities to improve patient care in the areas of Hematology and Oncology Medicine.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003eDate of Original Release: June 30, 2018\u003c\/div\u003e\n\u003cdiv\u003eTermination Date: June 30, 2021\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489239548058,"sku":"MED-AMB00907","price":15.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/0001866_the-brigham-and-dana-farber-board-review-in-hematology-and-oncology.jpg?v=1772076171"},{"product_id":"radiation-oncology-a-comprehensive","title":"Radiation Oncology – A Comprehensive Review 2018","description":"\u003ch3\u003eRadiation Oncology – A Comprehensive Review 2018\u003c\/h3\u003e\n\u003ch3\u003eRadiation Oncology – A Comprehensive Review\u003cbr\u003eOakstone Clinical Update (SA-CME)\u003c\/h3\u003e\u003cbr\u003eRadiation Oncology – A Comprehensive Review 2018 This CME program details the latest developments and emerging trends in curative and palliative radiotherapy techniques, along with expert advice to optimize patient outcomes.\u003cbr\u003e\u003ch3\u003eExplore Key Topics\u003c\/h3\u003e\u003cbr\u003eRadiation Oncology – A Comprehensive Review 2018 this CME program focuses on core concepts and emerging trends. Radiation Oncology – A Comprehensive Review includes case-based lectures on topics like proton radiation therapy in adults, radiation therapy for prostate cancer, spine stereotactic body radiation therapy, soft tissue sarcomas, skin cancer, and more. It will help you to better:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRecognize the importance of clinical evaluation of cancer patients during various treatment phases\u003c\/li\u003e\n\u003cli\u003eOutline effective curative and palliative treatment goals\u003c\/li\u003e\n\u003cli\u003eExplain the potential outcomes of combining immunotherapy and radiation therapy\u003c\/li\u003e\n\u003cli\u003eDiscuss the efficacy of stereotactic body radiation for spinal tumors\u003c\/li\u003e\n\u003cli\u003eEvaluate and overcome challenges encountered in radiation oncology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTOPICS\/SPEAKERS\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eNewer Modalities: Proton Radiation Therapy in Adults – Thomas F. Delaney, MD\u003c\/li\u003e\n\u003cli\u003eNew Modalities: Thermal Therapies and Nanotechnology – Mark W. Dewhirst, DVM, PhD, FASTRO\u003c\/li\u003e\n\u003cli\u003eImaging Applications in Radiation Therapy – Fang-Fang Yin, PhD\u003c\/li\u003e\n\u003cli\u003ePractical Radiotherapy Management of Brain Metastases – Scott Floyd, MD, PhD\u003c\/li\u003e\n\u003cli\u003eRadiation Therapy in the Treatment of Adult Primary Brain Tumors – John P. Kirkpatrick, MD, PhD\u003c\/li\u003e\n\u003cli\u003eHead and Neck Tumors: Trials and PET-CT – David S. Yoo, MD, PhD\u003c\/li\u003e\n\u003cli\u003eHead and Neck Tumors: HPV, Postop, Planning, Progression, Palliation – David S. Yoo, MD, PhD\u003c\/li\u003e\n\u003cli\u003eThoracic Tumors: Non-Small Cell Lung Cancer – Joseph K. Salama, MD\u003c\/li\u003e\n\u003cli\u003eThoracic Tumors: Small Cell Lung Cancer and Pleural Mesothelioma – Christopher Ryan Kelsey, MD\u003c\/li\u003e\n\u003cli\u003eRadiation Therapy for Upper GI Malignancies – Christopher G. Willett, MD\u003c\/li\u003e\n\u003cli\u003eLiver Stereotactic Body Radiation Therapy for Liver Metastases and Hepatocellular Carcinoma – Brian G. Czito, MD\u003c\/li\u003e\n\u003cli\u003eLower Gastrointestinal Tumors: Colon, Rectum, Anus – Manisha Palta, MD\u003c\/li\u003e\n\u003cli\u003eRadiation Therapy for Prostate Cancer – W. Robert Lee, MD, MS, MEd, FASTRO, FABS\u003c\/li\u003e\n\u003cli\u003eTreatment for Muscle-Invasive Bladder Cancer – Ronald C. Chen, MD, MPH\u003c\/li\u003e\n\u003cli\u003eEvidence Based Management of Testicular, Renal, and Penile Cancers – Jason A. Efstathiou, MD, Dphil\u003c\/li\u003e\n\u003cli\u003eRadiotherapy in Breast Cancer: Decision-Making after Mastectomy and Neoadjuvant Chemotherapy – Janet K. Horton, MD\u003c\/li\u003e\n\u003cli\u003eRadiotherapy in Breast Cancer: Decision-Making After Breast Conservation – Rachel C. Blitzblau, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSoft Tissue Sarcomas – David G. Kirsch, MD, PhD\u003c\/li\u003e\n\u003cli\u003eLymphomas: Non-Hodgkin Lymphoma – Andrea K. Ng, MD, MPH\u003c\/li\u003e\n\u003cli\u003eHematologic Malignancies Hodgkin Lymphoma and Plasma Cell Neoplasms – Christopher Ryan Kelsey, MD\u003c\/li\u003e\n\u003cli\u003eGynecologic Tumors: Cervix and Vagina – Akila N. Viswanathan, MD, MPH\u003c\/li\u003e\n\u003cli\u003eGynecologic Tumors: Uterus and Vulva – Junzo P. Chino, MD\u003c\/li\u003e\n\u003cli\u003eThe Experimental and Historical Development of Total Body Irradiation for Bone Marrow Transplantation – Edward C. Halperin, MD, MA\u003c\/li\u003e\n\u003cli\u003ePediatric Malignancies I – CNS Tumors – Torunn I. Yock, MD, MCH\u003c\/li\u003e\n\u003cli\u003ePediatric Malignancies II – Non-CNS Tumors – Torunn I. Yock, MD, MCH\u003c\/li\u003e\n\u003cli\u003eSkin Cancer – Paul M. Busse, MD, PhD\u003c\/li\u003e\n\u003cli\u003eImmunotherapy and Radiation Therapy – Yvonne Mowery, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSpine Stereotactic Body Radiation Therapy – Jordan Torok, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\u003cbr\u003eAt the conclusion of this activity, the participant should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDefine the initial clinical evaluation of a cancer patient – using the physical exam, history, relevant diagnostic studies, and communication with the referring and other physicians involved\u003c\/li\u003e\n\u003cli\u003eFormulate effective curative and palliative treatment goals\u003c\/li\u003e\n\u003cli\u003eDescribe and manage informed consent\u003c\/li\u003e\n\u003cli\u003eOrganize patient education\u003c\/li\u003e\n\u003cli\u003eApply treatment planning\u003c\/li\u003e\n\u003cli\u003eUse clinically appropriate treatment aids\u003c\/li\u003e\n\u003cli\u003eFormulate appropriate dosages\u003c\/li\u003e\n\u003cli\u003eDiscuss effective delivery of treatment\u003c\/li\u003e\n\u003cli\u003ePerform patient evaluation during treatment\u003c\/li\u003e\n\u003cli\u003ePerform follow-up evaluation of the patient\u003c\/li\u003e\n\u003cli\u003eDescribe the potential outcomes of combination therapy of radiotherapy and immunotherapy\u003c\/li\u003e\n\u003cli\u003eDiscuss the efficacy of stereotactic body radiation for spinal tumors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e.Intended Audience\u003c\/h3\u003e\u003cbr\u003eThe activity was planned for Radiation Oncologists in practice, Radiation Oncology Residents and Fellows.\u003cbr\u003e\u003cbr\u003eDate of Original Release: November 15, 2018\u003cbr\u003eDate Credits Expire: November 15, 2021\u003cbr\u003eEstimated time to complete: 29 hours\u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489248493722,"sku":"MED-AMB00923","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/0001998_radiation-oncology-a-comprehensive-review.jpg?v=1772076443"},{"product_id":"the-brigham-board-review-in-hematology","title":"The Brigham Board Review in Hematology and Oncology 2016","description":"\u003ch3\u003eThe Brigham Board Review in Hematology and Oncology 2016\u003c\/h3\u003e\u003cbr\u003eBrigham and Women’s Hospital and Oakstone Board Review\u003cbr\u003e\u003cbr\u003eA comprehensive board review designed to update knowledge and improve practice gaps in hematology and oncology based on American Board of Internal Medicine certification requirements. Ideal for MOC.\u003cbr\u003e\u003cbr\u003eStay Current with this CME Board Review in Hematology and Oncology\u003cbr\u003e\u003cbr\u003eThe Brigham Board Review in Hematology and Oncology is designed to update knowledge and improve practice gaps in hematology and oncology based on American Board of Internal Medicine certification requirements. This case-based board review will help you prep for certification\/recertification with an in-depth look at the clinical essentials in both specialties. You’ll learn to:\u003cbr\u003e\u003cbr\u003ePerform differential diagnosis of complex hematologic and oncologic disorders\u003cbr\u003eIdentify and apply current therapeutic options for hematologic and oncologic disorders\u003cbr\u003eEvaluate and interpret up-to-date literature relevant to hematology and oncology\u003cbr\u003eIllustrate knowledge of pathophysiology of hematologic and oncologic disorders\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eCourse Directors:\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eEdwin P. Alyea, III, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAssociate Professor of Medicine\u003c\/li\u003e\n\u003cli\u003eHarvard Medical School\u003c\/li\u003e\n\u003cli\u003eAssociate Director, Bone Marrow\/Stem Cell Transplantation Program\u003c\/li\u003e\n\u003cli\u003eDirector, Oncology Hospital Medicine\u003c\/li\u003e\n\u003cli\u003eDana Farber Cancer Institute\u003c\/li\u003e\n\u003cli\u003eDepartment of Medicine\u003c\/li\u003e\n\u003cli\u003eBrigham and Women’s Hospital\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eNancy Berliner, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eProfessor of Medicine\u003c\/li\u003e\n\u003cli\u003eHarvard Medical School\u003c\/li\u003e\n\u003cli\u003eChief, Division of Hematology\u003c\/li\u003e\n\u003cli\u003eDepartment of Medicine\u003c\/li\u003e\n\u003cli\u003eBrigham and Women’s Hospital\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eThe Brigham Board Review\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eDistance Learning Series\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eAjay K. Singh, MBBS, FRCP (UK), MBA\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSenior Associate Dean for Global and Continuing Education\u003c\/li\u003e\n\u003cli\u003eDirector, Master in Medical Sciences in Clinical Investigation (MMSCI) Program\u003c\/li\u003e\n\u003cli\u003eHarvard Medical School\u003c\/li\u003e\n\u003cli\u003eDirector, Office of Postgraduate Medical Education\u003c\/li\u003e\n\u003cli\u003ePhysician, Division of Nephrology, Department of Medicine\u003c\/li\u003e\n\u003cli\u003eBrigham and Women’s Hospital\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTOPICS\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMolecular Genetics of Cancer – Levi A. Garraway, MD, PhD\u003c\/li\u003e\n\u003cli\u003eAdvances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD\u003c\/li\u003e\n\u003cli\u003eInfections in Cancer Patients – Joel T. Katz, MD\u003c\/li\u003e\n\u003cli\u003eSymptom Management in Patients with Cancer – Janet L. Abrahm, MD\u003c\/li\u003e\n\u003cli\u003eCommunication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD\u003c\/li\u003e\n\u003cli\u003eBiology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD\u003c\/li\u003e\n\u003cli\u003eBiology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD\u003c\/li\u003e\n\u003cli\u003eAcute Leukemias – Daniel J. DeAngelo, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMyelodysplastic Syndrome – David P. Steensma, MD\u003c\/li\u003e\n\u003cli\u003eChronic Myelogenous Leukemia – Joseph H. Antin. MD\u003c\/li\u003e\n\u003cli\u003eMyeloproliferative Syndromes – Ann M. Mullally, MD\u003c\/li\u003e\n\u003cli\u003eMultiple Myeloma – Kenneth C. Anderson, MD\u003c\/li\u003e\n\u003cli\u003eWaldenstrom’s Macroglobulemia, Amyloidosis – Irene M. Ghobrial, MD\u003c\/li\u003e\n\u003cli\u003eLow Grade Lymphomas – Caron A. Jacobson, MD\u003c\/li\u003e\n\u003cli\u003eHigh Grade Lymphomas – Arnold S. Freedman, MD\u003c\/li\u003e\n\u003cli\u003eHodgkin’s Lymphoma – George P. Canellos, MD\u003c\/li\u003e\n\u003cli\u003eDiagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD\u003c\/li\u003e\n\u003cli\u003eHead and Neck Cancer – Robert I. Haddad, MD\u003c\/li\u003e\n\u003cli\u003eNatural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD\u003c\/li\u003e\n\u003cli\u003eNon Small Cell Lung Cancer – Mark Awad, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMesothelioma and Thymoma – Geoffrey R. Oxnard, MD\u003c\/li\u003e\n\u003cli\u003eThyroid Cancer – Jochen Lorch, MD\u003c\/li\u003e\n\u003cli\u003eCarcinoid and Pancreatic Neuroendocrine Tumors – Matthew H. Kulke, MD\u003c\/li\u003e\n\u003cli\u003eEsophageal and Gastric Cancer – Charles S. Fuchs, MD, MPH\u003c\/li\u003e\n\u003cli\u003ePancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD\u003c\/li\u003e\n\u003cli\u003eAnal Cancers – Robert J. Mayer, MD\u003c\/li\u003e\n\u003cli\u003eColorectal Cancers – Robert J. Mayer, MD\u003c\/li\u003e\n\u003cli\u003eGastrointestinal Cancer- Genetic Syndromes – Matthew Yurgelun, MD\u003c\/li\u003e\n\u003cli\u003eGerm Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Christopher J. Sweeney, MBBS\u003c\/li\u003e\n\u003cli\u003eRenal and Bladder Cancer – Toni K. Choueiri, MD\u003c\/li\u003e\n\u003cli\u003eProstate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD\u003c\/li\u003e\n\u003cli\u003eProstate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMelanoma – F. Stephen Hodi, MD\u003c\/li\u003e\n\u003cli\u003eSarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD\u003c\/li\u003e\n\u003cli\u003eOvarian Cancer – Ursula A. Matulonis, MD\u003c\/li\u003e\n\u003cli\u003eCervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD\u003c\/li\u003e\n\u003cli\u003eNeuro-oncology – David A. Reardon, MD\u003c\/li\u003e\n\u003cli\u003eBreast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH\u003c\/li\u003e\n\u003cli\u003eBreast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD\u003c\/li\u003e\n\u003cli\u003eManagement for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD\u003c\/li\u003e\n\u003cli\u003eBreast Cancer Survivorship – Ann H. Partridge, MD, MPH\u003c\/li\u003e\n\u003cli\u003eHematopoiesis and Cytokines – David T. Scadden, MD\u003c\/li\u003e\n\u003cli\u003eAcquired Bone Marrow Failure – Julie A. Losman. MD\u003c\/li\u003e\n\u003cli\u003eCongenital Bone Marrow Failure – David A. Williams, MD\u003c\/li\u003e\n\u003cli\u003eHemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD\u003c\/li\u003e\n\u003cli\u003eAnemia: An Overview – Ronald P. McCaffrey, MD\u003c\/li\u003e\n\u003cli\u003eIron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD\u003c\/li\u003e\n\u003cli\u003eImmune Hemolytic Anemia – Richard M. Kaufman, MD\u003c\/li\u003e\n\u003cli\u003eNon-immune Hemolytic Anemia – David E. Golan, PhD, MD\u003c\/li\u003e\n\u003cli\u003eSickle Cell Disease – Maureen M. Okam, MD, MBBS\u003c\/li\u003e\n\u003cli\u003eThalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD\u003c\/li\u003e\n\u003cli\u003eDisorders of Neutrophils – Nancy Berliner, MD\u003c\/li\u003e\n\u003cli\u003eAcquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD\u003c\/li\u003e\n\u003cli\u003eHemophilia – Ellis J. Neufeld, MD, PhD\u003c\/li\u003e\n\u003cli\u003eVon Willebrand Disease and Congenital Platelet Disorders – Robert I. Handin, MD\u003c\/li\u003e\n\u003cli\u003eCongenital and Acquired Thrombophilia – Kenneth A. Bauer, MD\u003c\/li\u003e\n\u003cli\u003eNew Oral Anticoagulants – Jean M. Connors, MD\u003c\/li\u003e\n\u003cli\u003eTransfusion Medicine for the Clinician – Walter H. Dzik, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\u003cbr\u003eUpon completion of this activity, the participant will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eApply current\/recommended Hematology and Oncology guidelines in clinical practice\u003c\/li\u003e\n\u003cli\u003ePerform differential diagnosis of complex clinical presentations related to Hematologic and Oncologic disorders\u003c\/li\u003e\n\u003cli\u003eIdentify\/apply current therapeutic options for for specific Hematologic and Oncologic disorders\u003c\/li\u003e\n\u003cli\u003eEvaluate and interpret up-to-date literature relevant to clinical practice in Hematology and Oncology\u003c\/li\u003e\n\u003cli\u003eIllustrate knowledge of pathophysiology as it applies to management of Hematology and Oncology disorders\u003c\/li\u003e\n\u003cli\u003eApply knowledge gained to the ABIM certification\/recertification Hematology and Oncology examinations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eIntended Audience\u003c\/h3\u003e\u003cbr\u003eThis course is designed to provide hematology\/oncology fellows\/trainees, hematologists, oncologists and internists with new knowledge and management strategies to enhance the care of their patients, as well prepare candidates for the ABIM subspecialty board exams in hematology or medical oncology.\u003cbr\u003e\u003cbr\u003eDate of Original Release: June 30, 2016\u003cbr\u003eTermination Date: June 30, 2019\u003cbr\u003e\u003cbr\u003eHOMEPAGE: http:\/\/www.oakstone.com\/the-brigham-board-review-in-hematology-and-oncology","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489248624794,"sku":"MED-AMB00927","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/the-brigham-board-review-in-hematology-and-oncology-2016.jpg?v=1772076512"},{"product_id":"oncology-board-and-certification-review-1000-questions","title":"oncology board and Certification Review 1000 questions and explanations 2023 edition 7th edition","description":"\u003ch2\u003eOncology: Board and Certification Review, 7th edition (Azw3 Book)\u003c\/h2\u003e\u003cbr\u003eoncology board and Certification Review 1000 questions and explanations 2023 edition 7th edition This StatPearls review (7th edition) is designed to help you maximize your score on the Oncology Exam. Our questions target the American Board of Internal Medicine® and American Osteopathic Board of Internal Medicine® content outlines and match the question structure. We have 1st, 2nd, and 3rd order multiple choice questions and four detailed teaching points to help you rapidly prepare and achieve the best score possible.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003ch3\u003eBy StatPearls Publishing LLC, Howard Goldsweig, Hani Babiker, Anup Kasi\u003c\/h3\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eGet the best possible score on the Oncology Exam\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eThis StatPearls review (7th edition) is designed to help you maximize your score on the Oncology Exam. Our questions target the American Board of Internal Medicine® and American Osteopathic Board of Internal Medicine® content outlines and match the question structure. We have 1st, 2nd, and 3rd order multiple choice questions and four detailed teaching points to help you rapidly prepare and achieve the best score possible.\u003c\/li\u003e\n\u003cli\u003eThe questions are updated annually by 915 authors and 992 editors to improve your learning experience and to better match exam requirements. The single best way to improve your performance is to DO MORE QUESTIONS!\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eKnow The American Board of Internal Medicine® and American Osteopathic Board of Internal Medicine® Exam\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eThe exam is approximately 7 hours and consists of 300 questions with a pass rate of 85%. The exam covers Hematologic Neoplasms – 14%, Thoracic Cancer – 11%, Breast Cancer – 13%, Genitourinary Cancer – 12%, Gynecologic Cancer – 4%, Gastrointestinal Cancer – 13.5%, Skin Cancer, Sarcomas, and Unknown Primary Sit – 6%, Anticancer Therapeutics, Clinical Research Methodology, and Ethics – 9.5%, Palliative Care, Survivorship, and Communication – 11%, Head, Neck, Thyroid, and Central Nervous System Malignancies – 4%, and Genetics, Genomics, and Tumor Biology – 2% .\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eAbout StatPearls\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eStarted as an academic teaching project in 2014, StatPearls has grown into the largest library of medical education in the world. More than 7,500 medical authors and editors have published more than 8,000 peer-reviewed PubMed indexed articles covering every specialty in healthcare. Along with these articles are more than 75,000 multiple choice questions with teaching points related to the content were created. These questions were then matched to the content outlines for every board and certification exam in healthcare, including our Oncology Exam review. This effort by thousands of sub-specialty experts has made StatPearls the most-comprehensive review resource available.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eASIN\u003c\/strong\u003e ‏ : ‎ B014OOYQOS\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePublisher ‏ :\u003c\/strong\u003e ‎ StatPearls Publishing, LLC; 7th edition (August 30, 2023)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePublication date ‏\u003c\/strong\u003e : ‎ August 30, 2023\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLanguage\u003c\/strong\u003e ‏ : ‎ English\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489257668762,"sku":"MED-AMB00975","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Oncology-Board-and-Certification-Review-7th-edition.jpg?v=1772077266"},{"product_id":"2022-best-of-asco-video-and-slide-bundle","title":"2022 Best of ASCO Video and Slide Bundle","description":"\u003ch2\u003e2022 Best of ASCO Video and Slide Bundle\u003c\/h2\u003e\u003cbr\u003eThe 2022 Best of ASCO Annual Meeting Video \u0026amp; Slides Bundle includes captured presentations and downloadable slides from all three of the 2022 Best of ASCO meetings, (pending presenter permission). Access the presentations and slides on your laptop, PC, or view using your mobile device. The slides are high-resolution images suitable for use in your personal presentations. There is no limit on the number of slides you can download, and access is provided for 3 years post meeting.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eNote: videos and slides become available within 6-12 hours after the presentation. Attendees of the Meeting automatically have access to this product included with their registration. Members receive a 20% discount on all products. During checkout, please enter your ASCO.org username or member ID for the discount to apply. This product does not provide continuing education credit.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eProgram :\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eWelcome and Chair Remarks\u003c\/li\u003e\n\u003cli\u003e Breast Cancer\u003c\/li\u003e\n\u003cli\u003e Central Nervous System Tumors\u003c\/li\u003e\n\u003cli\u003e Education Session: Implementing Geriatric Assessment in Community Oncology Clinics\u003c\/li\u003e\n\u003cli\u003e Education Session: Strategies to Advance Equity in Cancer Clinical Trials\u003c\/li\u003e\n\u003cli\u003e Gastrointestinal Cancers\u003c\/li\u003e\n\u003cli\u003eGenitourinary Cancers\u003c\/li\u003e\n\u003cli\u003eGynecologic Cancer\u003c\/li\u003e\n\u003cli\u003e Head and Neck Cancer\u003c\/li\u003e\n\u003cli\u003eHematologic Malignancies\u003c\/li\u003e\n\u003cli\u003e Lung Cancer\u003c\/li\u003e\n\u003cli\u003eMelanoma_Skin Cancers\u003c\/li\u003e\n\u003cli\u003eSarcoma\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489310982298,"sku":"MED-AMB01010","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/2022-Best-of-ASCO-Video-and-Slide-Bundle.jpg?v=1772077914"},{"product_id":"the-2022-md-anderson-cancer-center-baylor-college-of-medicine-hematology-and-medical-oncology-board-review-materials","title":"The 2022 MD Anderson Cancer Center\/Baylor College of Medicine Hematology and Medical Oncology Board Review Materials","description":"\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv\u003eThe 2022 MD Anderson Cancer Center\/Baylor College of Medicine Hematology and Medical Oncology Board Review Materials The course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies.\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cstrong\u003e84 Videos Mp4\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e120 PDF\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003ch3\u003e\u003cspan style=\"color: #1b1919; font-size: 18px;\"\u003eTarget Audience\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e - General Surgery, Geriatric Medicine, Gynecologic Oncology, Maternal-Fetal Medicine, Medical Biochemical Genetics, Medical Genetics and Genomics, Medical Microbiology Pathology, Neuroradiology, Pediatric Hospital Medicine, Thoracic Surgery\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e - Nurse - RN, Physician (MD or DO), Physician Associate, Student or Trainee\u003c\/div\u003e\n\u003ch4 class=\"activitysectionbold\"\u003eOverview\u003c\/h4\u003e\n\u003cbr\u003eThe course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv\u003eAt the conclusion of this activity, learners will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eApply knowledge gained to prepare for the hematology and medical oncology subspecialty.\u003c\/li\u003e\n\u003cli\u003eUtilize current standards of care for patients with cancer, blood disorders and malignancies.\u003c\/li\u003e\n\u003cli\u003eDemonstrate proficiency of knowledge in hematology and medical oncology.\u003c\/li\u003e\n\u003cli\u003eIncorporate recent advances in management of hematologic and oncologic patients.\u003c\/li\u003e\n\u003cli\u003eDefine molecular determinants of cancer risk and apply this knowledge in practice.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch4 class=\"activitysectionbold\"\u003eRegistration\u003c\/h4\u003e\n\u003cstrong\u003eA Virtual Live Streaming Course\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThe Comprehensive Board Review in Hematology and Medical Oncology will be virtual. This program will be presented only as a live streaming course. You will receive an email from the course platform to log in and access the live course online approximately a week before the conference.\u003cstrong\u003e \u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cstrong\u003eConference Date: October 3, 2022 – October 8, 2022\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003ca href=\"https:\/\/mdanderson.cloud-cme.com\/assets\/mdanderson\/pdf\/Board%20Review%20-%20H\u0026amp;MO\/19996%20agenda%206.24.2022.pdf\"\u003e19996 agenda 6.24.2022.pdf (cloud-cme.com)\u003c\/a\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSolid Tumor Session\u003c\/li\u003e\n\u003cli\u003eMalignant Hematology Session\u003c\/li\u003e\n\u003cli\u003eBenign Hematology Session\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489385398426,"sku":"MED-AMB01177","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/The-2022-MD-Anderson-Cancer-Center-Baylor-College-of-Medicine-Hematology-and-Medical-Oncology-Board-Review-Materials.webp?v=1772080256"},{"product_id":"nha-phlebotomy-exam-2022-2023","title":"NHA Phlebotomy Exam 2022-2023: Study Guide with 400 Practice Questions and Answers for National Healthcareer","description":"\u003ch3\u003eNHA Phlebotomy Exam 2022-2023: Study Guide with 400 Practice Questions and Answers for National Healthcareer Association Certified Phlebotomy Technician Examination (AZW3 + EPUB + Converted PDF)\u003c\/h3\u003e\n\u003ch3\u003e\u003cspan style=\"color: #555555; font-size: 14.4px;\"\u003eBy Mona Lindsey\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003cstrong\u003eIntroduction:\u003c\/strong\u003e The “NHA Phlebotomy Exam 2022-2023” study guide serves as an essential resource for individuals aiming to excel in the NHA Certified Phlebotomy Technician Exam. This guide offers comprehensive preparation, consolidating crucial information and practice questions in one accessible reference. By providing a detailed overview of the exam’s content, potential questions, and effective test-taking strategies, this study guide empowers aspiring phlebotomists to confidently approach the exam, thereby enhancing their prospects of obtaining certification and launching their careers.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eKey Features:\u003c\/strong\u003e The “NHA Phlebotomy Exam 2022-2023” offers a range of valuable features:\u003cbr\u003e\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eHolistic Exam Preparation:\u003c\/strong\u003e The study guide offers a systematic approach to preparing for the NHA Certified Phlebotomy Technician Exam, addressing the core knowledge areas required for success.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Question Bank:\u003c\/strong\u003e The guide contains an extensive array of practice questions, encompassing topics such as blood components, needlestick safety, vascular anatomy, routine blood collection, and more.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProgress Assessment:\u003c\/strong\u003e Aspiring phlebotomists can evaluate their knowledge and progress through the guide’s self-assessment tools, which facilitate tracking and readiness assessment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetailed Explanations:\u003c\/strong\u003e The guide includes comprehensive explanations for answers, enabling learners to grasp the rationale behind each response and learn from their mistakes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSimulated Exam Experience:\u003c\/strong\u003e Through comprehensive practice tests, the guide simulates the actual exam experience, covering critical subjects such as Safety and Compliance, Processing, and more.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cstrong\u003eTarget Audience:\u003c\/strong\u003e The “NHA Phlebotomy Exam 2022-2023” study guide is tailored for:\u003cbr\u003e\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eAspiring Phlebotomy Technicians:\u003c\/strong\u003e Individuals aspiring to become certified phlebotomy technicians benefit from this comprehensive guide, equipping them with the knowledge, confidence, and preparation needed to excel in the NHA Certified Phlebotomy Technician Exam.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cstrong\u003eConclusion:\u003c\/strong\u003e The “NHA Phlebotomy Exam 2022-2023” study guide is an indispensable tool for individuals on the path to becoming certified phlebotomy technicians. By offering a focused, comprehensive approach to exam preparation, it enhances candidates’ readiness and confidence. Through its practice questions, detailed explanations, and simulated exam experience, the guide provides a multifaceted resource that aids aspirants in mastering the exam’s content. Whether seeking to solidify existing knowledge or address potential gaps, this study guide empowers individuals to approach the NHA Certified Phlebotomy Technician Exam with assurance and determination.\u003cbr\u003e\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ Hanley Publications (August 4, 2022)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eeBook Digital ‏ : ‎ 252 pages\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 1951652630\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-1951652630\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489395851418,"sku":"MED-AMB01190","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/nha-phlebotomy-exam-2022-2023-study-guide-with-400-practice-questions-and-answers-for-national-healthcareer-association-certified-phlebotomy-technician-examination-azw3-epub-converted.jpg?v=1772080477"},{"product_id":"wintrobes-clinical-hematology-15th-edition","title":"Wintrobe’s Clinical Hematology, 15th Edition (converted pdf )","description":"By Robert T. Means Jr. MD, Daniel A. Arber MD, Bertil E. Glader MD PhD, Frederick R Appelbaum, George M. Rodgers MD PhD, Angela Dispenzieri, Todd A. Fehniger, Laura Michaelis, John Leonard\u003cbr\u003eSelected as a Doody’s Core Title for 2023! Comprehensive in scope and thoroughly up to date, Wintrobe’s Clinical Hematology, 15th Edition, combines the biology and pathophysiology of hematology as well as the diagnosis and treatment of commonly encountered hematological disorders.\u003cbr\u003e\u003cbr\u003eEditor-in-chief Dr. Robert T. Means, Jr., along with a team of expert section editors and contributing authors, provide authoritative, in-depth information on the biology and pathophysiology of lymphomas, leukemias, platelet destruction, and other hematological disorders as well as the procedures for diagnosing and treating them. Packed with more than 1,500 tables and figures throughout, this trusted text is an indispensable reference for hematologists, oncologists, residents, nurse practitioners, and pathologists.\u003cbr\u003e\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ LWW; Fifteenth edition (July 8, 2023)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eeBook Digital ‏ : ‎ 2544 pages\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 1975184696\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-1975184698\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\n\u003cli\u003eProvides expert coverage of new topics, including COVID-19, palliative care and survivorship, transitioning from pediatric to adult care, and ethical issues in hematology such as management of individuals with religious\/cultural objections to transfusion\u003c\/li\u003e\n\u003cli\u003eIntegrates WHO classifications of hematologic neoplasms and the latest knowledge in genetics and genomics, and includes focused chapters on hematopoietic cell transplantation, gene therapy, and immunotherapy\u003c\/li\u003e\n\u003cli\u003eEmphasizes four components of diagnosis: the morphology of the peripheral smear, bone marrow, lymph nodes, and other tissues; flow cytometry; cytogenetics; and molecular markers and mutations\u003c\/li\u003e\n\u003cli\u003eOffers fresh perspectives from new section editors Drs. John Leonard (Lymphoma) and Laura Michaelis (Leukemia\/MPN), as well as numerous new contributing authors, many of whom provide international viewpoints on hematologyEnrich Your eBook Reading Experience\u003c\/li\u003e\n\u003cli\u003eRead directly on your preferred device(s), such as computer, tablet, or smartphone.\u003c\/li\u003e\n\u003cli\u003eEasily convert to audiobook, powering your content with natural language text-to-speech.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489412137114,"sku":"MED-AMB01211","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/wintrobes-clinical-hematology-15th-edition-epub.webp?v=1772080814"},{"product_id":"the-osler-cytology-2023","title":"The Osler Cytology 2023 Subscription-Based Review","description":"\u003ch2\u003eThe Osler Cytology 2023 Subscription-Based Review\u003c\/h2\u003e\u003cbr\u003eThe Osler Cytology 2023 Subscription-Based Review The Osler Institute utilized state-of-the-art equipment to record our Live Virtual Webinar August 2023  comprehensive Cytology Review Course and bring it to you!  These files are stored “in the cloud,” so you can stream them anywhere, anytime, as long as you have an internet connection and watch or listen to them on your phone or computer.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAs a result, the learning experience is almost like being at a live activity without travel costs and time away from your practice.  In addition, each online review is a downloadable copy of the syllabus corresponding to the Video lectures for your use while viewing or as a free-standing study or clinical practice guide.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"col large-12\" id=\"comments\"\u003e\n\u003cstrong\u003e+ Include: 26 videos + 1 pdf, size: 4.33 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: pathologist\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eThis comprehensive review is designed to update your clinical knowledge base and help you pass your Cytopathology exams (certifying or CC).  Emphasis is on evidence-based practice and board-relevant standards of care, incorporating new concepts and testing strategies as well as quality control and laboratory management techniques to help you hone your diagnostic and consulting skills.  Many of our previous participants found the course provided them with improved diagnostic and evaluation skills and helped them recognize specific areas of weakness for self-study.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch4\u003e\u003cstrong\u003eRelease Date: September 18, 2023\u003c\/strong\u003e\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ch4\u003e\u003cstrong\u003eExpiration Date: September 17, 2026\u003c\/strong\u003e\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ch4\u003e\u003cstrong\u003eEstimated Time to Complete: 26 hours\u003c\/strong\u003e\u003c\/h4\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 class=\"yikes-custom-woo-tab-title yikes-custom-woo-tab-title-learning-objectives\"\u003eLearning Objectives\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe the common types of cytology specimens and how to prepare them for evaluation correctly.\u003c\/li\u003e\n\u003cli\u003eRecognize standard elements and benign reactive processes vs. abnormal and neoplastic lesions for each organ system.\u003c\/li\u003e\n\u003cli\u003eApply current consensus diagnostic terms and criteria for classifying non-neoplastic and neoplastic lesions of each organ system.\u003c\/li\u003e\n\u003cli\u003eUnderstand the importance of implementing rapid on-site evaluation (ROSE) of tissue samples derived from fine needle aspirations to reduce healthcare costs and patient inconvenience.\u003c\/li\u003e\n\u003cli\u003eApply increased knowledge of cytopathology to achieve subspecialty certification or recertification.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e01 Salivary Gland Cytopathology.ts\u003c\/li\u003e\n\u003cli\u003e02 Gastrointestinal Cytology.ts\u003c\/li\u003e\n\u003cli\u003e03 Breast Cytology.ts\u003c\/li\u003e\n\u003cli\u003e04 Virtual Lab Salivary Glands Gi And Breast.ts\u003c\/li\u003e\n\u003cli\u003e05 Bone And Soft Tissue Cytology I.ts\u003c\/li\u003e\n\u003cli\u003e06 Bone And Soft Tissue Cytology II.ts\u003c\/li\u003e\n\u003cli\u003e07 Cerebrospinal Fluid Cytology.ts\u003c\/li\u003e\n\u003cli\u003e08 Body Fluid Cytology.ts\u003c\/li\u003e\n\u003cli\u003e09 Virtual Lab Bone And Soft Tissue.ts\u003c\/li\u003e\n\u003cli\u003e10 Virtual Lab Csf And Body Fluids.ts\u003c\/li\u003e\n\u003cli\u003e11 Lymphoma And Mediatinum I.ts\u003c\/li\u003e\n\u003cli\u003e12 Lymphoma And Mediastinum II.ts\u003c\/li\u003e\n\u003cli\u003e13 Pancreatobiliary Cytology.ts\u003c\/li\u003e\n\u003cli\u003e14 Virtual Lab Pancreatobiliary.ts\u003c\/li\u003e\n\u003cli\u003e15 Gyn Cytology I.ts\u003c\/li\u003e\n\u003cli\u003e16 Gyn Cytology II.ts\u003c\/li\u003e\n\u003cli\u003e17 Gyn Cytology III.ts\u003c\/li\u003e\n\u003cli\u003e18 Gyn Cytology IV.ts\u003c\/li\u003e\n\u003cli\u003e19 Virtual Lab Gyn Cytology.ts\u003c\/li\u003e\n\u003cli\u003e20 Lung Cytology.ts\u003c\/li\u003e\n\u003cli\u003e21 Urine Cytology.ts\u003c\/li\u003e\n\u003cli\u003e22 Virtual Lab Lung And Urine.ts\u003c\/li\u003e\n\u003cli\u003e23 Thyroid Cytology.ts\u003c\/li\u003e\n\u003cli\u003e24 Virtual Lab Thyroid.ts\u003c\/li\u003e\n\u003cli\u003e25 Lab Management I.ts\u003c\/li\u003e\n\u003cli\u003e26 Lab Management II.ts\u003c\/li\u003e\n\u003cli\u003eCYT_2023.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"col s12 m12 l6 xl6\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489423245466,"sku":"MED-AMB01224","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/5967329052148744980_109-1.jpg?v=1772081039"},{"product_id":"2023-best-of-asco-annual-meeting","title":"2023 Best of ASCO Annual Meeting (Video and Slide Bundle)","description":"2023 Best of ASCO Annual Meeting (Video and Slide Bundle) The 2023 Best of ASCO Video \u0026amp; Slides Bundle includes captured presentations and downloadable slides from the 2023 BOA Symposium, (pending presenter permission), held from July 21-22nd. Access the presentations and slides on your laptop, PC, or view using your mobile device.\u003cbr\u003e\u003cbr\u003eThe slides are high-resolution images suitable for use in your personal presentations. There is no limit on the number of slides you can download, and access is provided for 3 years post meeting.\u003cbr\u003e\u003ch3\u003eFormat : 11 Videos + Slides\u003c\/h3\u003e\n\u003cdiv class=\"prod-filesize\"\u003e\n\u003ch3\u003eFile Size : 3.43 GB\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cfooter\u003e\n\u003cdiv class=\"container-footer\"\u003e\n\u003cdiv class=\"layout-zone-footer py-2 container-fluid\" id=\"footer\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"col-12 mb-3\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/footer\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489427079322,"sku":"MED-AMB01232","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/2022-Best-of-ASCO-Video-and-Slide-Bundle_c6e4c2c3-7ab9-489c-9a2e-d3d485c3782a.jpg?v=1772081139"},{"product_id":"hematology-basic-principles","title":"Hematology: Basic Principles and Practice, 8th Edition (True PDF from Publisher)","description":"\u003cdiv class=\"custom-single-product product type-product post-260382 status-publish first instock product_cat-hot-books product_cat-hematology has-post-thumbnail sale featured downloadable virtual sold-individually purchasable product-type-simple\" id=\"product-260382\"\u003e\n\u003cdiv class=\"single-product-desc\"\u003e\n\u003cdiv class=\"single-product-head\"\u003e\n\u003cdiv class=\"prod-info\"\u003e\n\u003cdiv class=\"woo-tab-container custom\"\u003e\n\u003cdiv class=\"tabcontent active\" id=\"descriptionTab\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003ch1\u003eHematology: Basic Principles and Practice, 8th Edition (True PDF from Publisher)\u003c\/h1\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eBy Ronald Hoffman MD, Edward J. Benz Jr. MD, Leslie E. Silberstein MD, Helen Heslop MD, Jeffrey Weitz MD, Mohamed Salama MD, Syed Ali Abutalib\u003cbr\u003eExtensively revised, comprehensive content from leading global contributors ensures that Hematology, 8th Edition, remains your #1 choice for expert guidance in all areas of this rapidly advancing subspecialty. This edition reflects the numerous advances that are redefining the field and dramatically influencing new approaches to diagnosis, treatment, and outcomes. Well-illustrated and clinically focused, it details the basic science and clinical practice of hematology and hematopoietic cellular therapy―covering virtually all aspects of hematology in one definitive resource.\u003cbr\u003e\u003cul class=\"a-unordered-list a-vertical\"\u003e\n\u003cli\u003eCovers all hematologic disorders, including comprehensive discussions of hematologic malignancies, individualized patient care, cell-based therapies, transplantation, transfusion medicine, hemostasis, thrombosis, and consultative hematology―in one convenient volume.\u003c\/li\u003e\n\u003cli\u003eProvides state-of-the-art guidance from global experts at the forefront of the latest research and clinical practice.\u003c\/li\u003e\n\u003cli\u003eProvides extensive updates throughout on basic science research, advances in molecular diagnostics, new drugs, immunotherapies, personalized medicine, laboratory medicine, transfusion medicine, stem cell transplantation, and clinical treatment for all hematologic malignancies and non-malignancies\u003c\/li\u003e\n\u003cli\u003eContains new chapters on gene editing; the impact of mitochondria on hematopoiesis; myelodysplastic syndrome\/myeloproliferative neoplasm overlap syndromes; immunotherapy and management of its toxicities; transfusion medicine in sickle cell disease; principles of radiation therapy; and COVID-19, including complications of vaccination and its impact on the hematologic system.\u003c\/li\u003e\n\u003cli\u003eDiscusses many new advances in the field, including details and the future of gene therapy for hemophilia, gene editing for sickle cell disease and thalassemia, the evolution of cellular therapy, use of cells, transfusion medicine vs. protein therapy, gene sequencing, immunotherapy, and new targeted drugs.\u003c\/li\u003e\n\u003cli\u003eIncludes more decision-making algorithms for formulating diagnoses and personalized treatment plans for those highly complex disorders that require individualized approaches.\u003c\/li\u003e\n\u003cli\u003eAddresses the effects of aging on hematopoiesis and on the manifestations of a variety of hematologic disorders.\u003c\/li\u003e\n\u003cli\u003eDiscusses cardio-oncology and its impact on the treatment of patients with hematologic disorders.\u003c\/li\u003e\n\u003cli\u003ePresents relevant basic science as background for clinical application in later sections.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ Elsevier; 8th edition (January 16, 2023)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eHardcover ‏ : ‎ 2512 pages\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 0323733883\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-0323733885\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003caside class=\"section-product__sidebar\"\u003e\n\u003cdiv class=\"prods-widget\"\u003e\n\u003ch2\u003eYou Might Also Like\u003c\/h2\u003e\n\u003cdiv class=\"prods-widget_body\"\u003e\n\u003cdiv class=\"related-products related-products-swiper section-books__body swiper-initialized swiper-horizontal swiper-pointer-events swiper-watch-progress swiper-backface-hidden\"\u003e\n\u003cdiv aria-live=\"polite\" class=\"books-list swiper-wrapper\" id=\"swiper-wrapper-8b10e8137fe5710199\"\u003e\n\u003cdiv aria-label=\"1 \/ 4\" class=\"books-list__item swiper-slide swiper-slide-visible swiper-slide-active\" role=\"group\"\u003e\n\u003cdiv class=\"book-li\"\u003e\n\u003cdiv class=\"book__img_block\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/aside\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489548058778,"sku":"MED-AMB01420","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/9780323733885.webp?v=1772083793"},{"product_id":"uscap-update-on-hematopathology-classification","title":"USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023","description":"\u003ch4\u003eUSCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023\u003c\/h4\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cbr\u003e\u003cbr\u003eUSCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023 The diagnosis and classification of hematopoietic tumors is increasingly complex and evolves rapidly.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cul\u003e\n\u003cli\u003eThe introduction of the International Consensus Classification (ICC) of Myeloid and Lymphoid Neoplasms and publication of the proposed 5th edition World Health Organization (WHO) classification of the same tumors is the latest stage in this evolution and both further expand the clinical, morphologic, immunophenotypic and molecular genetic criteria for diagnosis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cul\u003e\n\u003cli\u003eJoin USCAP and learn from developers of the ICC on what is new in the classification of these tumors and how the ICC and proposed WHO compare. Leading clinical experts in hematology\/oncology will also provide clinician perspectives on the importance of proper disease classification. The course will include disease specific lectures as well as opportunities to join experts in interactive microscopy sessions to gain practical knowledge on how to implement the new disease classifications into practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003ch5\u003eVideos+PDFs\u003c\/h5\u003e\n\u003ch5\u003e\n\u003cstrong\u003eOriginal release date: \u003c\/strong\u003eNovember 17, 2023\u003c\/h5\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608087\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608087\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003chgroup\u003e\n\u003ch3\u003eSmall B-cell Neoplasms – Rebecca King, MD\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608089\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608089\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eLymphoplasmacytic Lymphoma, Myeloma and Related Neoplasms – James Cook, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608091\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608091\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eCutaneous Lymphomas – John Goodlad, MD, MBChB, FRCPath\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608108\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608108\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eClinician Perspective on the Diagnosis of B-cell Lymphoma – Jane Winter, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608127\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608127\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eAggressive B-cell Lymphomas – Elias Campo, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608130\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608130\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eHodgkin Lymphoma and Grey Zone Lymphomas – Elias Campo, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608133\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608133\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eT-cell Lymphoma – Leticia Quintanilla-Fend, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 2 Presentations 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608134\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608134\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eMolecular Approach to Malignant Lymphoma – Laurence de Leval, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608139\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608139\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eClinician Perspective on the Diagnosis of T-cell Neoplasms – Steve Horwitz, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608141\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608141\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eImmunodeficiency-associated Lymphoproliferative Disorders – Elaine Jaffe, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"624828\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/624828\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eHistiocytic and Dendritic Cell Neoplasms – Elaine Jaffe, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608142\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608142\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eAcute Lymphoblastic Leukemia\/Lymphoma and Acute Leukemias of Ambiguous Lineage – Michael Borowitz, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608144\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608144\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eClonal Hematopoiesis and Myelodysplastic Syndromes – Robert Hasserjian, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608145\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608145\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eMyeloproliferative Neoplasms – Hans-Michael Kvasnicka, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"624802\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/624802\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"state-notices-block\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003chgroup\u003e\n\u003ch3\u003eMastocytosis – Attilio Orazi, MD, FRCPath\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"624812\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/624812\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eClinician Perspective on the Diagnosis of Eosinophilic and Mast Cell Disorders – Ayalew Tefferi, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608148\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608148\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eMyeloid\/lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions – Sa Wang, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"624824\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/624824\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eMyelodysplastic\/myeloproliferative Neoplasms – Attilio Orazi, MD, FRCPath\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608151\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608151\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003ePediatric and\/or Germline Disorders – Katherine Calvo, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608152\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608152\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eAcute Myeloid Leukemia – Daniel Arber, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608153\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608153\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eClinician Perspective on the Diagnosis of Acute Myeloid Leukemia – Olatoyosi Odenike, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"608154\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/608154\" data-updated-at=\"2023-11-28 17:28:16 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eMolecular Approach to Myeloid Disorders – Adam Bagg, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cul\u003e\n\u003cli style=\"list-style-type: none;\"\u003e\n\u003cul\u003e\n\u003cli class=\"meta\"\u003eSection: 1 Presentation 1 Document\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489599209626,"sku":"MED-AMB01490","price":90.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/USCAP-Update-On-Hematopathology-Classification-The-International-Consensus-Classification-Perspective-2023.png?v=1772084941"},{"product_id":"2023-asco-breakthrough-video-and-slide-bundle","title":"2023 ASCO Breakthrough (Video And Slide Bundle)","description":"\u003cdiv\u003e2023 ASCO Breakthrough (Video And Slide Bundle)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eThe 2023 ASCO Breakthrough Meeting Video \u0026amp; Slides Bundle includes captured presentations and downloadable slides from the 2023 Symposium, (pending presenter permission), held from August 3-5th. Access the presentations and slides on your laptop, PC, or view using your mobile device. The slides are high-resolution images suitable for use in your personal presentations. There is no limit on the number of slides you can download, and access is provided for 3 years post meeting.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489706688666,"sku":"MED-AMB01599","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/2023-ASCO-Breakthrough-Video-And-Slide-Bundle.jpg?v=1772086992"},{"product_id":"the-md-anderson-hematology-and-medical-oncology-board-review-2023","title":"The MD Anderson Hematology and Medical Oncology Board Review 2023 (Videos + PDF)","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cbr\u003e\u003cbr\u003eEdition : 2023\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cbr\u003e\u003cbr\u003eFormat : 85 MP4 + 118 PDF files\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"prod-filesize\"\u003e\n\u003cbr\u003e\u003cbr\u003eFile Size : 19.22 GB\u003cbr\u003e\u003ch3\u003e\u003cstrong\u003eConference Date: September 25, 2023 – September 30, 2023\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch3 class=\"activitysectionbold\"\u003eOverview\u003c\/h3\u003e\n\u003cbr\u003eThe MD Anderson Hematology and Medical Oncology Board Review 2023 (Videos + PDF) This program should be of interest to Physicians, Advanced Practice Providers, APNs, and Nurses.\u003cbr\u003e\u003ch3\u003eObjectives\u003c\/h3\u003e\n\u003cdiv\u003eAt the conclusion of this educational activity, participants should be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eApply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology;\u003c\/li\u003e\n\u003cli\u003eUtilize current standards of care for patients with cancer, blood disorders and malignancies;\u003c\/li\u003e\n\u003cli\u003eDemonstrate proficiency of knowledge in hematology and medical oncology;\u003c\/li\u003e\n\u003cli\u003eIncorporate recent advances in management of hematologic and oncologic patients; and\u003c\/li\u003e\n\u003cli\u003eDefine molecular determinants of cancer risk and apply this knowledge in practice.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003eProgram\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eBenign Hematology Session\u003c\/li\u003e\n\u003cli\u003eMalignant Hematology Session\u003c\/li\u003e\n\u003cli\u003eSolid Tumor Session\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"\" class=\"--description panel\" id=\"\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489708097690,"sku":"MED-AMB01600","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/The-MD-Anderson-Hematology-and-Medical-Oncology-Board-Review-2023-Videos-PDF-scaled.jpg?v=1772087008"},{"product_id":"2024-surgical-pathology-update","title":"2024 Surgical Pathology Update: Diagnostic Pearls for the Practicing Pathologist: Vol. VIII","description":"\u003ch1 class=\"product-title product_title entry-title\"\u003e2024 Surgical Pathology Update: Diagnostic Pearls for the Practicing Pathologist: Vol. VIII\u003c\/h1\u003e\u003cbr\u003e2024 Surgical Pathology Update: Diagnostic Pearls for the Practicing Pathologist: Vol. VIII This pathology CME video teaching activity has been designed to provide a comprehensive review of key topics in surgical pathology, including gastrointestinal, orthopedic, pulmonary, breast, head and neck, and gynecologic pathology.\u003cbr\u003e\u003ch3\u003eTopics\u003c\/h3\u003e\n\u003ch4\u003eRelease date feb 2024\u003c\/h4\u003e\n\u003ch2\u003eTITLES\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003eBarrett’s Esophagus and BE-Related Dysplasia\u003c\/li\u003e\n\u003cli\u003eKeratinizing Dysplasia and Viral-associated Cancers of the Upper Aerodigestive Tract\u003c\/li\u003e\n\u003cli\u003eA Robust Approach to Difficult Core Biopsies\u003c\/li\u003e\n\u003cli\u003eCurrent Issues in Prostate Pathology\u003c\/li\u003e\n\u003cli\u003eA Case-Based Discussion of Vulvar Pathology: Updates in Practice\u003c\/li\u003e\n\u003cli\u003eColorectal Polyps: Terminology and Diagnostic Issues\u003c\/li\u003e\n\u003cli\u003eA Practical Approach to Fatty Liver Disease\u003c\/li\u003e\n\u003cli\u003eBiopsy Diagnosis of Salivary Gland Neoplasms: Challenges and Diagnostic Pitfalls\u003c\/li\u003e\n\u003cli\u003ePathology of Recurrent and Metastatic Breast Carcinoma\u003c\/li\u003e\n\u003cli\u003eUpdates in Renal Tumor Diagnosis\u003c\/li\u003e\n\u003cli\u003eA Case-Based Discussion of Endometrial Carcinoma: Updates in Practice\u003c\/li\u003e\n\u003cli\u003ePancreatic Neoplasms and Inflammatory Mimics\u003c\/li\u003e\n\u003cli\u003eFollicular Patterned Thyroid Neoplasms: Diagnostic Challenges\u003c\/li\u003e\n\u003cli\u003eIBD and IBD-Related Dysplasia\u003c\/li\u003e\n\u003cli\u003eEverything HER2: Including Updates on “HER2 Low”\u003c\/li\u003e\n\u003cli\u003eSelect Topics in Bladder and Testicular Pathology\u003c\/li\u003e\n\u003cli\u003eLower Gastrointestinal Tract Cancers and Biomarker Reporting\u003c\/li\u003e\n\u003cli\u003eA Case-Based Discussion of Mesenchymal Neoplasia: Updates in Practice\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489709736090,"sku":"MED-AMB01601","price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/2024-Surgical-Pathology-Update-Diagnostic-Pearls-for-the-Practicing-Pathologist-2.jpg?v=1772087029"},{"product_id":"hematology-board-review-blueprint-study-guide-and-qa-2nd-edition","title":"Hematology Board Review: Blueprint Study Guide And Q\u0026A, 2nd Edition (Original PDF From Publisher)","description":"\u003ch3\u003eHematology Board Review: Blueprint Study Guide And Q\u0026amp;A, 2nd Edition (Original PDF From Publisher)\u003c\/h3\u003e\u003cbr\u003eHematology Board Review: Blueprint Study Guide And Q\u0026amp;A, 2nd Edition Now in its second edition, Hematology Board Review has been thoroughly revised and updated to contain the latest information that fellows and clinicians need to successfully prepare for the Hematology Certification Exam administered by the American Board of Internal Medicine (ABIM). The new edition now contains even more high yield board study content and review questions.\u003cbr\u003e\u003ch4 class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003eBy\u003cspan class=\"author notFaded\" data-width=\"\"\u003e\u003cb\u003e Khoriaty, Rami N., MD \u003c\/b\u003e\u003cspan class=\"contribution\"\u003e\u003cspan class=\"a-color-secondary\"\u003e(Author)\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eFor the hematology-oncology fellow, hematologist, medical oncologist, or internist looking to review a given disease or blueprint category prior to their examination, this extremely practical study guide provides the pertinent points of emphasis that are often highlighted on the exam. Chapters on blood disorders and disease sites cover epidemiology, etiology and risk factors, staging, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. Clinical pearls on other major subspecialty areas found on the exam include hematologic emergencies and supportive care, transfusion medicine, stem cell biology and hematopoiesis, cellular therapy, management of hematologic disease, complications after cellular therapy, and biostatistics. With 240 practice questions, detailed rationales, and a convenient print + digital package, Hematology Board Review gives you the tools to study your way and the confidence to pass the first time!\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv id=\"description\"\u003e\n\u003ch2\u003eKey Features:\u003c\/h2\u003e\n\u003cbr\u003eAligns with the latest Hematology Certification Exam ABIM blueprint Provides a comprehensive yet concise review of all hematologic malignancies, blood disorders, transfusion medicine, cellular therapy, standard treatment regimens, and biostatisticsRevised to include new treatment recommendations and FDA approvalsIncludes end-of-chapter assessment questions with detailed rationales - a total of 240 questions\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublisher: \u003c\/span\u003eSpringer Publishing Company; December 27, 2023\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eLanguage: \u003c\/span\u003eEnglish\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN: \u003c\/span\u003e9780826188021\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN: \u003c\/span\u003e9780826188038\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489754792090,"sku":"MED-AMB01643","price":5.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Hematology-Board-Review-Blueprint-Study-Guide-And-QA-2nd-Edition-Original-PDF-From-Publisher.webp?v=1772087648"},{"product_id":"the-esmo-gynaecological-cancers-congress-2023","title":"The ESMO Gynaecological Cancers Congress 2023","description":"\u003cspan style=\"color: #1b1919; font-size: 24px;\"\u003eThe ESMO Gynaecological Cancers Congress 2023\u003c\/span\u003e has become an essential annual appointment for oncology professionals treating patients with such malignancies – the place to learn the latest promising news, acquire high quality education and exchange ideas.\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cspan style=\"color: #1b1919; font-size: 24px;\"\u003e took place onsite in Barcelona, on 23-24 February 2023, and online, through a virtual platform.\u003c\/span\u003e\n\u003cbr\u003e\u003cul\u003eThis edition featured the innovative LIVE Plus format, which provided a wealth of opportunities for exchange of ideas among delegates.\u003c\/ul\u003e\n\u003cdiv class=\"ezxmltext-field\"\u003e\n\u003cbr\u003e\u003cbr\u003eAt this event, delegates had the chance to learn about practice challenges and controversies, brainstorm with peers and explore further opportunities to advance their careers.\u003cbr\u003e\u003cbr\u003eESMO Gynaecological Cancers has become an essential annual appointment for oncology professionals treating patients with such malignancies – the place to learn the latest promising news, acquire high quality education and exchange ideas.\u003cbr\u003e\u003ch3\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdl\u003e\n\u003cdt\u003eStart date 23 Feb 2023\u003c\/dt\u003e\n\u003cdt\u003eEnd date 24 Feb 2023\u003c\/dt\u003e\n\u003cdt\u003eLocation Barcelona, Spain\u003c\/dt\u003e\n\u003cdt\u003e\u003c\/dt\u003e\n\u003c\/dl\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch3\u003eESMO Gynaecological Cancers Scientific Co-Chairs\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSusana Banerjee\u003c\/strong\u003e, London, UK\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDomenica Lorusso\u003c\/strong\u003e, Rome, IT\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBradley J. Monk\u003c\/strong\u003e, Phoenix, AZ, USA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eScientific Committee Members\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRobert Coleman\u003c\/strong\u003e, Houston, TX, USA\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNicole Concin\u003c\/strong\u003e, Innsbruck, Austria\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKosei Hasegawa\u003c\/strong\u003e, Saitama, Japan\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAna Oaknin\u003c\/strong\u003e, Barcelona, Spain\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIsabelle Ray-Coquard\u003c\/strong\u003e, Lyon, France\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003ch2\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003eADCs in gynaecological cancers Introduction.mp4\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers Role of ADCs in cervical cancer treatment in the era of immunotherapy.mp4\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers Role of ADCs in cervical cancer treatment in the era of immunotherapy.pdf\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers The evolving ADC treatment landscape in ovarian cancer.mp4\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers The evolving ADC treatment landscape in ovarian cancer.pdf\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers The new challenge ADC class effects, on off-target adverse reactions and their interdisciplinary management.mp4\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers The new challenge ADC class effects, on off-target adverse reactions and their interdisciplinary management.pdf\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers Understanding the basics Structure, key properties, mechanism of action, optimal diagnostic test to determine the\u003c\/li\u003e\n\u003cli\u003etarget.mp4\u003c\/li\u003e\n\u003cli\u003eADCs in gynaecological cancers Understanding the basics Structure, key properties, mechanism of action, optimal diagnostic test to determine the\u003c\/li\u003e\n\u003cli\u003etarget.pdf\u003c\/li\u003e\n\u003cli\u003eAstraZeneca – Long-term survival Evidence from first-line PARPi maintenance trials.mp4\u003c\/li\u003e\n\u003cli\u003eAstraZeneca – Long-term survival Integrating the latest data into clinical practice.mp4\u003c\/li\u003e\n\u003cli\u003eAstraZeneca – Long-term survival Welcome and introduction.mp4\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Beyond immunotherapy What is the role of HER2, p53 and other molecular targets in the recurrent.mp4\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Beyond immunotherapy What is the role of HER2, p53 and other molecular targets in the recurrent.pdf\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Introduction.mp4\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Introduction.pdf\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Is immunotherapy changing the face of recurrent metastatic endometrial cancer.mp4\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Is immunotherapy changing the face of recurrent metastatic endometrial cancer.pdf\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Revisiting the adjuvant therapy in endometrial cancer ESMO Guidelines.mp4\u003c\/li\u003e\n\u003cli\u003eEndometrial cancer Revisiting the adjuvant therapy in endometrial cancer ESMO Guidelines.pdf\u003c\/li\u003e\n\u003cli\u003eESMO Colloquium supported Concluding remarks.mp4\u003c\/li\u003e\n\u003cli\u003eESMO Colloquium supported Emerging molecular profiling models for advanced endometrial cancer.mp4\u003c\/li\u003e\n\u003cli\u003eESMO Colloquium supported Introduction.mp4\u003c\/li\u003e\n\u003cli\u003eESMO Colloquium supported Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eESMO Colloquium supported Research insights- New immunotherapy combinations in clinical development for gynecological malignancies.mp4\u003c\/li\u003e\n\u003cli\u003eESMO Colloquium supported The landscape of approved immune checkpoint inhibitors and TKI combinations in advanced endometrial cancer.mp4\u003c\/li\u003e\n\u003cli\u003efinal_programme_gynae23hybrid.pdf\u003c\/li\u003e\n\u003cli\u003eGSK – Shifting the treatment paradigm of OC EC Live Q\u0026amp;A and discussion.mp4\u003c\/li\u003e\n\u003cli\u003eGSK – Shifting the treatment paradigm of OC EC Where are we going with EC- Aiming to improve outcomes in primary advanced or recurrent.mp4\u003c\/li\u003e\n\u003cli\u003eGSK – Shifting the treatment paradigm of OC EC Where are we going with OC- Evolving the management of 1L.mp4\u003c\/li\u003e\n\u003cli\u003eGSK – Shifting the treatment paradigm of OC EC Where are we now- Latest advances in treatment of gynecologic cancer.mp4\u003c\/li\u003e\n\u003cli\u003eHow hot is HIPEC treatment in ovarian cancer HIPEC is not IT (CON).pdf\u003c\/li\u003e\n\u003cli\u003eHow hot is HIPEC treatment in ovarian cancer Introduction and first vote.mp4\u003c\/li\u003e\n\u003cli\u003eHow hot is HIPEC treatment in ovarian cancer Introduction and first vote.pdf\u003c\/li\u003e\n\u003cli\u003eHow hot is HIPEC treatment in ovarian cancer Second vote and conclusions.mp4\u003c\/li\u003e\n\u003cli\u003eHow hot is HIPEC treatment in ovarian cancer Second vote and conclusions.pdf\u003c\/li\u003e\n\u003cli\u003eHow hot is HIPEC treatment in ovarian cancer The data absolutely support integration of HIPEC into primary ovarian cancer management (PRO).mp4\u003c\/li\u003e\n\u003cli\u003eHow hot is HIPEC treatment in ovarian cancer The data absolutely support integration of HIPEC into primary ovarian cancer management (PRO).pdf\u003c\/li\u003e\n\u003cli\u003eHow to interpret overall survival data with PARP inhibitors Is there a biological rationale to support decremental impact on overall survival.mp4\u003c\/li\u003e\n\u003cli\u003eHow to interpret overall survival data with PARP inhibitors Is there a biological rationale to support decremental impact on overall survival.pdf\u003c\/li\u003e\n\u003cli\u003eHow to interpret overall survival data with PARP inhibitors Is there clinical evidence to support the link between PARPi use and a negative impact on OS.mp4\u003c\/li\u003e\n\u003cli\u003eHow to interpret overall survival data with PARP inhibitors Is there clinical evidence to support the link between PARPi use and a negative impact on OS.pdf\u003c\/li\u003e\n\u003cli\u003eHow to interpret overall survival data with PARP inhibitors Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eHow to interpret overall survival data with PARP inhibitors Why are we having this Symposium Recent regulatory actions by FDA.mp4\u003c\/li\u003e\n\u003cli\u003eHow to interpret overall survival data with PARP inhibitors Why are we having this Symposium Recent regulatory actions by FDA.pdf\u003c\/li\u003e\n\u003cli\u003eIs cervical cancer still an orphan disease Immunotherapy in cervical cancer A paradigm shift.mp4\u003c\/li\u003e\n\u003cli\u003eIs cervical cancer still an orphan disease Immunotherapy in cervical cancer A paradigm shift.pdf\u003c\/li\u003e\n\u003cli\u003eIs cervical cancer still an orphan disease Innovative techniques in radiation oncology to increase cure and reduce toxicity.mp4\u003c\/li\u003e\n\u003cli\u003eIs cervical cancer still an orphan disease Innovative techniques in radiation oncology to increase cure and reduce toxicity.pdf\u003c\/li\u003e\n\u003cli\u003eIs cervical cancer still an orphan disease Molecular profiling and pathology of cervical cancer patients.mp4\u003c\/li\u003e\n\u003cli\u003eIs cervical cancer still an orphan disease Molecular profiling and pathology of cervical cancer patients.pdf\u003c\/li\u003e\n\u003cli\u003eIs cervical cancer still an orphan disease Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eKeynote address Introduction to the Keynote lecture.mp4\u003c\/li\u003e\n\u003cli\u003eKeynote address Pandemomics Challenging assumptions in gynecologic oncology.mp4\u003c\/li\u003e\n\u003cli\u003eKeynote address Pandemomics Challenging assumptions in gynecologic oncology.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session 1MO – Identification of RAD51 foci in cancer-associated circulating cells and their association.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session 1MO – Identification of RAD51 foci in cancer-associated circulating cells and their association.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session 22MO – Homologous Recombination Gene Mutations in Uterine Serous Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session 22MO – Homologous Recombination Gene Mutations in Uterine Serous Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session 36MO – Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (OC).mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session 36MO – Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (OC).pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session 37MO – Niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session 37MO – Niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session 39MO – Clinical evaluation of a low-coverage whole-genome test for homologous recombination deficiency detection in ovarian cancer.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session 39MO – Clinical evaluation of a low-coverage whole-genome test for homologous recombination deficiency detection in ovarian cancer.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session 40MO – Targetable Gene Mutations in Mucinous Ovarian Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session 40MO – Targetable Gene Mutations in Mucinous Ovarian Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session 74MO – Clinical outcomes for pelvic node-positive vulvar carcinoma in the PET and IMRT era.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session 74MO – Clinical outcomes for pelvic node-positive vulvar carcinoma in the PET and IMRT era.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session Invited Discussant of abstracts 22MO, 38MO, 39MO and 1MO.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session Invited Discussant of abstracts 22MO, 38MO, 39MO and 1MO.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session Invited Discussant of abstracts 36MO and 37MO.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session Invited Discussant of abstracts 36MO and 37MO.pdf\u003c\/li\u003e\n\u003cli\u003eMini Oral session Invited Discussant of abstracts 40MO and 74MO.mp4\u003c\/li\u003e\n\u003cli\u003eMini Oral session Invited Discussant of abstracts 40MO and 74MO.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 10P – Neoadjuvant chemotherapy with bevacizumab for IIb stage cervical cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 11P – Conization before radical hysterectomy in early cervical cancer A Korean multi-center study.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 12P – Tisotumab vedotin in recurrent or metastatic cervical cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 13P – Cervical cancer screening in a Basic Health Unit in South of Brazil impact of the COVID-19 pandemic.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 14P – Clinical Outcomes Of Women Who Attend The Cameroon Baptist Convention Health Services.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 15P – Efficacy and safety analysis of recombinant human endostatin (Endostar).pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 16P – Impact of Preoperative versus Postoperative radiotherapy and radical hysterectomy without systemic.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 17P – Impact of adjuvant chemoradiotherapy on survival outcome compared to other treatment modalities for cervical cancer stage IIIc.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 18P – Prospective Randomized Comparison of Quality of Life in Locally Advanced Cervical Cancer treated with Intracavitary or Interstitial Brachytherapy.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 19P – Neoadjuvant chemotherapy followed by radical surgery vs chemoradiotherapy in patients with cervical cancer (stage IIB, FIGO 2018).pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 20P – Randomized Comparison of four Radiotherapy schedules in locally advanced cervical cancer A Prospective study.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 21TiP – Molecular Alterations Predictive of Outcome in Early Staged Cervical Cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 23P – Pre-treatment inflammatory indexes predict the clinical outcome of patients with endometrial cancer a MITO24 study.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 24P – A phase II trial of Docetaxel cisplatin chemotherapy followed by pelvic radiation therapy.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 25P – Prognostic classification of endometrial cancer according to transcriptomic-based immunophenotype.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 26P – Demographics and survival outcomes in patients (pts) with advanced or recurrent (A R) endometrial cancer (EC) in the English real-world (RW) setting.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 27P – Treatment Outcomes and Toxicity Profiles in South Asian patients of High-Risk Endometrial Cancer treated with PORTEC-3 trial regimen.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 28P – Clinicopathologic characteristics and oncologic outcomes of mismatch repair-deficient microsatellite instability-high endometrial cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 29P – Outcomes of patients with intermediate-high risk early stage endometrial cancer after surgery according to adjuvant treatment.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 2P – Outcomes of patients with gynecological tumors harboring HER2 defects.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 30P – Validation of MODEPLEX technology for the determination of POLE hotspot mutations in endometrial carcinoma samples.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 31P – Uterine Cancer Metastasis Patterns and Racial Disparities A SEER Database Population Study 2010-2019.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 3P – NaPi2b Expression in High Grade Serous Ovarian Cancer results from combined data sets.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 41P – Phase 1 analysis of ubamatamab (MUC16xCD3 bispecific antibody) in patients with recurrent ovarian cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 42P – Efficacy of maintenance with PARPi in advanced ovarian cancer according to the location of BRCA mutation.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 43P – Time to next treatment (TTNT) of first-line maintenance (1Lm) niraparib monotherapy in epithelial ovarian cancer (EOC).pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 44P – Real-world overall survival in second-line maintenance niraparib monotherapy vs active surveillance in patients with recurrent ovarian cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 45P – MITO39 Effiacy and tolerability of PLD-Trabectedin in the treatment of relapsed Ovarian Cancer after maintenance therapy with PARP-i.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 46P – Long-term residual chemotherapy-induced peripheral neuropathy (CIPN) and relationship with single nucleotides polymorphisms (SNPs).pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 47P – Platinum rechallenge (PtRc) for high-grade epithelial ovarian cancer (HGEOC) patients (pts) considered not eligible for further platinum therapy.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 48P – Response to chemotherapy following PARP inhibition in ovarian cancer (OC) patients at Mount Vernon Cancer Centre.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 49P – First Report on Pan-Immune-Inflammation Value as a New Prognostic Factor in Ovarian Cancer A Biomarker Analysis of OVANORDEST-1 Study.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 4P – Evaluation of Antitumor Activity and Immunogenic Cell Death (ICD) Induction.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 50P – Can We Learn From Failures A Systematic Review and Metanalysis of Phase III Trials in Platinum Resistant Ovarian Cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 51P – Efficacy of PARP inhibitors in patients with advanced high grade serous ovarian cancer according to BRCA domain mutations.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 52P – Real world data of Niraparib in platinum sensitive relapsed ovarian cancer a multicenter experience of the MITO group.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 53P – Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 54P – Fallopian tube cancer and ovarian cancer A real-world comparison of epidemiological patterns, clinical outcomes, and mutational landscape.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 55P – Evolution of Genetic Testing after Ovarian Cancer (OC) diagnosis.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 56P – Differential response to DNA damaging agents of patients carrying the germline BRCA1 c.211 A-G pathogenic variant.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 57P – International Ovarian Tumor Analysis (IOTA) Simple Ultrasound Rules and Risk of Malignancy Index in differentiating benign.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 58P – The lymphocyte activation gene-3 (LAG-3) protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 59P – Expression of CD47 a potent `don’t eat me’ signal’ in ovarian cancer (OC)- Correlation with other immune features and evolution under neoadjuvant.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 5P – Physiologically relevant treatment models to investigate epigenetic mechanisms driving platinum.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 60P – Deciphering CD8+ T-cell-related gene signatures in the tumor microenvironment to predict the immunotherapy response and prognosis.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 61P – Fluorescent detection of epithelial cells in intraoperative flushes in ovarian cancer in the liquid biochip format.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 62P – Development of deep learning-based auto-segmentation algorithms to diagnose and indicate peritoneal carcinomatosis lesions of ovarian cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 63P – Redefining the role of CA 19-9 as a prognostic marker in Epithelial Ovarian Cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 64P – Malignant Brenner Tumor of the Ovary- impact of adjuvant chemotherapy, age, race, laterality and stage on survival outcome.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 65P – Clinical outcomes in ovarian clear cell carcinoma A UK single centre experience.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 66P – PD-L1 expression following neoadjuvant chemotherapy is upregulated and serves as a prognostic factor.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 67P – Survival and reproductive outcomes of patients with malignant ovarian germ cell tumors, a retrospective analysis.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 68P – Prognosis of ovarian cancer patients with the Mexican founder mutation (a BRCA1 long genomic rearrangement).pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 69P – Relationship between BRCA genotype by location and duration of response to iPARP treatment. Real-life data.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 6P – Unveiling the impact of intra-tumor heterogeneity in treatment response to achieve personalized medicine.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 70P – Prognostic factors and outcome in ovarian adult granulosa-cell tumours a retrospective real-world data.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 71P – survival outcomes of patients with recurrent malignant ovarian germ cell tumors, a retrospective analysis from a tertiary cancer center.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 72TiP – AVALON Trial Phase 2b Study of Maveropepimut-S and Low-Dose Cyclophosphamide in Subjects with Platinum-Resistant.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 73TiP – Niraparib maintenance in first line ovarian cancer MITO 40 an observational real-life study.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 75P – Clinical characteristics and Desensitization protocol of Chemotherapy-induced Hypersensitivity reactions in patients with gynecologic cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 76P – To do or not to do Endometrial biopsy in younger women with abnormal uterine bleeding.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 77P – The impact of COVID-19 on gynecological cancer diagnoses in Greece.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 78P – Electronic tool for high grade Adverse Event (AE) reporting in gynecology (gyne) clinical trials (ClinT) at Princess Margaret Cancer Centre (PM).pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 79P – The situation of gynecological cancer before and after COVID – 19 pandemic years in Kosovo.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 7P – Integration of whole genome sequencing (WGS) into NHS pathways for high-grade ovarian cancer (HGOC).pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 80P – Efficacy, FDA approval, innovativeness, clinical evidence, and price of breast, ovarian, endometrial, and cervical cancer drugs.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 8P – NXP800 versus cisplatin in ARID1a-mutated Ovarian Clear Cell Carcinoma xenograft models.pdf\u003c\/li\u003e\n\u003cli\u003ePoster Display session 9P – The Survival Effect And Prognost-c Factors Of Residual Tumor Conf.pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 32O – 5-year (y) overall survival (OS) with maintenance olaparib (ola) plus bevacizumab (bev) by clinical risk in patients (pts).mp4\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 32O – 5-year (y) overall survival (OS) with maintenance olaparib (ola) plus bevacizumab (bev) by clinical risk in patients (pts).pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 33O – PRIMA ENGOT-OV26 GOG-3012 study long-term conditional PFS.mp4\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 33O – PRIMA ENGOT-OV26 GOG-3012 study long-term conditional PFS.pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 34O – ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss.mp4\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 34O – ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss.pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 35O – Overall Survival of Niraparib with Individualized Starting Dose as Maintenance Therapy in Patients with Platinum-Sensitive Recurrent Ovarian Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eProffered Paper session 35O – Overall Survival of Niraparib with Individualized Starting Dose as Maintenance Therapy in Patients with Platinum-Sensitive Recurrent Ovarian Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session Invited Discussant of abstract 34O.mp4\u003c\/li\u003e\n\u003cli\u003eProffered Paper session Invited Discussant of abstract 34O.pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session Invited Discussant of abstract 35O.mp4\u003c\/li\u003e\n\u003cli\u003eProffered Paper session Invited Discussant of abstract 35O.pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session Invited Discussant of abstracts 32O and 33O.mp4\u003c\/li\u003e\n\u003cli\u003eProffered Paper session Invited Discussant of abstracts 32O and 33O.pdf\u003c\/li\u003e\n\u003cli\u003eProffered Paper session Q\u0026amp;A and discussion.mp4\u003c\/li\u003e\n\u003cli\u003eRare cancers Introduction.mp4\u003c\/li\u003e\n\u003cli\u003eRare cancers Is immune therapy definitely required for all clear cell carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eRare cancers Is immune therapy definitely required for all clear cell carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eRare cancers Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eRare cancers State-of-the-art management in carcinosarcoma From the biology to treatment.mp4\u003c\/li\u003e\n\u003cli\u003eRare cancers State-of-the-art management in carcinosarcoma From the biology to treatment.pdf\u003c\/li\u003e\n\u003cli\u003eRare cancers Which drugs could be relevant for LGSC The present and future.mp4\u003c\/li\u003e\n\u003cli\u003eRare cancers Which drugs could be relevant for LGSC The present and future.pdf\u003c\/li\u003e\n\u003cli\u003eRegeneron – VELOCISUITE- Leveraging Regeneron’s technologies to produce an innovative therapeutic pipeline.mp4\u003c\/li\u003e\n\u003cli\u003eSeagen – Driving towards the future Key messages and close.mp4\u003c\/li\u003e\n\u003cli\u003eSeagen – Driving towards the future Welcome and introduction.mp4\u003c\/li\u003e\n\u003cli\u003eSeagen – Driving towards the future What has changed and what’s next in the 1L setting for r_m CC-.mp4\u003c\/li\u003e\n\u003cli\u003eSeagen – Driving towards the future What’s new and how can we improve 2L management of r_m CC-.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs Do we still need radical surgery in the PARP inhibitor era.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs Do we still need radical surgery in the PARP inhibitor era.pdf\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs How to select the best first line maintenance treatment.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs How to select the best first line maintenance treatment.pdf\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs Introduction.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs New treatment in the current ovarian cancer beyond ADCs.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs New treatment in the current ovarian cancer beyond ADCs.pdf\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs PARP inhibitors Mechanism of resistance and how to overcome.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs PARP inhibitors Mechanism of resistance and how to overcome.pdf\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs Welcome to the ESMO Gynaecological Cancers Congress 2023.mp4\u003c\/li\u003e\n\u003cli\u003eWelcome from the Congress Chairs Welcome to the ESMO Gynaecological Cancers Congress 2023.pdf\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489797226650,"sku":"MED-AMB01658","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/European-Society-for-Medical-Oncology-Gynaecological-Cancers-Congress-2023-1.jpg?v=1772088112"},{"product_id":"physicians-cancer-chemotherapy-drug-manual-2024-24th","title":"Physicians' Cancer Chemotherapy Drug Manual 2024 24th","description":"\u003cp class=\"a-spacing-none a-text-normal\" id=\"title\"\u003e\u003cstrong style=\"color: #333333; font-size: 16px;\"\u003eThe Physicians’ Cancer Chemotherapy Drug Manual :\u003c\/strong\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e Completely revised and updated for 2024,\u003c\/span\u003e\u003cstrong style=\"color: #333333; font-size: 16px;\"\u003e the Physicians’ Cancer Chemotherapy Drug Manual\u003c\/strong\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens―both on- and off-label―for the treatment of all the major cancers. \u003c\/span\u003e\u003c\/p\u003e\nmore\n\u003cbr\u003e\u003ch2 class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003eKey Features:\u003c\/span\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e Includes 12 new agents and several new supplemental indications that have all been approved by the FDA within the past year \u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003eUpdated new indications for previously approved agents \u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003eIndications, drug doses and schedules, toxicities, and special considerations for each agent expanded and revised\u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e  A specific chapter focused on antiemetic treatment regimens for both acute and delayed nausea\/vomiting\u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e  Diagrams of drug structures and pathways for many of the agents \u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003eA comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages • Covers toxicity and drug–drug interactions \u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e A section on chemotherapy regimens for all major cancers\u003c\/span\u003e\u003c\/li\u003e\n\u003cli class=\"a-spacing-none a-text-normal\"\u003e\u003cspan style=\"color: #333333; font-size: 16px;\"\u003e  Provides an overview of the basic principles of cancer drug therapy Your must-have Physicians' Cancer Chemotherapy Drug Manual is available for your iPhone, iPad, and Android\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv aria-labelledby=\"\" class=\"--description panel\" id=\"\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003cdiv class=\"celwidget\" data-cel-widget=\"editorialReviews_feature_div\" data-csa-c-asin=\"\" data-csa-c-content-id=\"editorialReviews\" data-csa-c-id=\"hx2cdo-vw2cit-x9r05o-dehgmk\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-slot-id=\"editorialReviews_feature_div\" data-csa-c-type=\"widget\" data-feature-name=\"editorialReviews\" id=\"editorialReviews_feature_div\"\u003e\n\u003cdiv class=\"a-section a-spacing-small a-padding-base\"\u003e\n\u003ch3\u003eAbout the Author\u003c\/h3\u003e\n\u003cdiv class=\"a-section a-spacing-small a-padding-small\"\u003e\n\u003cbr\u003e\u003cbr\u003eDr. Edward Chu is a Professor of Medicine, Chief of the Division of Hematology-Oncology, and Deputy Director at the University of Pittsburgh Cancer Institute. Dr.Chu was also recently named Director of the National Cancer Institute-designated Albert Einstein Cancer Center, Vice President for Cancer Medicine at Montefiore Medicine, Professor of Medicine and of Molecular Pharmacology; and will hold the Carol and Roger Einiger Professorship of Cancer Medicine at Einstein. He received his MD degree from Brown University, where he also completed his residency training in Internal Medicine Residency. He then went to the National Cancer Institute in Bethesda, MD for fellowship training in Medical Oncology. Following completion of his fellowship, he remained at the NCI as a Senior Clinical Investigator. In 1996, he was recruited as a Professor of Medicine and Pharmacology at the Yale University School of Medicine where he assumed the positions of Director of the VACT Cancer Center, Associate Director of the Yale Cancer Center, and co-Director of the Developmental Therapeutics Program at the Yale Cancer Center. Dr. Chu is well-known for his basic research that has investigated the determinants of resistance to the fluoropyrimidine class of anticancer agents. In particular, his group has made seminal observations on the regulation of expression of thymidylate synthase, a critical target in cancer chemotherapy, with specific focus on elucidating novel translational regulatory mechanisms. In addition, his group is actively involved in developing novel compounds and strategies for the treatment of colorectal cancer as well as other human malignancies. He has worked closely with a number of drug companies to develop novel agents, and these companies include Roche, Bristol-MyersSquibb, Astra Zeneca, Eli Lilly, Pharmacia, GlaxoSmithKline, Imclone, Vion, and Tularik. He serves on the scientific advisory boards of Advrx Pharmaceuticals, Celator, Etex, Phytoceutica, and Eximias, all of which are drug development companies. He is the author of the Physicians’ Cancer Chemotherapy Drug Manual which includes a comprehensive review of all of the main drugs and drug regimens currently used in clinical practice for oncology. He is the founding Editor-in-Chief of the Clinical Colorectal Cancer journal and is the Chairman of the International Colorectal Congress, which is an annual international meeting focused on management and treatment of colorectal cancer.\u003cbr\u003e\u003cbr\u003eDr. DeVita is Professor of Medicine and Professor of Epidemiology and Public Health at the Yale University School of Medicine in New Haven, CT. He is the former Director of the National Cancer Institute and developed the cure for Hodgkin's Disease and other lymphomas. He is the Director Emeritus at the Yale Cancer Center and has received numerous awards including the Mary and Albert Lasker Prize, the Medal of Honor from the American Cancer Society, the first Pezcoller Award from the European School of Oncology, the Armand Hammer Cancer Prize and the Surgeon General's Exemplary Service Medal. He recently was recognized with the 50th Anniversary Commemorative Award from the Leukemia Society of America and was the recipient of the first Saul Rosenberg Research Award from the Lymphoma Research Foundation of America. Dr. DeVita also served as co-chair of the National Cancer Legislative Advisory Committee for revising the National Cancer Act of 1971.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"celwidget\" data-cel-widget=\"btfSubNavDesktop_feature_div\" data-csa-c-asin=\"\" data-csa-c-content-id=\"btfSubNavDesktop\" data-csa-c-id=\"ucp6e5-3vzmqn-7xqght-k3ngz9\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-slot-id=\"btfSubNavDesktop_feature_div\" data-csa-c-type=\"widget\" data-feature-name=\"btfSubNavDesktop\" id=\"btfSubNavDesktop_feature_div\"\u003e\n\u003cdiv class=\"a-row a-size-base\" id=\"btf-sub-nav-desktop-wrapper\" role=\"navigation\"\u003e\u003cnav aria-label=\"Navigate within the product detail page\" class=\"\" id=\"btf-sub-nav-desktop-tabs\"\u003e\n\u003cdiv class=\"top-tab-content\"\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cspan class=\"a-size-base\"\u003eTop\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tab-content\"\u003eAbout this item\u003c\/div\u003e\n\u003cdiv class=\"tab-content\"\u003eReviews\u003c\/div\u003e\n\u003c\/nav\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"celwidget\" data-cel-widget=\"detailBullets_feature_div\" data-csa-c-asin=\"\" data-csa-c-content-id=\"detailBullets\" data-csa-c-id=\"h8teyc-mcxm7x-fyv8lv-9vbjg\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-slot-id=\"detailBullets_feature_div\" data-csa-c-type=\"widget\" data-feature-name=\"detailBullets\" id=\"detailBullets_feature_div\"\u003e\n\u003cdiv class=\"a-section feature detail-bullets-wrapper bucket\" data-cel-widget=\"detailBulletsWrapper_feature_div\" data-feature-name=\"detailBullets\" data-template-name=\"detailBullets\" id=\"detailBulletsWrapper_feature_div\"\u003e\n\u003chr aria-hidden=\"true\" class=\"a-divider-normal bucketDivider\"\u003e\n\u003ch2\u003eProduct details\u003c\/h2\u003e\n\u003cdiv id=\"detailBullets_feature_div\"\u003e\n\u003cul class=\"a-unordered-list a-nostyle a-vertical a-spacing-none detail-bullet-list\"\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eASIN ‏ : ‎ \u003c\/span\u003eB0CMJC7KN2\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublisher ‏ : ‎ \u003c\/span\u003eJones \u0026amp; Bartlett Learning; 24th edition (December 28, 2023)\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eLanguage ‏ : ‎ \u003c\/span\u003eEnglish\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePaperback ‏ : ‎ \u003c\/span\u003e928 pages\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-10 ‏ : ‎ \u003c\/span\u003e1284000001\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-13 ‏ : ‎ \u003c\/span\u003e978-1284000009\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489815904410,"sku":"MED-AMB01667","price":12.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Physicians-Cancer-Chemotherapy-Drug-Manual-2024.jpg?v=1772088301"},{"product_id":"pediatric-board-review-2022","title":"Pediatric Board Review 2022","description":"\u003ch1\u003ePediatric Board Review 2022\u003c\/h1\u003e\u003cbr\u003eChild Development II – Developmental Disorders – Carrie Cuffman, MD\u003cbr\u003eImmunizations – Camille Sabella, MD\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eBoard Simulation Session – General Pediatrics\/Sports Medicine – Scott Francy, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Hematology and Oncology\u003c\/li\u003e\n\u003cli\u003eAnemia – An Approach to Evaluation – L. Kate Gowans, MD\u003c\/li\u003e\n\u003cli\u003eHemoglobinopathies – Ravi Talati, DO\u003c\/li\u003e\n\u003cli\u003eBleeding Disorders – L. Kate Gowans, MD\u003c\/li\u003e\n\u003cli\u003ePresenting Signs and Prognostic Factors of Common Pediatric Tumors – Ilia Buhtoiarov, MD\u003c\/li\u003e\n\u003cli\u003eBoard Simulation Session – Hematology\/Oncology – L. Kate Gowans, MD\u003c\/li\u003e\n\u003cli\u003eAdolescent Medicine\u003c\/li\u003e\n\u003cli\u003eSexually Transmitted Infections – Ellen Rome, MD\u003c\/li\u003e\n\u003cli\u003eAmenorrhea – Karen Vargo, MD\u003c\/li\u003e\n\u003cli\u003eAdolescent Medicine Board Simulation – Veronica Issac, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Emergency Medicine\/Critical Care\u003c\/li\u003e\n\u003cli\u003ePediatric Trauma – Purva Grover, MD\u003c\/li\u003e\n\u003cli\u003eIngestions – Rahul Damania, MD\u003c\/li\u003e\n\u003cli\u003eBoard Simulation – Critical Care and Emergency Medicine – Kshama Daphtary, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Infectious Diseases\/Immunology\/Rheumatology\u003c\/li\u003e\n\u003cli\u003ePediatric Infectious Diseases, Part I – Camille Sabella, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Rheumatology – Andrew Zeft, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Infectious Diseases, Part II – Camille Sabella, MD\u003c\/li\u003e\n\u003cli\u003eCongenital Immunodeficiencies – John McDonnell, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Infectious Diseases, Part III – Camille Sabella, MD\u003c\/li\u003e\n\u003cli\u003eBoard Simulation Session – Allergy and Immunology – Alton Melton, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Surgery\u003c\/li\u003e\n\u003cli\u003eCommon Problems in Pediatric Surgery – Anthony DeRoss, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Urology – Audrey Rhee, MD\u003c\/li\u003e\n\u003cli\u003eOrthopedics and Sports Medicine – Kelly Jenkins, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Ophthalmology – Allison Babiuch, MD\u003c\/li\u003e\n\u003cli\u003eBoard Simulation Session – Potpourri – Camille Sabella, MD\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489834877082,"sku":"MED-AMB01679","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/screenshot-2022-11-10-232610.jpg?v=1772088596"},{"product_id":"md-anderson-a-comprehensive-board-review","title":"MD Anderson A Comprehensive Board Review in Hematology and Medical Oncology 2021","description":"MD Anderson A Comprehensive Board Review in Hematology and Medical Oncology 2021 The course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies.\u003cbr\u003e\u003ch3\u003eObjectives\u003c\/h3\u003e\u003cbr\u003eAt the conclusion of this activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e– Apply knowledge gained to prepare for the hematology and medical oncology subspecialty.\u003c\/li\u003e\n\u003cli\u003e– Utilize current standards of care for patients with cancer, blood disorders and malignancies.Demonstrate proficiency of knowledge in hematology and medical oncology.\u003c\/li\u003e\n\u003cli\u003e– Incorporate recent advances in management of hematologic and oncologic patients.\u003c\/li\u003e\n\u003cli\u003e– Define molecular determinants of cancer risk and apply this knowledge in practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location Monday, September 27, 2021, 7:45 AM – Saturday, October 2, 2021, 11:00 PM, Online, Houston, TX\u003c\/div\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eThe course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEDUCATIONAL OBJECTIVES\u003c\/strong\u003e\u003cbr\u003eAt the conclusion of this educational activity, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology\u003c\/li\u003e\n\u003cli\u003e Utilize current standards of care for patients with cancer, blood disorders and malignancies\u003c\/li\u003e\n\u003cli\u003e• Demonstrate proficiency of knowledge in hematology and medical oncology\u003c\/li\u003e\n\u003cli\u003e• Incorporate recent advances in management of hematologic and oncologic patients; and\u003c\/li\u003e\n\u003cli\u003e• Define molecular determinants of cancer risk and apply this knowledge in practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Approach to Anemia.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Approach to Anemia.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Disorders of Platelet Function.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Hemolytic Anemias.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Hemolytic Anemias.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Thrombocytopenias.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Coagulation Platelets Red Cell Disorders Thrombocytopenias.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Bone Marrow Failure.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Bone Marrow Failure.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Hematopoietic Growth Factors.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Hematopoietic Growth Factors.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Iron Deficiency and Hemochromatosis.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Iron Deficiency and Hemochromatosis.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Issues in Transfusion Medicine.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Leukopenia and Leukocytosis.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION General Topics Red Cell Disorders Platelets Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Antithrombotic \u0026amp; Antiplatelet Therapy.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Antithrombotic \u0026amp; Antiplatelet Therapy.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Benign Hematology Q \u0026amp; A Session.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Coagulation Factor Deficiencies, Including von Willebrand’s Disease and Hemophilias.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Hypercoagulable States.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Hypercoagulable States.pdf\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Normal Coagulation.mp4\u003cbr\u003eBENIGN HEMATOLOGY SESSION Platelet Red Cell Disorders Transfusion Medicine Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Aggressive Non-Hodgkin Lymphoma.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Aggressive Non-Hodgkin Lymphoma.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin Lymphoma Acute Lymphoblastic Leukemia.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin Lymphoma Acute Lymphoblastic Leukemia.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin Lymphoma.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin Lymphoma.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Classification of Lymphoma.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Hodgkin Lymphoma.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Hodgkin Lymphoma.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Lymphoma Leukemia Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION MPNs Transplant Infectious Disease Infectious Complications in Cancer Patients.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION MPNs Transplant Infectious Disease Myleoproliferative Neoplasms.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION MPNs Transplant Infectious Disease Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION MPNs Transplant Infectious Disease Stem Cell Transplant Supportive Care.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION MPNs Transplant Infectious Disease Stem Cell Transplant Supportive Care.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Acute Myeloid Leukemia Malignant Hematology Q \u0026amp; A Session.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Acute Myeloid Leukemia Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Acute Myeloid Leukemia.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Acute Myeloid Leukemia.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Chronic Lymphocytic Leukemia and Hairy Cell Leukemia.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Chronic Lymphocytic Leukemia and Hairy Cell Leukemia.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Chronic Myeloid Leukemia.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Chronic Myeloid Leukemia.pdf\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Multiple Myeloma and Other Plasma Cell Dyscrasias.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Myelodysplastic Syndrome.mp4\u003cbr\u003eMALIGNANT HEMATOLOGY SESSION Myeloma Leukemia MDS Myelodysplastic Syndrome.pdf\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer ASH ASCO Choosing Wisely Recommendations.mp4\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer Screening Local Management of Breast Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer Screening Local Management of Breast Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer Special Issues in Breast Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer Systemic Treatment of Primary Breast Cancer Including HER2 Positive Breast Disease.mp4\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer Treatment of Metastatic Breast Cancer Including HER2 Positive Breast Disease.mp4\u003cbr\u003eSOLID TUMOR SESSION Breast Cancer Treatment of Metastatic Breast Cancer Including HER2 Positive Breast Disease.pdf\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Colorectal Cancer Biology and Adjuvant Therapy.mp4\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Colorectal Cancer Biology and Adjuvant Therapy.pdf\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Gastroesophageal Cancers Hepatocellular Carcinoma.mp4\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Gastroesophageal Cancers Hepatocellular Carcinoma.pdf\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Metastatic Colorectal Cancer and Anal Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Metastatic Colorectal Cancer and Anal Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Pancreaticobiliary Cancers Unknown Primary.mp4\u003cbr\u003eSOLID TUMOR SESSION Gastrointestinal Oncology Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Prostate Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Renal Cell Carcinoma.mp4\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Renal Cell Carcinoma.pdf\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Solid Tumor Q \u0026amp; A – Session 3 Gastrointestinal Oncology Genitourinary Oncology.mp4\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Testicular Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Urothelial Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Genitourinary Oncology Urothelial Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Charles A. Koller, MD Lectureship Award.mp4\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Early Stage and Locally Advanced Non-Small Cell Lung Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Early Stage and Locally Advanced Non-Small Cell Lung Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Head and Neck Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Head and Neck Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Metastatic Non-Small Cell Lung Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Metastatic Non-Small Cell Lung Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Small Cell Lung Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Small Cell Lung Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Solid Tumor Q \u0026amp; A – Session 2 Breast Cancer Lung Cancer Head and Neck Cancer Thyroid Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Solid Tumor Q \u0026amp; A – Session 2 Breast Cancer Lung Cancer Head and Neck Cancer Thyroid Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Lung Cancer Head and Neck Cancer Thyroid Cancer Thyroid Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Cervical Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Cervical Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Melanoma.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Melanoma.pdf\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Ovarian Cancer and Unusual Ovarian Histologies.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Ovarian Cancer and Unusual Ovarian Histologies.pdf\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Q \u0026amp; A Panel Discussion.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Sarcoma.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Sarcoma.pdf\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Solid Tumor Q \u0026amp; A – Session 1 Pharmacology Genetic Risk Factors Neuro-Oncology Melanoma Sarcoma GYN.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Uterine Cancer.mp4\u003cbr\u003eSOLID TUMOR SESSION Melanoma Sarcoma Gynecologic Oncology Uterine Cancer.pdf\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Genetic Risk Factors.mp4\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Genetic Risk Factors.pdf\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Neuro-Oncology.mp4\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Neuro-Oncology.pdf\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Pharmacology I Chemotherapy.mp4\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Pharmacology I Chemotherapy.pdf\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Pharmacology II Targeted Therapy (Alk, EGFR, VEGR, HER2, HH, mTOR, PARP).mp4\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Pharmacology III Targeted Therapy (CD20, CD30, CD33, Proteasome, BCR-ABL KIT, FLT3, IDH12, CDK46, PI3K).mp4\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Pharmacology IV Immunotherapy.mp4\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Pharmacology IV Immunotherapy.pdf\u003cbr\u003eSOLID TUMOR SESSION Pharmacology Genetic Risk Factors Neuro-Oncology Q \u0026amp; A Panel Discussion.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489960214682,"sku":"MED-AMB01810","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/img_20220921_173331_086.jpg?v=1772089900"},{"product_id":"uscap-journey-to-the-center-of-the-chest-an-experts-perspective-on-mediastinal-pathology-2023","title":"USCAP Journey to the Center of the Chest: An expert’s perspective on mediastinal pathology 2023","description":"\u003csection class=\"content\" tabindex=\"0\"\u003e\n\u003cdiv class=\"description\" data-role=\"course-description\"\u003e\n\u003ch2\u003eUSCAP Journey to the Center of the Chest: An expert’s perspective on mediastinal pathology 2023\u003c\/h2\u003e\n\u003cstrong\u003eOriginal release date: \u003c\/strong\u003eNovember 20, 2023\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eUSCAP Journey to the Center of the Chest: An expert’s perspective on mediastinal pathology 2023 \u003c\/strong\u003eMediastinal pathology has a fascinating specificity in surgical pathology, because it is focused primarily on a single gland (the thymus) that involutes as we age, is more prominent in children than in adults, and requires a unique approach to diagnosis and clinical course.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe infrequency of mediastinal tumors influences evolution of expertise by individual pathologists and their institutions. The recent introduction of new classification and staging schemas poses a novel challenge for those confronted with assessing mediastinal lesions.\u003c\/li\u003e\n\u003cli\u003eIt is essential for practicing pathologists to become familiar with new modalities that impact treatment options and clinical outcomes. It is even more important to become familiar with the diversity of tumors that can occur in the mediastinal compartment.\u003c\/li\u003e\n\u003cli\u003eThis course provides a unique opportunity for a tutorial in mediastinal pathology by a \u003cem\u003esingle\u003c\/em\u003e internationally recognized expert from MD Anderson Cancer Center.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cdetails open=\"\"\u003e\u003csummary\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/summary\u003ePracticing academic and community pathologists, and pathologists-in-training\u003cbr\u003e\u003cbr\u003e\u003c\/details\u003e\u003cdetails open=\"\"\u003e\u003csummary\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003c\/summary\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eExpand the knowledge of mediastinal pathology in general.\u003c\/li\u003e\n\u003cli\u003eDetermine which features are important in separating some of the most common thymic tumors.\u003c\/li\u003e\n\u003cli\u003eBecome familiar with different staging schemas.\u003c\/li\u003e\n\u003cli\u003eBecome familiar with different nomenclatures.\u003c\/li\u003e\n\u003cli\u003eDetermine which cases need further work-up with immunohistochemistry or molecular techniques.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003etopics\u003c\/h1\u003e\n\u003c\/details\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003csection class=\"included\" data-role=\"course-items-list\"\u003e\n\u003cdiv class=\"media ui-sortable\" data-parent=\"course\" id=\"58251\"\u003e\n\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"592362\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/592362\" data-updated-at=\"2023-11-29 22:19:46 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cul\u003e\n\u003cli\u003eHistological Classification and Staging of Thymic Epithelial Neoplasm\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"592366\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/592366\" data-updated-at=\"2023-11-29 22:19:46 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cul\u003e\n\u003cli\u003eCase Discussion: Thymic Epithelial Neoplasms\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"592373\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/592373\" data-updated-at=\"2023-11-29 22:19:46 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cul\u003e\n\u003cli\u003eInterpretation of Mediastinal Biopsies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"597079\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/597079\" data-updated-at=\"2023-11-29 22:19:46 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cul\u003e\n\u003cli\u003eCase Discussion: Uncommon Tumors of the Mediastinum\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"597080\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/597080\" data-updated-at=\"2023-11-29 22:19:46 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"sellable-buttons\"\u003e\n\u003cdiv class=\"ecommerce\" data-id=\"66124\" data-type=\"Section\"\u003e\n\u003cdiv class=\"price-list\"\u003e\n\u003cul\u003e\n\u003cli class=\"price-box price-tooltiped\"\u003eCase Discussion: Lymphoid Tumors of the Mediastinum\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"597081\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/597081\" data-updated-at=\"2023-11-29 22:19:46 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cul\u003e\n\u003cli\u003eMediastinal Germ Cell Tumors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"597083\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/597083\" data-updated-at=\"2023-11-29 22:19:46 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cul\u003e\n\u003cli\u003eCase Discussion: Germ Cell Tumors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489973059738,"sku":"MED-AMB01819","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/USCAP-Journey-to-the-Center-of-the-Chest-An-experts-perspective-on-mediastinal-pathology-2023-1.png?v=1772090036"},{"product_id":"uscap-breast-pathology-for-all-ages","title":"USCAP Breast Pathology for All Ages: Diagnostic Pearls and Pitfalls (And How to Stay Out of Trouble) 2022","description":"\u003ch3\u003eUSCAP Breast Pathology for All Ages: Diagnostic Pearls and Pitfalls 2022\u003c\/h3\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eBased on multi-institutional practices handling large volumes of breast pathology cases at established cancer centers and cumulative consultation cases, this expert faculty has identified areas that pose diagnostic and interpretative challenges in recurrent problematic areas deserving attention: intraductal epithelial proliferations and microinvasive carcinoma, lobular neoplasia including LCIS variants, papillary lesions, and benign vs malignant spindle cell lesions.\u003c\/li\u003e\n\u003cli\u003eThe interpretation of immunohistochemical stains (IHC) with focus on predictive markers can also be challenging. This interactive microscopy course is designed to illustrate distinct challenging entities and problematic issues, with practical approaches to their resolution in real time, in the context of intimate mentoring.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTarget Audience\u003c\/h3\u003e\n\u003cdiv\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/div\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eUpon completion of this educational activity, learners will be able to:\u003c\/li\u003e\n\u003cli\u003eDevelop a practical approach for the diagnostic evaluation of intraductal epithelial proliferations (UDH, FEA, ADH, DCIS)\u003c\/li\u003e\n\u003cli\u003eRefine the diagnosis of LCIS (including WHO 2019 criteria for Pleomorphic and Florid LCIS) and invasive lobular carcinomas, with interpretation of related IHC.\u003c\/li\u003e\n\u003cli\u003eDevelop a practical approach for the diagnosis of papillary lesions, including variants of papillary carcinoma, with review of ancillary IHC and management at core biopsy\u003c\/li\u003e\n\u003cli\u003eCultivate a practical approach for the diagnosis of fibroepithelial neoplasms and special subtypes of breast carcinomas, including needle biopsy diagnoses and patient management\u003c\/li\u003e\n\u003cli\u003eLearn about the applications of diagnostic, prognostic and predictive IHC markers in breast pathology, with emphasis on the interpretation, reporting an possible pitfalls\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eItems Included in the Purchase of this Course\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eIntraductal Epithelial Proliferations and Microinvasive Carcinoma – Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eIn Situ and Invasive Lobular Neoplasia – Melissa P. Murray, DO\u003c\/li\u003e\n\u003cli\u003eImmunohistochemistry in Breast Pathology (With Focus on Predictive Markers) – Kimberly H. Allison, MD\u003c\/li\u003e\n\u003cli\u003eSpecial Subtypes of Invasive Carcinoma – Melinda E. Sanders, MD\u003c\/li\u003e\n\u003cli\u003ePapillary Neoplasms – Edi Brogi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSpindle Cell Lesions of the Breast: Benign vs. malignant, and their distinction – Melinda E. Sanders, MD\u003c\/li\u003e\n\u003cli\u003eBreast Cancer in The Era of Neoadjuvant Therapy – Kimberly H. Allison, MD\u003c\/li\u003e\n\u003cli\u003eFibroepithelial Lesions – Melissa Murray, DO\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eOriginal release date: December 19, 2022\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47489978728602,"sku":"MED-AMB01824","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/1671479706-0548296_breast_banner-600x155-1.jpg?v=1772090122"},{"product_id":"2022-topics-in-mammography","title":"2022 Topics In Mammography – 8th Edition (Videos)","description":"\u003ch3\u003e2022 Topics In Mammography – 8th Edition (Videos)\u003c\/h3\u003e\n\u003cem\u003eTopics in Mammography\u003c\/em\u003e is the eighth edition of our comprehensive evidence-based breast imaging program. This online CME course features engaging commentary of case-based topics and state-of-the-art literature updates. Under the direction of University of California, San Diego’s R. James Brenner, MD, JD, FACR, FCLM, speakers guide you in evaluating the potentials and pitfalls of both current and new imaging approaches.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eYou’ll get presentations focused on specialized topics — artificial intelligence (AI), supplementary screening (including a special lecture on contrast enhanced mammography), the physics of DBT, imaging of young cancer patients — as well as:\u003c\/li\u003e\n\u003cli\u003eNew, more efficient approaches to traditional imaging work-ups\u003c\/li\u003e\n\u003cli\u003eA comprehensive anatomy-pathophysiology discussion clarifying the correlation between imaging and histology\u003c\/li\u003e\n\u003cli\u003eAn extensive review of MRI and multifaceted applications\u003c\/li\u003e\n\u003cli\u003eInsightful commentary on medical legal aspects for your practice, avoiding false negatives, communication, implications and consequences related to use of AI and DBT\u003c\/li\u003e\n\u003cli\u003eCritical analyses of different imaging approaches and avoiding advocacy or bias\u003c\/li\u003e\n\u003cli\u003eAnd more…\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cem\u003eAt the conclusion of this activity, the participant will be able to:\u003c\/em\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDifferentiate the imaging findings of benign and malignant breast masses\u003c\/li\u003e\n\u003cli\u003eRecognize the features of benign or malignant calcifications on mammogram\u003c\/li\u003e\n\u003cli\u003eFormulate approaches to one- and two-view asymmetries seen on screening mammogram\u003c\/li\u003e\n\u003cli\u003eRecognize the issues regarding and methods to detect sentinel lymph nodes of the breast\u003c\/li\u003e\n\u003cli\u003eEvaluate the issues regarding risk and breast density\u003c\/li\u003e\n\u003cli\u003eAnalyze the different approaches to supplementary screening imaging modalities beyond mammography\u003c\/li\u003e\n\u003cli\u003eRecognize the indications and limitations of stereotactic breast biopsy\u003c\/li\u003e\n\u003cli\u003eAnalyze different approaches and limitations of ultrasound guided breast techniques\u003c\/li\u003e\n\u003cli\u003eCompare different methods of preoperative image-guided localization of nonpalpable lesions for surgical excision\u003c\/li\u003e\n\u003cli\u003eDecide on appropriate management recommendations following percutaneous breast biopsies of “high risk” lesions\u003c\/li\u003e\n\u003cli\u003eDistinguish the criteria and conditions for recommending surveillance imaging as opposed to biopsy for probably benign breast lesions identified on imaging\u003c\/li\u003e\n\u003cli\u003eRecognize the signs of silicone implant rupture\u003c\/li\u003e\n\u003cli\u003eAnalyze the indications and outcome expectations of applied criteria for interpreting MRI studies\u003c\/li\u003e\n\u003cli\u003eRecognize current molecular profiles assigned to breast cancer diagnosis\u003c\/li\u003e\n\u003cli\u003eUnderstand the histologic basis for macroscopic findings on mammography\u003c\/li\u003e\n\u003cli\u003eUnderstand the potentials and limitations of incorporating artificial intelligence (AI) into breast imaging practice\u003c\/li\u003e\n\u003cli\u003eEvaluate the parameters and implications involved in breast cancer staging\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eIntended Audience\u003c\/h3\u003e\u003cbr\u003eThis course is intended for radiologists in academics or private practice, and involved in breast imaging and interventional procedures. Any physician (e.g. surgeons) working in the field of evaluation and treatment of breast disease who desires a more comprehensive understanding of the imaging aspects of evaluation.\u003cbr\u003e\u003ch4\u003eTOPICS \/ SPEAKERS\u003c\/h4\u003e\n\u003cdiv class=\"product-tab-content\"\u003e\n\u003cdiv id=\"tab-speaker\"\u003e\n\u003ch3\u003eHistopathology and Conventional Imaging: Novel Approaches\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eHistopathology of Breast Disease – A Radiologist's Guide - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSentinel Node Evaluation - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eLesions Initially Seen in One (or Two) View Only Evaluation - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eEvaluation of Mammographic Masses - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast Calcifications: The Good, the Bad, the Ugly - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSpecial Topics in Breast Imaging\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePhysics of FFDM and DBT - \u003cem\u003eDavid Hall, PhD, DABR\u003cbr\u003e\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eScreening for Breast Cancer - \u003cem\u003eMohammad Eghtedari, MD\u003cbr\u003e\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eImaging Evaluation of the Young Patient with Breast Cancer - \u003cem\u003eHaydee Ojeda-Fournier, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast Imaging in Young, Pregnant, and Lactating Women - \u003cem\u003eVivian Lim, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eEvaluation of the Male Breast - \u003cem\u003eHaydee Ojeda-Fournier, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast Density – Risk Assessment - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eIssues of Masking: Dense Breasts Supplementary Screening Imaging - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eBreast Imaging and Intervention\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eImaging Surveillance vs Biopsy - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eEvaluation of Spontaneous Nipple Discharge - \u003cem\u003eHaydee Ojeda-Fournier, MD\u003cbr\u003e\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eStereotactic Biopsy of Breast Lesions - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eStereotactic Breast Biopsy Using Digital Breast Tomosynthesis - \u003cem\u003eMohammad Eghtedari, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eUltrasound Guided Intervention - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNew Approaches to Preoperative Localization - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eControversies in Percutaneous Breast Biopsy - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast Cancer Staging - \u003cem\u003eMohammad Eghtedari, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDynamic Imaging: Contrast Enhanced Mammography and MRI\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMagnetic Resonance Imaging Breast: Silicone Evaluation - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMagnetic Resonance Imaging Breast: Tumor Studies - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eContrast Enhanced Mammography - \u003cem\u003eAzi Elmi, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMRI Interventional Techniques - \u003cem\u003eMohammad Eghtedari, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAI in Breast Imaging - \u003cem\u003eTara Retson, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eMedical Legal Issues, Risk Management in the Era of AI\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eLegal Concepts as Applied to Screening and Diagnostic Breast Imaging, Issues with DBT Implemenation, Incorporation Challenges of AI - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePreventable Causes of False Negative Mammograms with Medical Legal Considerations - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMedical Legal Aspects of Breast Imaging – Communication - \u003cem\u003eR. James Brenner, MD, JD, FACR, FCLM\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDate Of Original Release:\u003c\/strong\u003e \u003cstrong\u003eApril 30, 2022\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eDate Credits Expire:\u003c\/strong\u003e \u003cstrong\u003eApril 30, 2025\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col s12 m12 l6 xl6\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47490055930010,"sku":"MED-AMB01908","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/single-topic-topics-in-mammography-8th-edition__73453.jpg?v=1772091277"},{"product_id":"diagnostic-imaging-update-msk-chestcv","title":"Diagnostic Imaging Update: MSK; Chest\u0026CV; Abdominal; Genitourinary; Breast; Oncological Imaging 2022 (Videos)","description":"\u003ch3\u003eDiagnostic Imaging Update: MSK; Chest\u0026amp;CV Abdominal; Genitourinary; Breast; Oncological Imaging 2022 (Videos)\u003c\/h3\u003e\n\u003ch2\u003eObjectives\u003c\/h2\u003e\n\u003cdiv class=\"tab-row\"\u003e\n\u003cdiv class=\"col seventy\"\u003e\n\u003cbr\u003e\u003cbr\u003eDiagnostic Imaging Update: MSK; Chest\u0026amp;CV Abdominal; Genitourinary; Breast; Oncological Imaging 2022 (Videos) The Imaging in Jackson Hole course is designed to provide the tools for participants to enhance interpretation skills utilizing the latest imaging technologies. Lectures and cases will cover evidence-based practice techniques and protocols for improved diagnostic accuracy in multiple applications.\u003cbr\u003e\u003cbr\u003eAt the conclusion of this activity, participants should be able to:\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tab-para\"\u003e\n\u003cul\u003e\n\u003cli\u003eDevelop a differential diagnosis that relates to the pertinent imaging and clinically relevant findings for each of the cases covered in this course.\u003c\/li\u003e\n\u003cli\u003eDescribe the imaging anatomy and protocols that are necessary to arrive at a diagnosis of liver diseases.\u003c\/li\u003e\n\u003cli\u003eOptimize imaging methods to reduce the number of false-positive mammography interpretations.\u003c\/li\u003e\n\u003cli\u003eAssess the current status and future applications of advanced breast imaging technologies.\u003c\/li\u003e\n\u003cli\u003eExplain the performance and processing of MRI and CT studies designed to depict anatomy and pathology.\u003c\/li\u003e\n\u003cli\u003eUse contemporary imaging techniques and protocols to accurately diagnose, stage and manage diseases and injuries of the musculoskeletal system.\u003c\/li\u003e\n\u003cli\u003eOutline the fundamentals of the latest advanced techniques in MRI and CT and their current roles and limitations in clinical practice.\u003c\/li\u003e\n\u003cli\u003eIntegrate information presented in this course into efforts to improve the imaging skills of the participants.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"tab-row\"\u003e\n\u003cdiv class=\"col seventy\"\u003e\n\u003ch3\u003eTarget Audience\u003c\/h3\u003e\n\u003cbr\u003eThe course is intended for practicing radiologists and radiologic nurses, physician assistants, technologists, scientists, residents, fellows and others who are interested in current techniques and applications for advanced diagnostic imaging.\u003cbr\u003e\u003ch2\u003eProgram :\u003c\/h2\u003e\n\u003ch3\u003eMonday, July 11, 2022- Chest and Cardiovascular Imaging-\u003cbr\u003eGeoffrey D. Rubin, MD\u003c\/h3\u003e\n\u003ctable align=\"left\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"schedule\" style=\"height: 243px;\" width=\"999\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTime\u003c\/th\u003e\n\u003cth\u003e Session\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30-8:25\u003c\/td\u003e\n\u003ctd\u003eAortic Endografts: Issues for the Imager\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:25-9:20\u003c\/td\u003e\n\u003ctd\u003eDiagnosing Acute Aortic Syndromes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:20-9:40\u003c\/td\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:40-10:25\u003c\/td\u003e\n\u003ctd\u003eCT Angiography in the Diagnosis and Triage of Coronary Artery Disease\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:25-11:10\u003c\/td\u003e\n\u003ctd\u003eNon-Coronary Applications for CT of the Heart\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:10-11:55\u003c\/td\u003e\n\u003ctd\u003eCT Angiography of Peripheral Arterial Disease\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:55-12:15pm\u003c\/td\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003eTuesday, July 12, 2022- Abdominal Imaging- Michael P. Federle, MD\u003c\/h3\u003e\n\u003ctable align=\"left\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"schedule\" style=\"height: 242px;\" width=\"1019\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTime\u003c\/th\u003e\n\u003cth\u003e Session\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30-8:15\u003c\/td\u003e\n\u003ctd\u003eExpert Differential Diagnosis: Cystic Hepatic Mass\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:15-9:00\u003c\/td\u003e\n\u003ctd\u003eExpert Differential Diagnosis: Cystic Pancreatic Mass\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00-9:45\u003c\/td\u003e\n\u003ctd\u003eDilated Bowel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:45-10:00\u003c\/td\u003e\n\u003ctd\u003eQuestions, Answers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:00-10:45\u003c\/td\u003e\n\u003ctd\u003eExpert Differential Diagnosis: Bowel Wall Thickening\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:45-11:30\u003c\/td\u003e\n\u003ctd\u003eInteractive Case Challenges\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:30-12:00pm\u003c\/td\u003e\n\u003ctd\u003eQuestions, Answers and Discussion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003eWednesday, July 13, 2022 – Musculoskeletal Imaging – Geoffrey Riley, MD\u003c\/h3\u003e\n\u003ctable align=\"left\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"schedule\" style=\"height: 230px;\" width=\"1006\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTime\u003c\/th\u003e\n\u003cth\u003eSession\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30-8:00\u003c\/td\u003e\n\u003ctd\u003eChallenging Anatomy, Upper Extremities\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:00-8:30\u003c\/td\u003e\n\u003ctd\u003eChallenging Anatomy, Lower Extremities\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:30-9:00\u003c\/td\u003e\n\u003ctd\u003eMRI of Bone Marrow, What is Normal?\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00-9:30\u003c\/td\u003e\n\u003ctd\u003eMRI of Bone Marrow, Abnormal Patterns\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:30-9:45\u003c\/td\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:45-10:15\u003c\/td\u003e\n\u003ctd\u003eMRI of Infections, What Terms to Use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15-10:45\u003c\/td\u003e\n\u003ctd\u003eCases That you Will See\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003ca id=\"faculty\"\u003e\u003c\/a\u003e10:45-11:15 pm\u003c\/td\u003e\n\u003ctd\u003eCases That you Might See\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:15-12:00 pm\u003c\/td\u003e\n\u003ctd\u003eQuestions, Answers and Discussion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003eThursday, July 14, 2022- Breast Imaging – Debra M. Ikeda, MD, FACR, FSBI\u003c\/h3\u003e\n\u003ctable align=\"left\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"schedule\" style=\"height: 299px;\" width=\"1049\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTime\u003c\/th\u003e\n\u003cth\u003eSession\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30-8:15\u003c\/td\u003e\n\u003ctd\u003eBreast MRI Update and MRI Biopsy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:15-9:00\u003c\/td\u003e\n\u003ctd\u003eInterval Cancer on Digital Breast Tomosynthesis and Digital Mammography\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00-9:45\u003c\/td\u003e\n\u003ctd\u003eUS Diagnosis and US Biopsy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:45-10:00\u003c\/td\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:00-10:30\u003c\/td\u003e\n\u003ctd\u003eTricky Stereotactic\/DBT Biopsy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:30-11:15\u003c\/td\u003e\n\u003ctd\u003ePost-Operative and Reconstructed Breast on MRI US Mammography\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:15-12:00pm\u003c\/td\u003e\n\u003ctd\u003ePost COVID Vaccination Imaging on MRI US Mammography and PET-CT\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:00-12:35\u003c\/td\u003e\n\u003ctd\u003eMultimodality Breast Imaging on MRI US and Mammography\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:35-1:00\u003c\/td\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003eFriday, July 15, 2022-\u003c\/h3\u003e\n\u003ch3\u003eAbdominal Imaging Update- \u003cstrong\u003eAya Kamaya, MD\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003ctable align=\"left\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"schedule\" style=\"height: 399px;\" width=\"1060\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eTime\u003c\/th\u003e\n\u003cth\u003eSession\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:30-8:00\u003c\/td\u003e\n\u003ctd\u003eCystic Renal Masses and Updated Bosniak Classification v. 2019\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:00-8:30\u003c\/td\u003e\n\u003ctd\u003eOvarian Cystic Lesions: Revised ACR, SRU Guidelines, and O-RADS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:30-9:00\u003c\/td\u003e\n\u003ctd\u003ePostpartum Bleeding\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00-9:15\u003c\/td\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003ch3\u003eOncological Imaging Update- Sebastian \u003cstrong\u003eFeuerlein, MD, FSAR\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:15-9:45\u003c\/td\u003e\n\u003ctd\u003eRECIST 1.1 Update: Strategies and Pitfalls\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:45-10:15\u003c\/td\u003e\n\u003ctd\u003eImaging Findings and Complications of Oncologic Therapies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15-10:55\u003c\/td\u003e\n\u003ctd\u003eFundamentals of Diffusion-Weighted Imaging (DWI)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:55-11:35\u003c\/td\u003e\n\u003ctd\u003ePostate MRI and PIRADS Update\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:35-12:00\u003c\/td\u003e\n\u003ctd\u003eQuestions and Answers\u003cbr\u003e\u003cbr\u003e \u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\n\u003ch3\u003e\u003c\/h3\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":47490057207962,"sku":"MED-AMB01909","price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Diagnostic-Imaging-Update-MSK-ChestCV-Abdominal-Genitourinary-Breast-Oncological-Imaging-2022-Videos.jpg?v=1772091293"},{"product_id":"national-diagnostic-imaging-2","title":"National Diagnostic Imaging Symposium™ 2022","description":"\u003cdiv\u003eNational Diagnostic Imaging Symposium™ 2022\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNational Diagnostic Imaging Symposium™ 2022 In this comprehensive online CME program, high caliber faculty deliver 119 lectures spanning multiple radiology subspecialties, including Chest, Musculoskeletal, Breast, Gastrointestinal, Ultrasound, Emergency, Genitourinary, Neuroradiology, and Cardiovascular.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eWorld Class CME’s National Diagnostic Imaging Symposium is designed to meet the continuing medical education needs of radiologists — whether in general or specialized care — and radiology residents\/fellows who wish to learn to use imaging in a clinical practice setting for screening, diagnosis and staging of injury and disease, including:\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eUsing CT and MRI to assess injury and disease in the extremities, spine, and cranium\u003c\/li\u003e\n\u003cli\u003eApplying ultrasound to musculoskeletal, gynecological, obstetrical, cardiovascular, and other organ systems\u003c\/li\u003e\n\u003cli\u003eEffectively using MDCT and MR imaging to evaluate the abdomen, liver, pancreas, spleen, and bowel\u003c\/li\u003e\n\u003cli\u003eImproving assessment of genitourinary malignancies, masses, and anomalies using MRI, CT, and US\u003c\/li\u003e\n\u003cli\u003eCorrectly interpreting and staging CT findings in the context of a lung cancer-screening program\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cdiv\u003eAnd more…\u003c\/div\u003e\n\u003cdiv\u003eUnique Learning Objectives\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this CME activity, you will be better able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eIncrease diagnostic capabilities in multiple radiology sub-specialties\u003c\/li\u003e\n\u003cli\u003eUtilize CT and MRI to assess injury and disease in the extremities, spine, and cranium\u003c\/li\u003e\n\u003cli\u003eApply ultrasound to musculoskeletal, gynecological, obstetrical, cardiovascular, and other organ systems\u003c\/li\u003e\n\u003cli\u003eEffectively use MDCT and MR imaging to evaluate the abdomen, liver, pancreas, spleen, and bowel\u003c\/li\u003e\n\u003cli\u003ePlan the appropriate imaging of emergency department patients\u003c\/li\u003e\n\u003cli\u003eImprove assessment of genitourinary malignancies, masses and anomalies using MRI, CT, and US\u003c\/li\u003e\n\u003cli\u003eImprove diagnostic accuracy in breast imaging and distinguish advantages of the newest breast screening and diagnostic technologies\u003c\/li\u003e\n\u003cli\u003eCorrectly interpret and stage CT findings in the context of a lung cancer-screening program\u003c\/li\u003e\n\u003cli\u003eUnderstand how to utilize non-invasive options such as CT, MR, and ultrasound for the evaluation of vascular problems\u003c\/li\u003e\n\u003cli\u003eImprove skills in MR and US-guided radiology procedures\u003c\/li\u003e\n\u003cli\u003eIntended Audience\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eNational Diagnostic Imaging Symposium was designed to meet the educational needs of radiologists whether in general or specialized care and radiology residents\/fellows who desire to learn, in depth, how to use imaging in a clinical practice setting for screening, diagnosis and staging of injury and disease.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eTOPICS \/ SPEAKERS\u003c\/div\u003e\n\u003ch3\u003eChest Radiology\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eLung Cancer Screening Practice Guidelines – Jared D. Christensen, MD, MBA\u003c\/li\u003e\n\u003cli\u003eSmoking-Related Lung Disease – Thomas E. Hartman, MD, FACR\u003c\/li\u003e\n\u003cli\u003eDiffuse Nodular Disease – Jonathan H. Chung, MD\u003c\/li\u003e\n\u003cli\u003eImaging of Pleural Disease – Carol C. Wu, MD\u003c\/li\u003e\n\u003cli\u003eApproach to Fibrotic Lung Disease – Jonathan H. Chung, MD\u003c\/li\u003e\n\u003cli\u003eImaging of Cystic Lung Disease – Thomas E. Hartman, MD, FACR\u003c\/li\u003e\n\u003cli\u003eApproach to Ground Glass Opacities – Carol C. Wu, MD\u003c\/li\u003e\n\u003cli\u003eCardiothoracic Manifestations of COVID-19 – Jared D. Christensen, MD, MBA\u003c\/li\u003e\n\u003cli\u003eCT Pulmonary Angiography – Pearls and Pitfalls – Carol C. Wu, MD\u003c\/li\u003e\n\u003cli\u003eImaging of Cardiothoracic Surgical Complications – Jared D. Christensen, MD, MBA\u003c\/li\u003e\n\u003cli\u003eNon-Malignant Airways Disease – Thomas E. Hartman, MD, FACR\u003c\/li\u003e\n\u003cli\u003eSigns in Cardiopulmonary Imaging – Jonathan H. Chung, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eMusculoskeletal Radiology\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eOsseous Stress Injuries – Who, What, Where, and Why? – Mark W. Anderson, MD\u003c\/li\u003e\n\u003cli\u003eImaging Assessment of Hip Morphology – FAI and Dysplasia – MK Jesse, MD\u003c\/li\u003e\n\u003cli\u003eElbow MRI: Case-based Review – Robert D. Boutin, MD\u003c\/li\u003e\n\u003cli\u003ePost Operative Imaging of the Hip – MK Jesse, MD\u003c\/li\u003e\n\u003cli\u003eSoft-tissue Masses: Practical Pearls and Pitfalls – Robert D. Boutin, MD\u003c\/li\u003e\n\u003cli\u003eTip of the Iceberg Fractures – Little Fractures That Mean Big Trouble – Mark W. Anderson, MD\u003c\/li\u003e\n\u003cli\u003eKnee MRI: Case-based Review of Misses that Matter – Robert D. Boutin, MD\u003c\/li\u003e\n\u003cli\u003eAnkle Tendon Pathology – MK Jesse, MD\u003c\/li\u003e\n\u003cli\u003eMR of the Shoulder – What If It’s Not a Rotator Cuff or Labral Tear? – Mark W. Anderson, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eBreast MP\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eBreast MRI in the Newly Diagnosed Cancer Patient – Debra Monticciolo, MD, FACR\u003c\/li\u003e\n\u003cli\u003eOptimizing Breast MR Image Quality – Tips for Troubleshooting – Bonnie N. Joe, MD, PhD\u003c\/li\u003e\n\u003cli\u003eHow We Can Improve Upon Routine Breast MRI – Maxine S. Jochelson, MD\u003c\/li\u003e\n\u003cli\u003eResults of the EA-1141 Abbreviated Breast MRI Trial – Christopher E. Comstock, MD, FACR\u003c\/li\u003e\n\u003cli\u003eMRI of the Post-Surgical Breast – Reduction, Reconstruction, and Implants – Debra Monticciolo, MD, FACR\u003c\/li\u003e\n\u003cli\u003eBreast MR Biopsy – From Basics to Tips and Tricks – Bonnie N. Joe, MD, PhD\u003c\/li\u003e\n\u003cli\u003eVascular Breast Imaging – MRI vs CEDM – Maxine S. Jochelson, MD\u003c\/li\u003e\n\u003cli\u003eWorkstation Readout and Reporting of Breast MRI – Christopher E. Comstock, MD, FACR\u003c\/li\u003e\n\u003cli\u003eBreast MRI Teaching Cases – Debra Monticciolo, MD, FACR\u003c\/li\u003e\n\u003cli\u003eBreast MRI BI-RADS, Challenging and Confusing Scenarios – Bonnie N. Joe, MD, PhD\u003c\/li\u003e\n\u003cli\u003eBreast MRI in the Neoadjuvant Setting – Maxine S. Jochelson, MD\u003c\/li\u003e\n\u003cli\u003eClearly Benign Lesions on Breast MRI – Christopher E. RIComstock, MD, FACR\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eGastrointestinal Radiology\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eDiffusion Weighted Imaging – Frank H. Miller, MD\u003c\/li\u003e\n\u003cli\u003eQuantitative CT for Diffuse Liver Disease – Perry J. Pickhardt, MD\u003c\/li\u003e\n\u003cli\u003eMDCT of Pancreatic Cancer – Elliot K. Fishman, MD\u003c\/li\u003e\n\u003cli\u003eHow to Manage Incidental Hepatic Lesions – Richard M. Gore, MD\u003c\/li\u003e\n\u003cli\u003eMDCT for Peptic Ulcer Disease – Perry J. Pickhardt, MD\u003c\/li\u003e\n\u003cli\u003eCT of the Small Bowel: Inflammatory Disease – Elliot K. Fishman, MD\u003c\/li\u003e\n\u003cli\u003eChallenging Cases in Abdominal Imaging – Perry J. Pickhardt, MD\u003c\/li\u003e\n\u003cli\u003eCT Evaluation of Gastric Tumors – Elliot K. Fishman, MD\u003c\/li\u003e\n\u003cli\u003eMR of Liver Metastases – Frank H. Miller, MD\u003c\/li\u003e\n\u003cli\u003eMDCT of Bowel Obstruction – Richard M. Gore, MD\u003c\/li\u003e\n\u003cli\u003eMR of Benign Pancreatic Masses – Frank H. Miller, MD\u003c\/li\u003e\n\u003cli\u003eComplications of Pancreatic Surgery – Richard M. Gore, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eUltraso\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eUS Imaging of IBD – Contributions of Elastography and CEUS – Stephanie R. Wilson, MD, FRCPC\u003c\/li\u003e\n\u003cli\u003eOB Legal Cases – Lessons Learned – Dolores H. Pretorius, MD, FACR\u003c\/li\u003e\n\u003cli\u003eUltrasound of the Painful Scrotum – Thomas C. Winter III, MD\u003c\/li\u003e\n\u003cli\u003eAdvanced Gallbladder Sonography – William D. Middleton, MD\u003c\/li\u003e\n\u003cli\u003eProblem Solving in the Abdomen with CEUS – Stephanie R. Wilson, MD, FRCPC\u003c\/li\u003e\n\u003cli\u003eFirst Trimester Fetal Ultrasound: Basics \u0026amp; Anomalies – Dolores H. Pretorius, MD, FACR\u003c\/li\u003e\n\u003cli\u003eUltrasound-Guided Biopsies in the Abdomen – Thomas C. Winter III, MD\u003c\/li\u003e\n\u003cli\u003eClassic Signs in Abdominal Sonography – William D. Middleton, MD\u003c\/li\u003e\n\u003cli\u003eLiver Imaging: Why CEUS? – Stephanie R. Wilson, MD, FRCPC\u003c\/li\u003e\n\u003cli\u003eFetal Spine: Pearls and Pitfall – Dolores H. Pretorius, MD, FACR\u003c\/li\u003e\n\u003cli\u003eMolar Pregnancy, RPOC, and Enhanced Myometrial Vascularity – What to Do? – Thomas C. Winter III, MD\u003c\/li\u003e\n\u003cli\u003eDoppler Evaluation of the Liver – Williaundm D. Middleton, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eBreast Imaging\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eEverything You Wanted to Know About Breast Pain…But Were Afraid to Ask – Daniel Herron, MD\u003c\/li\u003e\n\u003cli\u003eLifestyle Changes to Help Prevent Breast Cancer – Daniel Herron, MD\u003c\/li\u003e\n\u003cli\u003eOptimizing Practice Efficiency with the MQSA Audit – Karla A. Sepulveda, MD\u003c\/li\u003e\n\u003cli\u003eFalse-negative Mammography Outcomes – Causes – Edward A. Sickles, MD\u003c\/li\u003e\n\u003cli\u003eSubtle Mammographic Signs of Malignancy – Edward A. Sickles, MD\u003c\/li\u003e\n\u003cli\u003eEvaluation and Management of Asymmetries – A Multimodality Approach – Catherine S. Giess, MD\u003c\/li\u003e\n\u003cli\u003eAdvances in Preoperative Localization Techniques – Karla A. Sepulveda, MD\u003c\/li\u003e\n\u003cli\u003eWhole Breast US Scanning – Techniques and Methods – Daniel Herron, MD\u003c\/li\u003e\n\u003cli\u003eChallenges and Pitfalls in Tomosynthesis-Guided Biopsies – Catherine S. Giess, MD\u003c\/li\u003e\n\u003cli\u003eEmerging Technologies: Radiogenomics and Artificial Intelligence – Karla A. Sepulveda, MD\u003c\/li\u003e\n\u003cli\u003eRisk Assessment Models and Potential Screening Applications – Daniel Herron, MD\u003c\/li\u003e\n\u003cli\u003eThings That Look Malignant But are Benign and Things That Look Benign But are Malignant – Catherine S. Giess, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eEmergency Radiology\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eEasily Missed Cervical Spine Injuries – Mark P. Bernstein, MD, FASER\u003c\/li\u003e\n\u003cli\u003eImaging of Bowel Obstruction: What Really Matters? – Jorge A. Soto, MD\u003c\/li\u003e\n\u003cli\u003eCT and MR of Intracranial Infections – Wayne S. Kubal, MD\u003c\/li\u003e\n\u003cli\u003eImaging Pelvic Ring Trauma – Mark P. Bernstein, MD, FASER\u003c\/li\u003e\n\u003cli\u003eImaging Chest Trauma: Avoiding Pitfalls – Jorge A. Soto, MD\u003c\/li\u003e\n\u003cli\u003ePearls and Pitfalls of Imaging Orbital Trauma – Krystal L. Archer-Arroyo, MD\u003c\/li\u003e\n\u003cli\u003eTorso Trauma Bleeding: Pearls and Pitfalls – Mark P. Bernstein, MD, FASER\u003c\/li\u003e\n\u003cli\u003eAcute Pancreatitis and Acute Cholecystitis – Jorge A. Soto, MD\u003c\/li\u003e\n\u003cli\u003eCT and MR of Traumatic Brain Injuries – Wayne S. Kubal, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch4\u003eGenitourinary Radiology\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003eCystic Renal Masses – Applying Bosniak Classification v. 2019 – Stuart G. Silverman, MD, FACR\u003c\/li\u003e\n\u003cli\u003eMR Imaging for Leiomyomas and Adenomyosis – Iva Petkovska, MD\u003c\/li\u003e\n\u003cli\u003eDifferentiating Benign from Malignant Pelvic Masses – How and When Not to Sit on the Fence – Hebert Alberto Vargas, MD\u003c\/li\u003e\n\u003cli\u003ePrimer on PIRADS for Prostate Cancer – Pointers for Optimal MR Imaging Technique and Interpretation – Mukesh Harisinghani, MD\u003c\/li\u003e\n\u003cli\u003eCT Urography – How, When, and Why in 2021 – Stuart G. Silverman, MD, FACR\u003c\/li\u003e\n\u003cli\u003eMullerian Duct Anomalies on MR Imaging – Iva Petkovska, MD\u003c\/li\u003e\n\u003cli\u003eMR Imaging of the Treated Female Pelvis: Pearls and Pitfalls – Hebert Alberto Vargas, MD\u003c\/li\u003e\n\u003cli\u003eInflammatory Conditions Affecting the GU Tract: Entities You Need to be Aware of – Mukesh Harisinghani, MD\u003c\/li\u003e\n\u003cli\u003ePearls and Pitfalls in Gynecological Oncological Imaging – Iva Petkovska, MD\u003c\/li\u003e\n\u003cli\u003eImaging Advanced Prostate Cancer: MRI and New (and Not So New) PET Tracers – Hebert Alberto Vargas, MD\u003c\/li\u003e\n\u003cli\u003eMR Imaging of Pelvic Floor Disorders – Mukesh Harisinghani, MD\u003c\/li\u003e\n\u003cli\u003eGU Potpourri of Challenging Cases – Stuart G. Silverman, MD, FACR\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eAdvanced Topics in Breast\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eApproach to a Mammogram – Beyond the Basics – Michael J. Ulissey, MD, FACR\u003c\/li\u003e\n\u003cli\u003eApplications of AI in Breast MRI – Karla A. Sepulveda, MD\u003c\/li\u003e\n\u003cli\u003eDiffusion Weighted Imaging – Is It Ready for Primetime? – Bonnie N. Joe, MD, PhD\u003c\/li\u003e\n\u003cli\u003eTeaching Points in Patient Management – Michael J. Ulissey, MD, FACR\u003c\/li\u003e\n\u003cli\u003eInteresting Multi-Modality Breast Imaging Cases – Karla A. Sepulveda, MD\u003c\/li\u003e\n\u003cli\u003eMRI Safety – Bonnie N. Joe, MD, PhD\u003c\/li\u003e\n\u003cli\u003eBreast Imagers as Patient Advocates – Karla A. Sepulveda, MD\u003c\/li\u003e\n\u003cli\u003eInteractive MRI Case Review – Bonnie N. Joe, MD, PhD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eNeuroradiology\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eInflammatory and Infectious Disorders of the Spine – Erik Gaensler, MD\u003c\/li\u003e\n\u003cli\u003eFacial Swelling – Tabassum A. Kennedy, MD\u003c\/li\u003e\n\u003cli\u003eCystic Lesions of the CNS – James G. Smirniotopoulos, MD\u003c\/li\u003e\n\u003cli\u003eDental Disease – Harprit Bedi, MD\u003c\/li\u003e\n\u003cli\u003eLumbar Spine Update – Erik Gaensler, MD\u003c\/li\u003e\n\u003cli\u003eA Patterned Approach to White Matter Disease – Tabassum A. Kennedy, MD\u003c\/li\u003e\n\u003cli\u003eMeningioma and Dural Based Masses – James G. Smirniotopoulos, MD\u003c\/li\u003e\n\u003cli\u003eTemporal Bone Imaging – Harprit Bedi, MD\u003c\/li\u003e\n\u003cli\u003eIatrogenic Disorders of the CNS – Erik Gaensler, MD\u003c\/li\u003e\n\u003cli\u003eIs it a Pituitary Adenoma? – Tabassum A. Kennedy, MD\u003c\/li\u003e\n\u003cli\u003ePhakomatoses – James G. Smirniotopoulos, MD\u003c\/li\u003e\n\u003cli\u003eNeck Imaging – Focus on the Thyroid Gland and Lymph Nodes – Harprit Bedi, MD\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eCardiovascular Radiology\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eCT of Cardiac Masses: Pearls and Pitfalls – Elliot K. Fishman, MD\u003c\/li\u003e\n\u003cli\u003eCardiac CT: Imaging of Plaque, Stenosis and Flow – Nikhil Goyal, MD\u003c\/li\u003e\n\u003cli\u003eUpper Extremity CT Angiography – Geoffrey D. Rubin, MD\u003c\/li\u003e\n\u003cli\u003eVascular Applications of Ultrasound Contrast – John S. Pellerito, MD, FACR\u003c\/li\u003e\n\u003cli\u003eCardiac MRI: Patterns of Enhancement – Nikhil Goyal, MD\u003c\/li\u003e\n\u003cli\u003eCT Evaluation of Vasculitis: Key Findings – Elliot K. Fishman, MD\u003c\/li\u003e\n\u003cli\u003eCT Angiography of the Abdominal Aorta and Its Branches – Geoffrey D. Rubin, MD\u003c\/li\u003e\n\u003cli\u003eDifficult Carotid Case Review – John S. Pellerito, MD, FACR\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eDate of Original Release: March 15, 2022\u003c\/div\u003e\n\u003cdiv\u003eDate Credits Expire: March 15, 2025\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47490067202202,"sku":"MED-AMB01917","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/National-Diagnostic-Imaging-Symposium-2022.jpg?v=1772091431"},{"product_id":"oakstone-cytopathology-2022","title":"Oakstone Cytopathology 2022","description":"\u003cdiv class=\"product-gallery large-6 col\"\u003e\n\u003ch5 class=\"product-images relative mb-half has-hover woocommerce-product-gallery woocommerce-product-gallery--with-images woocommerce-product-gallery--columns-4 images\" data-columns=\"4\"\u003e\u003cspan style=\"color: #1b1919; font-size: 22px;\"\u003eLearn the Latest: Advances in Cytopathology CME\u003c\/span\u003e\u003c\/h5\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"woocommerce-product-gallery__image slide first\" data-thumb=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Oakstone-Cytopathology-2022_801bb679-d756-413c-a1d1-97b65a57b632.jpg?v=1772091592\" data-thumb-alt=\"\"\u003e\n\u003cbr\u003e\u003cbr\u003eOakstone Cytopathology 2022 This online CME program, led by Christopher J. VandenBussche, MD, PhD, focuses on recent developments in modern diagnostic cytopathology and reviews important cytopathology concepts according to specimen type. It's geared towards those who may not have formal cytopathology training, covering classic cytomorphology, common pitfalls, and updates on reporting systems such as The Paris System for Reporting Urinary Cytology.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eIn \u003cem\u003eMasters of Pathology Series – Cytopathology\u003c\/em\u003e, experts present short, high-yield continuing medical education lectures that help you to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify ancillary lung specimen tests needed when a new diagnosis of non-small cell carcinoma is made\u003c\/li\u003e\n\u003cli\u003eDescribe changes in the newest version of The Bethesda System for Reporting Thyroid Cytopathology\u003c\/li\u003e\n\u003cli\u003eUnderstand situations in which a SUMP diagnosis can be made\u003c\/li\u003e\n\u003cli\u003eRecognize the cytomorphologic features of common bone and soft tissue tumors on fine needle aspiration\u003c\/li\u003e\n\u003cli\u003eCompare different methodologies used for HPV testing\u003c\/li\u003e\n\u003cli\u003eAnd more…\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"woocommerce-product-gallery__image slide\" data-thumb=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Oakstone-Cytopathology-2022_801bb679-d756-413c-a1d1-97b65a57b632.jpg?v=1772091592\" data-thumb-alt=\"\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"product-gallery large-6 col\"\u003e\n\u003cdiv class=\"product-thumbnails thumbnails slider-no-arrows slider row row-small row-slider slider-nav-small small-columns-4\" data-flickity-options=\"{ \"\u003e\n\u003cdiv class=\"col is-nav-selected first\"\u003e\u003ca\u003e\u003cimg alt=\"\" class=\"attachment-woocommerce_thumbnail lazyload\" height=\"100\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Oakstone-Cytopathology-2022_801bb679-d756-413c-a1d1-97b65a57b632.jpg?v=1772091592\" width=\"100\"\u003e\u003cimg alt=\"\" class=\"attachment-woocommerce_thumbnail\" height=\"100\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Oakstone-Cytopathology-2022_801bb679-d756-413c-a1d1-97b65a57b632.jpg?v=1772091592\" width=\"100\"\u003e\u003c\/a\u003e\u003c\/div\u003e\n\u003cdiv class=\"col\"\u003e\u003ca\u003e\u003cimg alt=\"\" class=\"attachment-woocommerce_thumbnail lazyload\" height=\"100\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Oakstone-Cytopathology-2022_801bb679-d756-413c-a1d1-97b65a57b632.jpg?v=1772091592\" width=\"100\"\u003e\u003cimg alt=\"\" class=\"attachment-woocommerce_thumbnail\" height=\"100\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/Oakstone-Cytopathology-2022_801bb679-d756-413c-a1d1-97b65a57b632.jpg?v=1772091592\" width=\"100\"\u003e\u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cstrong\u003e+ Include: 47 videos + 2 pdfs, size: 13.6 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: pathologists needing to improve their understanding and confidence in the diagnosis of cytopathology specimens\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch1\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003eIntroduction: The Changing Cytopathology Landscape – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Bethesda System for Reporting Thyroid Cytopathology, Third Edition – \u003cem\u003eSyed Z. Ali, MD, FRCPath, FIAC\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThyroid Cytomorphology Part I – \u003cem\u003eDaniel Lubin, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThyroid Cytomorphology Part II – \u003cem\u003eDaniel Lubin, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMolecular Testing in Thyroid FNA Specimens – \u003cem\u003eMichiya Nishino, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Thyroid FNA Cases – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Milan System for Reporting Salivary Gland Cytopathology Second Edition – \u003cem\u003eWilliam C. Faquin, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSalivary Gland Cytology – Common, Uncommon, and Challenging Cases – \u003cem\u003eZahra Maleki, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eFNA of Laeral Neck Lesions – A Case-Based Approach – \u003cem\u003eDarcy A. Kerr, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Cases – Head and Neck FNA Specimens – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eApproach to Liver Cytopathology and Small Biopsies – \u003cem\u003eM. Lisa Zhang MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe WHO System for Reporting Pancreaticobiliary Cytology – \u003cem\u003eMartha Bishop Pitman, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe FNA of Solid Lesions of the Pancreas – \u003cem\u003eMonica T. Garcia-Buitrago, MD, FCAP\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eApproach to the Diagnosis of Pancreatic Cysts – \u003cem\u003eM. Lisa Zhang, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Pancreas FNA Cases – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe International System for Reporting Serous Fluid Cytopathology – \u003cem\u003eAshish Chandra, FRCPath, DipRCPath (Cytol)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePleural Fluid Specimens – Malignant Tumors and Mimickers – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePelvic Washing Specimens – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Pelvic Washing Cases – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe WHO International System for Reporting Soft Tissue Cytopathology – \u003cem\u003eVickie Y. Jo, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSoft Tissue FNA – A Pattern-Based Approach – \u003cem\u003eVickie Y. Jo, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSoft Tissue Cytopathology – An Update on Immunohistochemical Markers – \u003cem\u003eVickie Y. Jo, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eFine Needle Aspiration of Bone Tumors – Lesions that May Actually Cross Your Desk – \u003cem\u003eValerie A. Fitzhugh, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSoft Tissue FNA Cytology – Lesions Most Likely to Cross Your Desk – \u003cem\u003eValerie A. Fitzhugh, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Sydney System for Classification and Reporting Lymph Node Cytopathology – \u003cem\u003eOscar Lin, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eLymph Node Cytology – A Case Based Approach in Small Biopsies – \u003cem\u003eSara E. Monaco, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCerebrospinal Fluid and Vitreous Fluid Specimens – \u003cem\u003eCheng-Ying Ho, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eGynecologic Cytology – Human Papillomavirus Biology and Testing in Pap Test Specimens – \u003cem\u003eMichael J. Thrall, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eGynecologic Cytology – ASCCP Guidelines and the Role of Cytology in Screening – \u003cem\u003eMichael J. Thrall, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eSquamous Lesions in Gynecologic Cytology – \u003cem\u003eDonna Russell, CT (ASCP)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eGlandular Lesions and Rare Lesions in Gynecologic Cytology – \u003cem\u003eDonna Russell, CT (ASCP)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eChallenging GYN Unknown Cases – \u003cem\u003eDonna Russell, CT (ASCP)\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCytology of Non-Small Cell Lung Carcinoma: Does Morphology Matter? – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eLung Tumors Other Than Non-Small Cell Lung Carcinoma – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eAncillary Testing in Non-Small Cell Lung Carcinoma: Why, When and How to Perform? – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNon-Neoplastic Pulmonary Cytology: Bugs, BALs, and Beyond – \u003cem\u003ePeter Illei, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eKidney Fine Needle Aspiration and Small Biopsy Specimens I – \u003cem\u003eMadelyn Lew, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eKidney Fine Needle Aspiration and Small Biopsy Specimens II – \u003cem\u003eMadelyn Lew, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eIntroduction to the Yokohama System – \u003cem\u003eGary M. Tse, MBBS\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eChallenging Cases in Breast Cytology – \u003cem\u003eChristine Noga Booth, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Paris System for Reporting Urinary Cytology – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eBenign and Reactive Findings in Urine Specimens – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNeoplastic Findings in Urine Specimens – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eInstructive Urine Cytology Cases – \u003cem\u003eMadelyn Lew, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eMiscellaneous FNA Challenge Cases – \u003cem\u003eChristopher J. VandenBussche, MD, PhD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCommonly Missed Cytopathology CAP Checklist Items I – \u003cem\u003eSana Tabbara, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eCommonly Missed Cytopathology CAP Checklist Items II – \u003cem\u003eSana Tabbara, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47490079490202,"sku":"MED-AMB01927","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/single-topic-cytopathology__15410_2.jpg?v=1772091603"},{"product_id":"uscap-diagnostic-challenges","title":"USCAP Diagnostic Challenges in Urologic Pathology 2024","description":"\u003csection class=\"content\" tabindex=\"0\"\u003e\n\u003cdiv class=\"description\" data-role=\"course-description\"\u003e\n\u003cstrong\u003eUSCAP Diagnostic Challenges in Urologic Pathology 2024\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eJoin internationally recognized urological pathologists as they lead you through cases on new entities and other difficult tumors. Faculty will discuss new and modified grading and staging criteria, reporting requirements, and new diagnostic tools and roles of pathologists in precision patient management.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003ch2\u003e16 MP4 + 8 PDF Files\u003c\/h2\u003e\n\u003cdiv class=\"description\" data-role=\"course-description\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"single-main-content\"\u003e\n\u003cstrong\u003erelease date: \u003c\/strong\u003eFebruary 20, 2024\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003ePracticing academic and community pathologists, and pathologists-in-training\u003cbr\u003e\u003cbr\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eTo distinguish benign mimickers from neoplasia in GU system\u003c\/li\u003e\n\u003cli\u003eTo learn the diagnostic approaches to difficult common and uncommon urologic lesions\u003c\/li\u003e\n\u003cli\u003eTo correctly apply new and modified staging criteria for GU cancers\u003c\/li\u003e\n\u003cli\u003eTo learn new reporting requirements for GU tumors\u003c\/li\u003e\n\u003cli\u003eTo recognize emerging urologic tumor entities with important clinical implications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003eTopics\u003c\/h1\u003e\n\u003csection class=\"main-container\" id=\"main-container\"\u003e\u003csection class=\"course\" data-id=\"63227\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection\u003e\u003csection class=\"included\" data-role=\"course-items-list\"\u003e\n\u003cdiv class=\"media ui-sortable\" data-parent=\"course\" id=\"63227\"\u003e\n\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"649510\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/649510\" data-updated-at=\"2024-02-28 00:03:26 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ch3\u003eKidney Pathology – Ming Zhou, MD, PhD\u003c\/h3\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"649511\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/649511\" data-updated-at=\"2024-02-28 00:03:26 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\"\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"state-notices-block\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 20.16px;\"\u003eProstate Pathology – Adeboye Osunkoya, MD \u003c\/span\u003e\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"649512\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/649512\" data-updated-at=\"2024-02-28 00:03:26 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\"\u003e\u003c\/div\u003e\n\u003cul\u003e\n\u003cli class=\"state-notices-block\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 20.16px;\"\u003eTesticular Pathology – Michelle Hirsch, MD, PhD \u003c\/span\u003e\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"649515\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/649515\" data-updated-at=\"2024-02-28 00:03:26 UTC\" role=\"link\"\u003e\n\u003cul\u003e\n\u003cli class=\"state-notices-block\"\u003e\u003cstrong\u003e\u003cspan style=\"font-size: 20.16px;\"\u003eBladder Pathology – Manju Aron, MD \u003c\/span\u003e\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47490089844890,"sku":"MED-AMB01935","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/USCAP-Diagnostic-Challenges-in-Urologic-Pathology-2024.png?v=1772091739"},{"product_id":"2023-classic-lectures-in-pet-ct-imaging","title":"2023 Classic Lectures in PET\/CT Imaging – A CME Teaching Activity","description":"\u003csection class=\"content\" tabindex=\"0\"\u003e\n\u003cdiv class=\"description\" data-role=\"course-description\"\u003e\n\u003cp class=\"product-title product_title entry-title\"\u003e2023 Classic Lectures in PET\/CT Imaging – A CME Teaching Activity This CME activity brings together some of our most popular lectures in PET and PET\/CT imaging. Basic to advanced applications of PET and PET\/CT are put in the context of disease detection and treatment planning. Faculty share techniques, tips and pitfalls through case-based presentations.\u003c\/p\u003e\n\u003cbr\u003eThis CME activity should benefit radiologists, oncologists, and nuclear medicine physicians. The course should also prove valuable for physicians who order these studies.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003ch3\u003eCategories Radiology, Nuclear Medicine, Oncology, Radiation Oncology\u003c\/h3\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eRelease Date October 15 2023\u003c\/h4\u003e\n\u003ch4\u003eTopics under this Course\u003c\/h4\u003e\n\u003ctable style=\"height: 1214px;\" width=\"654\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT Techniques and Reporting Principles\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eErik S. Mittra, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT Neurodegenerative Diseases\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eGagandeep Choudhary, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Coronary Disease and Cardiac Sarcoidosis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eMark I. Travin, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT for Non-Neurodegenerative Diseases\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eGagandeep Choudhary, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Head and Neck Cancer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eDon C. Yoo, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Thyroid Cancer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eMark Tulchinsky, M.D., FACNM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Lung Cancer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eDon C. Yoo, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Malignancy of the Breast and Female Pelvis\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eKatherine Zukotynski, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eQualitative and Quantitative Response Criteria\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eErik S. Mittra, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Infection and Inflammation Imaging\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eDon C. Yoo, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Theragnostics\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eErik S. Mittra, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eGa-68 and Lu-177 DOTATATE in Neuroendocrine Tumors\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eKatherine Zukotynski, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Lymphomas\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eMark Tulchinsky, M.D., FACNM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Prostate Cancer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eErik S. Mittra, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Skeletal Tumors: Primary and Metastatic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eKatherine Zukotynski, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET\/CT in Cancers of the Skin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eMark Tulchinsky, M.D., FACNM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003ePET – Tumor and Whole Body Imaging\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eEdwin L. Palmer, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eEndocrine Radionuclide Imaging\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eCarl K. Hoh, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eCNS Radionuclide Imaging\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eCarl K. Hoh, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eCardiovascular Radionuclide Imaging\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"430\"\u003eEdwin L. Palmer, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":47490091352218,"sku":"MED-AMB01936","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/2023-Classic-Lectures-in-PET-CT-Imaging-_E2_80_93-A-CME-Teaching-Activity.png?v=1772091758"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/collections\/61.jpg?v=1772058815","url":"https:\/\/ambosscourse.com\/collections\/hematology-oncology.oembed","provider":"Amboss","version":"1.0","type":"link"}